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Abstract 
This thesis describes the development of the 4-bromobenzylsulphonyl (4-
Bbs) group as an enzymatically cleavable protecting group for the side chain of 
arginine. The protected arginine was utilised to synthesise RGD peptidcs both 
with and without a spacer arm and these peptides were incorporated into 
hydrogels. Hydrogels were made from 1,2-propandiol-3-methacrylate (glycerol 
methacrylate, GM MA) or butyl methacrylate (BMA) and 1,2-ethandiol 
dimethacrylate (ethylene glycol dimethacrylate, EGDMA) and photopolymerized 
as 60~m coatings. Removal of the 4-Bbs protecting group was achieved by 
incubation with the enzyme Glutathione-S-Transferase. 
Culture of human dermal fibroblasts on the materials showed significant 
improvements in cell adhesion and viability in serum free media on glycerol 
methacrylate hydrogels with nominal RGD concentrations of 1 ~mol/g or greater. 
A spacer arm between the peptide and the bulk was not necessary to promote cell 
attachment. No significant improvement in cell adhesion and viability to butyl 
methacrylate hydrogels was observed at any of the peptide concentrations tested. 
The effects of peptide concentration, GST pre-treatment of materials, cell 
passage number and culture with soluble RGD were investigated by examining 
cell morphology, adhesion, viability and F-actin organisation. 
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1 Aims and Hypotheses 
Novel biomaterials that come into contact with anchorage dependent cells 
can be divided into two general groups, those that are intended to support the 
attachment of the cells and those that are designed to resist the attachment. Of the 
materials where it is desirable to support the attachment of cells there are two 
main types, those that possess functionalities that bind directly to cells and those 
that rely upon protein adsorption and subsequent binding of the proteins to cells. 
The adhesion of proteins to materials allows the direction of cell 
attachment and growth by the non-specific adsorption of a wide range of proteins 
from serum in the media and / or cell derived products. The non-specific 
adsorption of proteins has the advantage that cells perceive an environment 
where they have access to a large range of growth factors and signalling 
mechanisms to promote normal cell behaviour. The disadvantages are that the 
processes are improperly understood and therefore the results may be variable. 
Also non-specific adsorption removes the ability to control and direct cell growth 
and functions into areas dictated by the needs of tissue engineering. In addition 
the use of serum from animal sources is controversial as there are possibilities of 
viral transfection. 
Functionalised biomaterials have the potential to direct cell growth and 
behaviour. These attributes may make it possible to encourage better integration 
of implantable biomaterials and improve the culture of cells in vitro without the 
use of serum. Background materials that resist protein adsorption allow materials 
with well-defined and controllable properties. However the resistance of a 
substrate to protein adsorption may result in cells being unable to access 
necessary growth factors or signalling mechanisms. 
Peptides containing the sequence ROD are known to bind to integrins and 
to promote the adhesion of cells to biomaterials in which they are incorporated. 
Different flanking sequences affect the degree of affinity of the peptide for 
different integrins leading to the ability to confer selectivity onto the material, for 
example some cyclic ROD containing peptides can only bind to integrins found 
in osteoblast cells. However most cell types do not possess an integrin by which 
selective adhesion can be mediated such that in the majority of cases wherein 
ROD is utilised it is in a non-selective manner. This gives rise to a number of 
questions on the usefulness of ROD peptides: 
1. If the adhesion of cells to the substrate is non-integrin selective is there value 
to be obtained in combining the two strategies of supporting cell adhesion, 
namely in promoting cell adhesion by ROD and supporting cell functions by 
protein adsorption to the substrate? 
2. Does the ability of ROD to promote cell adhesion hold in the case where 
protein adsorption is present, i.e. are the processes competitive or 
cumulative? 
3. Does the use of ROD peptides confer any value on the substrate that is not 
obtainable by protein adsorption? 
In summary "Is the incorporation of ROD peptides into polymeric 
biomaterials a useful tool for promoting non-selective cell adhesion for tissue 
engineering purposes?" 
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Hypotheses 
The processes of cell adhesion to substrates via protein adsorption and 
RGD modification will be competitive. On materials that are not able to 
effectively mediate cell attachment by protein adsorption the inclusion of RGD 
will result in a large increase in cell attachment. On substrates that are better able 
to support cell attachment by protein adsorption the inclusion of RGD will cause 
an improvement in cell attachment but the magnitude of the improvement will be 
less than on the poorly adhesive materials. On substrates that are able to support 
high levels of cell attachment by protein adsorption the inclusion of RGD will 
not improve cell attachment. A hypothetical model of how the incorporation of 
an RGD peptide would improve the ability of substrates to adhere cells is shown 
in Figure 1-1. 
--Without Peptide 
With Peptide 
extent of 
improvement 
Non-improvement point 
Affinity of Non-modified Substrate for Protein Adsorption 
Figure 1-1 Hypothetical model of how the incorporation of an RGD peptide would improve 
the ability of substrates to adhere cells. 
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4. If the nature of the peptide and the concentration and type of integrins are 
kept constant the extent of improvement and the non-improvement point will 
depend on the concentration of the peptide. With a higher peptide 
concentration the extent of improvement will increase and the non-
improvement point will be advanced such that peptide inclusion will provide 
improvement at higher intrinsic level of cell attachment as illustrated in 
Figure 1-2. 
,--------------------------~.--~- --------
--Without Peptide 
large 
improvemen 
With Low Peptide Concentration 
With High Peptide Concentration 
1 
\ moderate I imp,""m," 
\ 
Non-improvement point at higher 
level of native cell adhesion ~ith 
high peptide concentration 
Non-improvement point at 
lo\\Cr level of nat ive cell adhesion 
~th lowpeptidc concentration 
Affinity of Non-modified Substrate for Protein Adsorption 
Figure 1-2 Hypothetical model of how the incorporation of an RGD peptide would improve 
the ability of substrates to adhere cells at low and high concentrations of peptide. 
5. The extent of improvement and the non-improvement point will be advanced 
by increased integrin binding. Increased integrin binding can be achieved 
through use of more affine ligands, use of cells with greater integrin density 
or use of cells wherein the integrin type has a greater affinity for the peptide 
utilised. 
6. The effectiveness of the inclusion of a ROD peptide will decrease with time 
as a surface becomes remodelled and supports greater protein adsorption. 
If these hypotheses are proved correct there are several implications for 
the use of ROD in substrates designed for tissue engineering purposes: 
4 
1. RGD incorporation will only be an effective strategy in materials that do not 
adsorb proteins to a significant degree. 
2. Higher concentrations of peptide will be more effective at promoting cell 
adhesion in the same substrate. The minimum concentration of peptide 
required to elicit a significant effect will increase as the ability of a substrate 
to adsorb proteins increases. 
3. The effectiveness of the inclusion of an RGD peptide will decrease with 
increasing passage number for primary cells. The integrin expression profile 
of a cell type will determine how effective ROD inclusion will be. The use of 
RGD peptides that are more affine to a particular cell type will promote a 
larger improvement and allow the use of smaller peptide concentrations to 
achieve a significant effect. 
4. The inclusion of RGD peptides will be effective at promoting short term 
adhesion but will not be an effective strategy for long-term cell survival and 
normal functioning without the ability for the background substrate to adsorb 
proteins. The inclusion of RGD peptides may be an effective strategy in 
combination with other functionalities such as growth factors that promote 
the normal behaviour of cells in different aspects other than the short term 
integrin-mediated cell attachment. 
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2 Definitions and Abbreviations 
These definitions are used in this text for purposes of clarity for a current 
and future interdisciplinary readership. 
• Modification: any procedure in which a peptide-containing species is 
chemically attached to a pre-existed material in situ 
• Incorporation: any procedure in which a peptide-containing species is 
chemically attached to a substrate as that substrate is being formed 
• Coating: any procedure wherein the peptide-containing species is not 
chemically attached to a material in situ 
• Blend: a coating procedure where an ROD-containing specIes IS 
incorporated into a material as it being formed by non-covalent means. 
• Coupling reagent: any species that mediates the attachment of the 
peptide without leaving a residue in the final product. 
• Cross-linker: any species that mediates the attachment of the peptide 
and leaves a residue in the final product. 
• Specificity / specific: effects caused by the binding of ROD to intcgrins 
rather than through other mechanisms e.g. protein adsorption. 
• Selectivity / selective: effects caused by the binding of an ROD 
sequence to a particular integrin type 
• Scrambled ROD peptide: a peptide sequence of any length that contains 
arginine, glycine and aspartic acid next to each other but not in the 
correct ROD sequence to form an active peptide 
• Substituted RGD peptide: a peptide sequence of any length that contains 
a tripeptide sequence similar to ROD that has one of the amino acids 
substituted with another that is similar in structure to form a non-active 
sequence 
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Abbreviation Full name 
AA ACl}'lic acid 
AIBN Azobisisobutironitri le 
BMA Butyl methacrylate 
BSA Bovine serum albumin 
CIPAAM 2-carboxyisopropylacrylamide 
DCC Di~lcohexy1carbodiimide 
DIPEA Diis~r~lethylamine 
DMAEM Dimethyl aminoethyl methacrylate 
DMAP 4-dimeth-.YJaminopyridine 
DMF Dimethyl formamide 
DMSO Dimeth-.YJ sulphoxide 
DVB DiviTlyl benzene 
EDC l-ethyl-3-(3-dimethy lam inopropyl )carbodi imide 
EGDMA 1,2-ethandiol dimethacrylate, 
Et1!Y..lene glycol dimethacrylate 
ELISA Enzyme-linked immunosorbent assay 
GMMA 1,2-propandiol-3-methacrylate, 
GlYcerol mono methacrylate 
GSH Reduced glutathione 
GST Glutathione-S-Transferase 
HBTU 2-(1 H-Benzotriazole-l-yl)-l, 1 ,3,3-tetramethyluronium 
hexafluoro~hosphate 
HOBt N -H-'ydrox-'ybenzotriazole 
HPLC High performance liquid chromatography 
LC-SPDP N-succinimidyl-6-(3-[2-pyridyldithio ]-
pro~ionamido )hexanoate 
LMA 
Lau!yl methacrylate 
MES 2-Mo~holinoethanesulfonic acid 
MSNT 1-(Mesitylene-2-sulfony1)-3-nitro-l H-l ,2,4-triazole 
NHS N-hydroxy succinimide 
NHS N-l}ydroxy succinimide 
NIPAAM N-iso~roylacrylamide 
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NIPAM or NIP AAM N-isopropyl acrylamide 
NMR Nuclear magnetic resonance 
OWLS Optical waveguide lightmode spectroscopy_ 
PBS Phosphate buffered saline 
PCS Peptide-containing species 
PEG Poly ethylene glycol 
PET Polyethylene terephthalate 
PLGA Poly(L-glycolic acid) 
PLLA Poly(L-lactic acid) 
PTFE Po lytetrafluoroethylene 
PyBOP Benzotriazole-I-yl-oxy-tris-pyrrolidino-phosphonium 
hexafluorophosphate 
RGD Arginine-Glycine-Aspartic Acid or longer peptide 
sequence containing this active moiety 
SAM Self-assembling monolayer(s) 
SANPAH N-Succinimidyl-6-[ 4' -azido-2' -nitrophenylamino] 
hexanoate 
5MBP N-succinimidYI-4p-maleimidophenyl-butirate 
SMCC N-succinimidyl trans-4-
(maleimid}'1methyl)cylcohexane-I-carboxylate 
SMP N-succinimidyl-3-maleimidopropionate 
SPDP N-succinimidyl-3-(2-pyridyldithio )-propionate 
TCP Tissue culture plastic 
TsU N,N,N' ,N' -tetramethyl(succinimido )uranium 
tetrafluoroborate 
UV Ultra-violet 
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3 Introduction 
-
3.1 Biomaterials for Tissue Engineerin2 
The use of cell culture for standard applications is well established but 
most techniques are based on the "cell-derived matrix model" where the 
substrate only provides sufficient attachment for the cells to produce their own 
extra-cellular matrix. The culture of cells on these substrates generally results in 
rapid growth but the replication ceases upon contact such that the cells form, at 
best, monolayer coverage of the substrate rather than the three-dimensional 
matrixes of natural tissue 1,2. In addition many of the natural functions of cells are 
lost or altered once they are removed from their native environment such as 
protein secretion, respiratory capacity and other functions such as the internal 
potassium levels. There is also a growing awareness of the need to reduce the 
amounts of animal derived products, such as fetal calf serum, in tissue 
engineering to minimise the risks of infection. In consequence there is a 
considerable interest in producing materials that can modulate and direct the 
functions of cells for use in tissue engineering. 
3.1.1 Requirements for Biomaterials 
The requirements of a material intended for use in tissue engineering vary 
dramatically depending on the specific purpose for which they are intended. 
Areas that are currently being investigated as targets for tissue engineering 
include skin, cartilage, bone, vascular, nerve and liver regeneration3.5. 
The physical properties that may be of importance include strength (yield, 
tensile, compressive, shear, flexural, fatigue, impact and adhesion), resistance 
(creep, friction, wear, fatigue, abrasion), elastic modulus, shear modulus, 
stiffness and hardness. Other physical properties may become important in 
specific applications, for example colour, opacity and refractive index become 
important in the production of artificial comeas6• The biological properties that 
may be of importance include lack of adverse effects (non-toxic, non-irritant, 
non-allergenic, non-carcinogenic, non-thrombogenic)7, the promotion of 
beneficial effects (cell adhesion, migration, growth and differentiated function)8 
and the interaction of the material with its surroundings (protein adsorption, 
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initiation of immune response and biodegradation). Chemical properties include 
biostability (resistance to corrosion, hydrolysis and oxidation) and 
biodegradation and the chemical composition both in bulk and at the surface 
affects the physical and biological properties9• In addition the processing and 
fabrication of the material must be considered in terms of reproducibility, quality 
and sterilizabilitylO. 
The tissue engineering of skin poses a simpler challenge than that of most 
other tissues, as the structure is a sheet rather than a 3D structure. Serious 
damage to the skin, which affects the dermal and sub dermal layers of the skin as 
well as the upper epidermal layer, can cause many problems such as severe 
dehydration and infection. The body cannot heal these multi-layer wounds 
properly and grafting is required to replace the skin. Auto grafting is problematic 
as the donor site becomes a new wound and finding a donor site can be difficult 
when the area of damage is extensive. Disease transmission and adverse immune 
responses are problems with cadaver skin grafting and xenografting techniques. 
Consequently a large number of researchers are working towards therapies that 
regenerate or help the body to regenerate the dermis, epidermis or full-thickness 
of skin. 
3.1.2 Approaches to Tissue Engineering 
The development of novel materials for cell culture and tissue 
engineering has been a fertile area of research with many different approaches 
being taken to increase the effectiveness of the substrate. The only common 
factor that links the various researches into materials designed for tissue 
engineering is the stipulation that the products that come into contact with cells 
must be non cytotoxic and provide a solid support for the attachment of cells. 
The approaches that are used to encourage cell adhesion are varied and make use 
of a wide range of materials that impart varying properties to the substrate. 
For the purposes of tissue engineering with anchorage dependent cells the 
material used as the substrate must be a solid for the duration of the time that 
cells are in contact with it. Some polymers can be utilised in liquid form, to allow 
injection of material or encapsulation of cells and later solidifiedll ,12. Other 
polymers may originally be solid but degrade under physiological conditions thus 
leaving a space for replacement tissue 13• 
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Amphiphilic polymers mImIC the extracellular matrix's material 
properties and high water content. The cell adhesion is controlled by adsorbed 
proteins, which are in turn regulated by the surface properties of the polymer 
network I4-17. Studies have shown that both the degree of adsorption and the 
conformation of the protein are directed by the surface's properties l5,16. Increased 
hydrophilicity of the surface (determined by contact angle)14 and increased bulk 
hydration (water content)17 decrease the extent of protein adsorption and hence 
the utility of the material as a cell culture substrate. However there is evidence 
that a minimum hydration is necessary to allow cell adhesion and that polar 
groups contained in networks with low hydration (caused by extensive cross-
linking) increase the amount of protein adsorption 17. The amount of an adsorbed 
protein does not determine the extent of the biological activity. A protein that has 
been adsorbed in low concentrations may present more favourable conformations 
for an increased percentage of protein bound to integrins or an increased binding 
strength 16. 
Glass, metals and some polymers are static systems where the surfaces 
are fixed into place. Polymers are often highly solvated under culture conditions 
and can possess very mobile chains that can dynamically re-arrange under 
changing conditions (e.g. on hydration to cell culture conditions). The dynamic 
nature of the surface may affect the adsorption of proteins and the ability of cells 
to adhere to a substrate. 
Another strategy utilised to increase the effectiveness of materials used 
for tissue engineering is to include peptide sequences with active moieties to 
promote some aspect of cell behaviour. The tripeptide sequence Arginine-
Glycine-Aspartic acid (RGD) is often used to promote cell attachment and 
spreading as it binds to transmembrane proteins called integrins that are found in 
most mammalian cells. The integrins contain two receptor sites that bind to a 
peptide adhesion sequence outside the cell membrane and to the protein talin on 
the internal side of the cell membrane. Talin is in turn linked to actin filaments of 
the cell via the protein vinculin such that the binding of the adhesion sequence 
induces a change in the conformation of the cytoskeleton to promote cell 
adhesion and spreading. The adhesion of cells to substrates affects other cellular 
characteristics and mechanisms (for example migration and protein expression) 
I I 
such that the binding of integrins to RGD peptides can affect many different 
aspects of cell behaviour. 
3.1.3 Types of Materials used for RGD Modification 
The processing of materials can generate different shapes and forms such 
as sheets, membranes, spheres l8•19 and three-dimensional structures. Of 
considerable interest is the production of three-dimensional scaffolds to aid the 
development of vascularisation 20, cellular in-growth and three-dimensional tissue 
structure21 . In addition these 3D scaffolds can be utilized as in vitro models of 
tissue and to study relationships between structure and function 22. Examples of 
3D scaffolds that have been functionalised with RGD include chitosan23 , 
poly(D,L-lactide-co-glycolide)24.26, fibrin 27 and collagen28. The 3D nature of the 
scaffold can be developed through foaming, freeze gelation23 and electro-
spinning of linear polymers26. Some images of 3 dimensional structures that can 
be formed from polymers for use in cell culture can be found in Figure 3-1 
below. 
Figure 3-1 Left: Morphology of the chitosan scaffold prepared by the freeze gelation 
method (SEM, x200) after RGDS immobilization, reproduced from Ho et al t •23, Right: 
Scanning electron micrograph showing the porous structure of PLLA scaffolds (surface 
view), reproduced from Hsu et al. 2006:.24 
Also of interest is the encapsulation of cells as the material is formed by 
photo-polymerisation27.29.37, this poses challenges in that the precursors must be 
non-cytotoxic and the material must be formed under sterile conditions38 • 
t Reproduction of Figure 1 from "Ho, M.-H., Wang, D.-A ., Hsieh, H.-J., Liu, H.-C., Hsien, T.-
Y., Lai, J.-Y. & Hou, L.-T. Preparation and characterization of ROD-immobilized chitosan 
scaffolds. Biomaterials 26, 3197-3206 (2005)", with pennission from EIsevier Ltd. 
t Reproduction of Figure 2 from "Hsu, S.-H., Chang, S.-H., Yen, H .-J., Whu, S. W., Tsai, c.-L. 
& Chen, D. C. Evaluation of Biodegradable Polymers Modified by Type IT Col1agen and Arg-
Gly-Asp as Tissue Engineering Scaffolding Materials for Cartilage Regeneration. ArtifiCial 
Organs 30, 42·55 (2006)", with pennission from Blackwell Publishing. 
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All background materials modified with bioactive functionalities are 
required to be biocompatible, which effectively means that they must all exhibit 
a lack of adverse effects at the site of application during the timescale of their 
use
39
• In addition the substrate can be either bioinert or bioactive. Substances that 
are desired to be bioinert are required to have as little effect on the biological 
system as possible and to resist protein deposition and remodelling of the 
surface. These materials are often derivatised with RG 0 peptides and are 
generally intended to investigate the pathways of specific RGD-mediated cell 
adhesion40 or in situations where non-specific adhesion is a problem such as re-
endothelialisation in vivo41. Bioactive materials can interact with the biological 
system either directly through chemical groups on the surface or indirectly (by 
protein deposition). In some cases the substance that provides the mechanical 
properties may be completely masked by modifications or coatings. 
The types of materials that fit requirements for tissue engineering and are 
most often used with RGD-peptides fall into two main categories, polymers and 
inorganic materials. 
The polymers utilised in tissue engineering can be derived from natural 
sources or can be made synthetically. Some examples of naturally derived 
polymers that have been modified with the RGD-peptide are albumin, alginate, 
cellulose, chitosan, collagen, dextran, gelatin, glycosaminoglycan, fibrin, 
halouronic acid, keratin and streptavidin23.36,42-51 ,52,53. 
There is a large amount of literature related to RGD-containing synthetic 
polymers, which may be linear, branched, or cross-linked. Linear and branched 
polymers are usually mounted onto a suitable substrate, such as tissue culture 
plastic or glass, before assessment as their physical properties are not generally 
suitable for handling without support. There are two main methods of 
synthesizing polymers: step-growth polymerisation and chain growth 
polymerisation. 
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The backbone of polymers synthesised by step-growth polymerisation are 
most commonly formed of ester, amide, or urethane bonds as shown in Figure 
3-2. 
Ester Amide Urethane 
Figure 3-2 Common backbone linkages of step-growth polymers 
Examples of esters include polyester54, poly(lactic acid)55, poly(lactic-co-
glycolic acid)56 and poly(caprolactonei7-59. Examples of ami des include poly (L-
Lysine)60. Examples of urethanes include polyurethane6J -63, polycarbonate 
urethane64.65 and polyether urethane66. 
Chain growth polymers are synthesised by the use of an initiator to 
instigate the formation of the chain. These initiators may be free-radical, cationic 
or anionic depending on the choice of monomer and desired properties of the 
resultant polymer. In addition the initiator may be activated by heat, 
electromagnetic radiation, or chemical reaction. Some monomers that are used to 
make chain growth polymers that have been utilised as RGD-containing 
biomaterials include acrylic acrylamide68-72, N-
isopropylacrylamide I8,32,33,73-76, methyl methacrylate 77-80, hydroxyethyl 
methacrylateS1 ,82, hydroxypropyl methacrylateS3-S5, aminoethyl methacrylate J8, 
vinyl alcohol86, ethylene glycol vinyl ether87 and styrene (as in tissue culture 
polystyrene )S8-93. The most utilized synthetic polymer appears to be 
poly(ethylene glycol) (PEG) with at least 30 articles published using this 
polymer as one of the components I8,30-34,40,41,55.80,8J,94-115. PEG can be obtained 
with various chain lengths (and hence various molecular weights) and also can be 
derivatised with various end groups such as acrylates31.41.98,99, amines80.105 and 
carboxylic acids. 
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Inorganic materials that have been derivatised with RGD-peptides include 
glass, ceramic, metals and inorganic polymers. Metals that have been either 
coated with or had the peptide sequence attached to them include titanium 116-119 
and goldl\8. Inorganic polymers including silicon 120, silicone l21 and 
alumina122membranes have been utilised for ROD-modification. Glass has been 
frequently derivatised with RGD peptides I23- 127,128-131 ,\32, 
3.1.4 Protein Adsorption on Biomaterials 
The responses of cells cultured on biomaterials in vitro or in contact with 
biomaterials in vivo is controlled or affected by the adsorption of proteins on the 
surface. In the majority of cases materials being investigated or utilised in vivo 
are exposed to a wide range of proteins from serum in media, cell-derived 
proteins or body fluids such as blood or plasma. The roles and mechanisms of 
each of these proteins in controlling cell behaviour singly and in combination are 
still under investigation by researchers however there are several families of 
proteins that are known to promote cell adhesion to extracellular matrix or to 
other cells. 
3.1.4.1 Adhesion Proteins 
Cells produce surface proteins called CAMs that regulate the adhesion of 
cells to other cells of the same type (homophilic adhesion), to cells of a different 
type (heterophilic adhesion) or to the extracellular matrix. There are 5 principal 
classes of CAMs: cadherins, the immunoglobulin (Ig) superfamily, selectins, 
mucins, and integrins. 
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Figure 3-3 Major Families of Cell Adhesion Molecules 
Cadherins are trans-membrane proteins that are believed to mediate 
homophilic cell adhesion by forming a parallel homodimer with another cadherin 
molecule133 . The binding of cadherins is Ca2+ dependent and the calcium binding 
ridifies the cadherin molecule and expose residues that form the dimer. 
N-CAMs are part of the immunoglobin family of proteins and, like 
cadherins, promote homophilic cell-cell adhesion. N-CAMs contain variou 
amount of sialic acid chain which weaken the binding of N-CAMs by 
electrostatic repulsion so the strength of the adhesion is controlled by differential 
glyco ylation. N-CAMs often possess type ill fibronectin repeat sequences that 
Selectins mediate leukocyte-vascular interaction to allow white blood 
cells to move into tissue to protect against bacteria and viruses. The selectins 
bind to specific sugar sequences and are activated by inflammatory signal that 
promote the localization of leukocytes at sites of tissue inflammation. 134 
Integrins are compo ed of an a and a ~ subunit; there are 17 known a 
units and 8 known ~ units and 22 different combination have been identified in 
mammalian cell. The binding site of an integrin is compri ed of parts of both 
subunit and i selective towards a particular amino acid sequence. 
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3.1.4.2 Factors Affecting Protein Adsorption 
Protein adsorption is affected by many different factors pertaining to the 
solid surface, the protein, other proteins present, the solvent and solutes 135 . 
The amino acid side chains in a peptide sequence affect the electrostatic 
properties of a peptide or region of a peptide. The region can be neutral and 
hydrophilic, neutral and hydrophobic, positively charged or negatively charged. 
Neutral hydrophilic electrostatic interactions are the weakest of the interactions 
and neutral hydrophobic electrostatic interactions are the strongest in aqueous 
systems as the desolvation energy is higher for hydrophilic surfaces 136. 137. The 
strength of charged interactions depend on the charge density, ionic strength and 
pH of the solution \38. The amount of a protein that will adsorb onto a surface is 
dependent on the strength of the electrostatic interaction between the protein and 
the surface. Consequently proteins with regions where the hydrophilicity or 
charge is complimentary to the surface will adhere preferentially and in larger 
quantities to non-complimentary proteins. When a non-complimentary protein 
has been pre-adsorbed to a surface the addition of a more complimentary protein 
in solution will result in the displacement of the original protein. 
Large proteins have a greater surface area with which to interact with the 
surface so the amount of larger proteins adsorbed tends to be greater than the 
amount of a smaller protein139,140. The molecular weight and the shape of the 
protein contribute to the surface area of a protein so the degree of adsorption can 
be altered by solvent properties that affect the shape of the protein. 
The amount of a given protein that adsorbs to a given surface is 
dependent on the concentration of the protein in solution. Where there are a 
number of proteins present in solution in varying concentrations then the relative 
amounts of the proteins adsorbed to the surface will depend on the strength of the 
electrostatic interactions and the relative concentrations of the components l41 . 
A single protein can contain regions with each of the different types of 
electrostatic interaction. Consequently the same protein could adsorb in the same 
concentration to different surfaces but via different mechanisms and by exposing 
different areas of the protein sequence. The positioning of the region that 
preferentially binds to the surface affects the area of the protein that is exposed -
the protein can adsorb horizontally along the surface of the material or can stand 
end on, perpendicular to the surfaceI42.143. The exposure of different areas of the 
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same protein towards cells can affect the cellular response dependent on whether 
active regions are exposed or masked by the protein conformation. The stability 
and rigidity of proteins will affect the amount of a protein that will adsorb to a 
surface as it affects the ability of a protein to adopt a conformation that will 
preferentially adsorb onto a given surface and the rapidity that a protein can alter 
confirmation affects the speed of adsorptionl44. However proteins that alter 
conformation to adsorb strongly onto a surface may lose their bioactive 
function 145.146. 
The aqueous conditions to which a pre-adsorbed protein is subjected to, 
(such as pH, solutes or competing proteins) can affect the adsorption and / or 
conformation of the adsorbed protein, which can alter the cell-protein binding 
through masking or exposing active moieties I6,147. 
3.1.4.3 Effects of Protein Adsorption on Cell Behaviour 
In general the response of cells to a biomaterial corresponds to the total 
amount of protein adsorbed onto the surface as the cells cannot adhere to the 
surface 1 48-1 so. However there are cases in which the cell response is not 
dependent on the total amount of protein adsorbed as a specific protein can have 
a different adsorption profile to the majority of the proteins. In these cases a 
reduced adsorption of the majority of proteins can lead to preferential adsorption 
of an adhesion protein such as fibronectin that can promote high levels of cell 
adhesion. 
In a series of copolymers of N-isopropylacrylamide (NiPAAm) and N-
tert-butylacrylamide (NtBAAm) it was found that total protein adsorption from 
serum-containing media decreased with increasing NtBAAm concentration (i.e. 
increasing hydrophobicity)lsl. When the adsorption of albumin and fibronectin 
were investigated it was found that albumin followed the same adsorption trend 
as the total protein adsorption but the amount of adsorbed fibronectin increased 
with increasing NtBAAm concentration. The amounts of cells on the polymers 
also increased with increasing NtBAAm showing that the adhesion of cells was 
more strongly affected by the adsorption of specific adhesion proteins that by the 
total amount of adsorbed proteins. 
SAMs with different end groups were formed and it was found that 
hydrophilic OH and PEG surfaces adsorbed less proteins than amine, acid or 
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methyl surfaces 136. However despite the methyl surfaces adsorbing similar 
amounts of protein to the amine and acid surfaces the percentage of cell 
attachment and the average cell area was much poorer. It appears that the more 
hydrophobic proteins that adsorbed to the methyl surfaces were not as successful 
at promoting cell adhesion as the charged proteins that preferentially adhered to 
the acid and amine surfaces. 
Cells were grown on laminin coated surfaces and it was found that the 
cell number was dependent on the amount ofCM6 epitope available (as assessed 
by ELl SA) 152. The amount of CM6 available was partly dependent on the total 
amount of laminin adsorbed on the surface but was also affected by the coating 
conditions, which were performed in PBS, phosphate-high TWEEN or 
phosphate-low TWEEN. Whilst the total amount of laminin adsorbed at a given 
coating concentration was similar with all coating buffers the phosphate-high 
TWEEN promoted greater availability of CM6 and consequently promoted 
greater levels of cell adhesion. 
Fibronectin was adsorbed to SAMs with OH, acid, amine or methyl 
functionalities at a fixed density 153 • It was shown that the integrin <l5~ 1 binding 
efficiency to fibronectin went in the order OH > acid = amine >methyl whereas 
the integrin <lv~3 binding efficiency went in the order acid> amine » OH = 
methyl. This shows that the underlying surface chemistry affects the orientation 
and conformation of an adsorbed protein such that its affinity for different 
integrins can be substantially altered. The differentiation of cells on these 
fibronectin coated surfaces was also dependent on the underlying surface 
chemistry 154. 
Serum proteins were adsorbed to colloidal silica surfaces and the total 
amount of protein was found to be similar on all surfaces 155. However the cell 
adhesion was much higher on the control silica that the colloidal silica surfaces 
implying that the active moieties were less exposed when adsorbed onto the 
rougher colloidal surfaces. 
Adsorbed proteins do not always have a positive effect on cell adhesion -
some of the proteins that can adsorb to a surface have a regulatory role in 
preventing cell adhesion 156. 
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On the Design, Analysis and Effectiveness of RGD-
containing Biomaterials: Literature Review 
What a Biomaterials Designer Should Know About RGD 
It is well known that the peptide sequence Arginine-Glycine-Aspartic 
Acid (RGD) can promote cell adhesion through integrin mediated attachment 
when immobilised in or on a solid materiaI157-16o. 
This literature review aims to analyse the effectiveness of RGD-
containing biomaterials designed for the purposes of tissue engineering and 
assess their performance and suitability. It seeks to answer what effect the design 
of an RGD-containing material will have on the various behaviours of cells. This 
will be done by investigation of the ways in which RGD peptides can be included 
in biomaterials to present them towards anchorage-dependant cells. It will also 
determine how the fabrication of the biomaterial and the design of the cell-based 
experimental analysis can affect the reported results. 
3.2 Materials Design and Synthesis 
In the cases under review where materials have been designed to include 
an RGD-peptide the goals tend to be to promote cell adhesion through the 
peptide onto materials whose other characteristics (chemical, physical or 
biological) are desirable. Due to the range of uses that these materials have been 
intended for these characteristics can vary significantly. 
There are many different ways in which an RGD motif can be presented 
towards cells and the manner in which the peptide is immobilised on a surface 
can affect the peptide concentration, density, retention, accessibility, 
arrangement, conformation and activity. This review of synthesis methods 
therefore concentrates on the manner in which the final biomaterial is assembled 
and not the ways in which the peptide can be synthesised or derivatised with 
active functional groups. For this reason the synthesis methods deal with the 
peptide-containing species (peS), which have the general formula A-B-(RGD)-
B-A where B denotes any number of flanking amino acids and A denotes other 
chemical groups or species. Peptide-containing species do not always contain all 
of these groups and include simple peptides (of any length), peptides derivatised 
20 
with active functional groups (vinyl groups, bromide etc) and polymers 
derivatised with RGD (e.g. PEG-RGD). 
The methods of presenting RGD moieties towards cells have been 
divided into 2 groups, physical methods and chemical methods, as the method of 
including the PCS may affect the properties of the materials. Physical methods of 
including RGD involve the deposition, adsorption or precipitation of a PCS onto 
or into a solid material; the PCS is not covalently linked to the material that 
provides the bulk properties of the system. Chemical methods of presenting RGD 
towards cells involve the formation of covalent bonds between the PCS and the 
substrate either as the solid is being formed or by immobilising the pes onto a 
pre-formed solid (modification). 
Physical Methods: 
Coatings - the adsorption of a PCS onto a pre-formed solid material. 
Blends - the adsorption or co-precipitation of a PCS and other chemical entities 
onto a solid or formed into a bulk substrate. 
Self-Assembled Monolayers (SAMs)- the adsorption of a pes, possibly with 
other chemical entities, onto a pre-formed solid material where the orientations 
of the chemical species are controlled. 
Chemical Methods 
Modification - the chemical attachment of a PCS onto a pre-formed surface. 
Incorporation - the chemical attachment of a pes into a solid as it is formed. 
3.2.1 Physical Methods 
Physical methods are those in which PCS are adsorbed or precipitated 
onto a surface. The peptide is immobilised by physical forces such as 
electrostatic attraction or entanglement of polymer chains. The accessibility of 
the immobilised peptides towards ligands is dependent on the way that coatings 
or deposits form on the surface and the steric hindrance from other chemical 
groups. 
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3.2.1.1 Coatings 
Coatings are made by the simple adsorption of PCS or proteins onto 
surfaces that are pre-formed. The surfaces on which the coating is formed may be 
2-dimensional flat sheets or 3-dimensional porous networks24 . Peptide-containing 
species of vastly different sizes have been utilised as coatings from the minimal 
tripeptide sequence57 to entire proteins containing93,I61 or grafted with42,43,53 the 
active sequence. The amount of RGD peptides coated onto surfaces can be 
controlled (within limits) by the concentration of the coating solution. The 
coating of a substrate is usually performed in an aqueous buffer at temperatures 
ranging from 4 to 37°C for times ranging from 30 minutes to 24 hours. The 
amount of functional moieties present can be assessed by their activities towards 
antibodies and can be used to denote relative (not absolute) quantities of RGD 
moieties in proteins or peptides44,162. Elloumi et al showed that the adsorbed 
concentration of a PCS relative to the coating solution concentration up to 10nM 
was roughly linear but after 10nM a plateau of maximum adsorbed protein was 
reached162 , The extent of the coating and the retention of the coating may be 
affected by the peptide sequence, the chemical groups attached to the peptide (if 
any) and the substrate on which the peptide is coated, In addition the availability 
of the peptide sequence to bind to integrins may be affected by the spatial 
arrangement of the peptide coating on the substrate l63 • 
A strong anchoring of RGD peptides to surfaces is required and small 
RGD peptides are often ineffective when coated onto materials if the motif is not 
firmly attached. This can lead to reductions in the levels of observed cell 
behaviour82 as the peptides can become detached and provide soluble 
competition for integrins (see section 4.4.1.1 Soluble Peptides) or lead to cell 
death through apoptosis164, 
Sharma et al showed that when a peptide was conjugated to albumin 
nanocarriers and these were adsorbed to a surface they presented a greater 
number of active moieties than the simple adsorbed peptide44 • 
Sawyer et al showed that a peptide sequence with a polyglutamate chain 
was adsorbed in significantly greater concentrations than the peptide without the 
polyglutamate chain 165. If the concentration of the adsorbed peptide had not been 
quantified it might have been assumed that the polyglutamate chain was 
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responsible for the increased cell adhesion rather than the increased 
concentration of the peptide present. Kurihara et al coated peptides containing 2, 
21 or 43 repeat sequences of RGD and found that the amount of (RGD)43 coated 
was 4-fold greater than the other peptides89 although this may be due to the 
formation ofa self-assembled peptide hydrogel at the surface of the material 166 . 
However, Rapuano et al showed that H2N-ENGEPRGDNY-C02H and 
H2N-YESENGEPRGDNYRA YEDEYSYFKG-C02H formed coatings where the 
amounts of the two peptides deposited were nearly identical over a large 
concentration range90 . 
Bhadriraju et al found that a 2.3kD RGD containing peptide (P2) 
promoted different levels of cell attachment when coated onto different types of 
plastic. As the concentration of peptide was not analyzed it is not known whether 
this is a result of altered adsorption or conformation 93. Other peptide coatings 
investigated in the same study as above did not alter the cell morphology or DNA 
synthesis when the background substrate was altered. In addition there are other 
studies where coatings have had the same effect regardless of the substrate on 
which they are coated53 . However this is a phenomenon that researchers should 
be aware of. 
It should also be noted that coatings may become de-adsorbed from 
surfaces over time and in competition with proteins in solution, with the de-
adsorption being a function of the nature of the PCS and the substrate. The de-
adsorption of a peptide from a material was demonstrated by Sawyer et al who 
investigated the amounts of various coated peptides remaining on hydroxyapatite 
after agitation in serum-free for up to 48 hours 165 • This study found levels of 
peptide were significantly reduced during the time periods measured. 
It is evident that the extent of the coating, the retention of the coating, the 
accessibility of the ligand and the conformation of the peptide depend both on 
the nature of the PCS and the nature of the substrate on which the coating is 
formed. 
3.2.1.2 Blends and Precipitates 
Blends are formed by physically combining a pes and other chemical 
entities into a solid or by co-depositing them onto a surface in a manner similar 
to coatings. The formation of the blend can be achieved by co-adsorption onto a 
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surface91 , pre-adsorption onto a solid prior to processing l67, precipitation (or 
evaporation) from solution78.79.168, entanglement of polymer chains55 and gelation 
of thermally controlled polymers32.33.75. 
Blends can take the form of a surface modification where the mix of PCS 
and other species forms a coating on the surface or a bulk incorporation where 
the entire 3-dimensional solid contains peptide. The coatings formed from 
adsorption from solution are generally mono layers however coatings formed 
from precipitation or entanglements are thicker, films of I-5nm have been 
reported from spin-coating79. Altering the ratio of PCS to other chemical species 
can control the concentration of ROD in blends. However the orientation and 
arrangement of the groups cannot be controlled and the peptide may be masked 
by the other species in the system. 
3.2.1.3 Self-Assembling Systems 
There are two main types of self-assembly that have been utilised in the 
production of ROD-containing biomaterials: the self-assembly of amphiphiles at 
an interface or the spatially controlled adsorption ofthiols onto gold surfaces. 
Self-assembling systems are created when the interactions between 
hydrophobic sections and hydrophilic sections drive the assembly of well-
defined structures, usually as the formation of mono layers at interfaces. The PCS 
can be blended with non-peptide containing amphiphiles to control the 
concentration of peptide in the monolayer. Consequently the amount of ROD 
present is usually expressed as a molar percentage of the total composition of the 
monolayerllo.169-171. 
Self-assembling systems do not encounter many of the problems 
encountered with other methods in estimating peptide density as the peptide 
cannot be obscured by other chemical species as long as the monolayer is formed 
properly. However this must be proven to be so as some authors have found that 
some ROD-containing amphiphiles did not pack well at high molar 
169 172 I dd" h h 1 percentages . . n a thon w en t e mono ayers are created by adsorption 
from solution the ratio of components deposited in a mixed system may not be 
the same as the ratio of components in solution 171. 
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3.2.2 Chemical Methods 1: Modification 
All modification methods require a functional group in the material to 
which the peptide can be attached, either via a coupling reagent or a cross-linker. 
Functional groups that can be utilized include carboxylic acids, amines, 
aldehydes, alcohols and thiols. There are many different ways of incorporating or 
modifying a surface l73 to include functional groups but these are outside the 
scope of this review. These groups can be reacted directly with functional groups 
on or attached to the PCS. Coupling reagents are used to activate the functional 
groups on either the material or the PCS and mediate bond formation. The bond 
formation may be achieved in a one-step synthesis where the peptide and 
coupling reagent are added simultaneously or in a two-step synthesis where a 
semi-stable activated group is prepared in the first step and the peptide is added 
in the second step. Alternatively the functional groups in the material can be 
reacted with one side of a bifunctional entity, the other side of which reacts with 
the PCS. These bifunctional chemicals are called cross-tinkers as they are 
commonly used to cross-link proteins and are often hetero-bifunctional (contain 
two different functional groups)174. 
The approximate RGD concentration in the final material can be 
controlled by the input concentration. However the coupling efficiency of the 
synthesis method may not be constant at varying concentrations of peptide 
leading to a non-linear relationship between input concentration and final 
concentration. This has been shown by Reinhart-King et al 17S with an NHS 
activation scheme and Bruers et al66 with benzoquinone activation. Examples of 
studies where a linear relationship between input peptide concentration and 
obtained peptide concentration include 46,124 
3.2.2.1 Coupling Reagents 
l-ethyl-3-(3-dimethylaminopropyl) carbodiimide CEDC) is a coupling 
reagent that mediates the formation of amide bonds between a carboxylic acid 
and a primary amine. The mechanism of EDC mediated coupling involves the 
activation of the carboxylic acid followed by the replacement of the EDC with 
the primary amine. 
When coupling RGD derivatives to surfaces there are multiple carboxylic 
acids and amines present and the peptides will react with each other to form oligo 
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peptides. In addition peptides possess reactive side chains that will be linked to 
other chemical species and destroy the integrin binding activity of the peptide 
particularly with the peptide sequence ROD that contains a carboxylic acid side 
chain on D and an amine on R. Another problem with EDC coupling is that the 
activated carboxylic acid can be deactivated by hydrolysis. 
Despite this EDC coupling has been frequently used to derivatise surfaces 
with ROD peptides. Amines67.126-128.176 or carboxylic acids64.76 on a material can 
be utilised to modify a surface with EDC as the coupling reagent as the peptide 
possess the respective functionality. The solid surface to be derivatised is 
immersed in a solution containing the peptide, solvent and often N-ethyl 
morpholine. Dimethyl formamide (DMF) can used as a solvent as the water can 
be removed from the system and the reaction performed under an inert 
atmosphere thus removing the problem of hydrolysisI26.127.176. Alternatively an 
aqueous buffer such as MES67 or PBS can be utilised76. Coupling times range 
from 30 minutes76 to 24 hours l26 and input concentrations of the ROD peptide 
ranging from SOl-lM67 to 2mM76 have been utilized although many of the 
references cited do not specify the volume of solution used. 
N-hydroxysuccinimide (NHS) or sulfo-N-hydroxysuccinimide (sulfo-
NHS) can be added to the reaction mixture to increase the efficiency of an EDC 
mediated coupling by providing an active intermediate that is not subject to 
hydrolysis46.59.62.177. Rowley et al investigated the effects of changing the EDC 
concentration, pH, sodium chloride molarity and peptide concentration on the 
efficiency of an EDC/sulfo-NHS mediated coupling reaction between ORODY 
and alginate46. It was found that the maximum coupling efficiency was obtained 
with an EDC concentration that gave 10% theoretical uronic acid activation. The 
optimum pH was 6.S and the optimum sodium chloride molarity was 0.3M. A 
linear relationship between the input amount of ROD and the immobilised 
density was obtained. 
3.2.2.2 Activation Strategies 
Activation agents mediate the formation of bonds between substrates and 
a peptide by a two step reaction. The first step involves the formation of a semi-
stable conjugate that activates a functional group on the substrate and the second 
step involves the replacement of the activating group by the peptide to form the 
26 
final product. As the peptide is never present at the same stage as a coupling 
reagent oligo peptides cannot be formed by activation procedures. 
EDC can also be used as an activation agent with the attachment of a 
peptide sequence being performed in a second step rather than a one-pot 
synthesis54,178. Dicyclohexylcarbodiiimide (DCC), a non-water soluble analogue 
ofEDC, can also be used in this manner179. 
N-hydroxysuccinimide (NHS) and its charged, water soluble derivative 
sulfo-N-hydroxysuccinimide (sulfo-NHS) are frequently used to synthesise PCS 
and to immobilise peptides on solid materials I9,40,46,68,78,79,81,95,IOI-I05.175. 
Carboxylic acids present on a solid substrate are reacted with NHS or sulfo-NHS 
by means ofa coupling reagent, either EDC or DCC78,79 or by use ofN,N,N',N'-
tetramethyl(succinimido )uranium tetrafluoroborate (TsU), which forms NHS 
esters without the need for an additional coupling reagent. The NHS activated 
esters have a half life of minutes to hours at neutral pH and can be stored for 
months if dried, NHS activated esters containing vinyl groups are also stable 
enough to be copolymerised into polymers or cross-linked gels68,180. The 
structures of some reagents used to form NHS activated esters are shown in 
Figure 3-4 below, 
/~~(-N9 b) 0 \\ H\\-O-N8' f-O-y 0 
o /N __ 0 
Figure 3-4 Structures of a.) N-hydroxysuccinimide, b.) sulfo-N-hydroxysuccinimide, c.) TsU 
and d.) succinimide activated carboxylic acid. 
Reaction of the peptide to an NHS activated ester occurs through free 
amines in the peptide to form amide bonds and can be performed in aqueous 
media or a combination of aqueous media and organic solvents40,79, Amine 
functionalities on side chains can also react with the NHS activated esters. The 
peptide concentration immobilised onto the substrate may be controlled by the 
amount of carboxylic acids incorporated into the system or by the input amount 
of peptide reacted with the system. 
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Brandley et al and Reinhart-King et al both investigated the relationship 
between input concentration of Y A VTGRGDS and the amount of immobilised 
peptide onto acrylamide based gels copolymerised with the succinimide ester of 
acrylamidohexanoic acid68•175 • Brandley et al found a linear relationship between 
input concentration and amount of immobilized peptide over a concentration 
range of I-20nmol/cm2 that was not dependent on the amount of NHS activated 
ester incorporated into the system. Reinhart-King et al reported a non-linear 
relationship over the concentration range 0.001-1 mg/ml (-1.2nmol/cm2 to 
I.2~mol/cm2). The relationships between input concentration and immbobilised 
peptide concentration found by the two sets of authors are shown in Figure 3-5 
overleaf. 
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Figure 3-5 Top - Efficiency of YA VTGRGDS immobilisation to acrylamide-co-
bisacrylamide gels containing 0.1 (open triangle), 1 (closed circle) and 10 (open circle) 
~mol/ml of succinimide ester activated acrylamidohexanoic acid. Reaction performed in 
SOmM HEPES (pH 8) for 16 hours at 4°C. Reproduced from Brandley et alt ,68. 
Bottom- Efficiency of Y A VTGRGDS coupling to N-hydroxyl succinimide activated 
acrylamidohexanoic acid (20~mol/ml) copolymerised with N,N'-bisacrylamide (S wt%) fe's 
in SOmM HEPES buffer (pHS) at 4°C for 2 hours. Reproduced from Reinhart-King et al ,m 
t Reproduction of Figure 1 from "Brandley, B. K. & Schnaar, R. L. Covalent Attachment of an 
Arg-Gly-Asp Sequence Peptide to Derivatizable Polyacrylamide Surfaces: Support of Fibroblast 
Adhesion and Long-Term Growth. Analytical Biochemistry 172, 270-278 (1988)" with 
permission from Elsevier Ltd. 
:\: Reprinted with permission from "Reinhart-King, C, A., Dembo, M. & Hammer, D. A. 
Endothelial Cell Traction Forces on RGD-Derivatized Polyacrylamide Substrate. Langmuir 19, 
1573-1579 (2003)" Copyright 2003 American Chemical Society 
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The reason for the non-linear relationship found by Reinhart-King may be 
due to the increased concentrations or it may be due to the short coupling time 
utilised (2hrs at 4°C). Drumheller et al showed that the coupling of YRGDS to 
succinimide polymers at high concentrations took up to 12 hours to complete 
although the solvent utilised in this case was DMF:DIPEA:H20 98.5:0.5: 1 rather 
than aqueous buffer40. 
Alcohols can be activated with mesyl or tresyl chloride to form an 
intermediate that reacts with amines from a peptide to form new C-N 
bonds63,107,129,130,181-184. The mechanism for this reaction IS shown below in 
Figure 3-6. 
° 11 
OH + TI R'/ CI-~\ HO-R\ Ii Cn 
° CF, 
Tn:syl chlocidc 
Figure 3-6 Reaction scheme for activation of alcohols by tresyl chloride followed by 
replacement with primary amines. 
Alcohols can also be activated with benzoquinone, which attaches to the 
substrate to form an ether and provides an additional site that is reactive towards 
amines. 
Bruers et al investigated the pH and concentration dependence of the 
reaction of GRGDS with benzoquinone activated surfaces66. Maximum peptide 
immobilisation was achieved at pH 3 and the efficiency of the coupling 
decreased with increasing input peptide concentration. Benzoquinone activation 
has also been utilised to immobilise peptides with diene functionality via a Diels-
Alder reaction I 85. 
Aldehydes can be utilised to immobilise peptides onto surfaces vIa 
primary amines, which act as nucleophiles and form imines l86,I87 that can be 
reduced to the more stable secondary amines. Sodium cyanoborohydride has 
b '1' d d' 48 188 189 Th I' ffi' f d . een uti Ise as a re ucmg agent ' , . e coup mg e IClency 0 re ucttve 
amination was investigated by Glass et al who found an exponential relationship 
between the amount of input peptide and the amount of bound peptide 186. 
Thiol moieties in keratin52 or BSA 190 have been used to immobilise 
peptides containing bromine residues as the sulphur replaces the bromine in an 
SN2 reaction to form a sulphide. More normally with thiol-based immobilisation 
chemistry a peptide sequence containing cysteine is utilised to immobilise a 
peptide onto a surface via the thiol side chain of cysteine. A Michael-type 
30 
o 
addition reaction can be utilised to immobilise thiols to surfaces containing a,p-
unsaturated carbonyl groups such as methacrylates I11 or maleimides 191. An 
example of a Michael-type addition reaction is demonstration in Figure 3-7 
below. 
HX 
Figure 3-7 Example of a Michael-type addition reaction of a thiol to a methacrylate. 
Alternatively the thiol can be utilised to form disulphide bonds with a 
thiol activated by DMS051 or by replacing activated disulphide moieties I 14,192,193 
on the surface of the substrate. 
Aryl azides form nitrene groups when exposed to UV-light that can 
initiate addition reactions with double bonds, insert into C-H and N-H sites or 
undergo a ring expansion to react as a nuc1eophile with a primary amine l94 . The 
latter reaction path dominates when primary amines are present in the sample. 
Phenyl azides can be incorporated into PCS and utilised to immobilise the 
peptide onto a solid surface58 • 
Benzophenone can also be used as a photoactive strategy to immobilise 
peptides onto surfaces. The amount of peptide incorporated is proportional to the 
exposure of UV -irradiation as shown by Herbert et a1 195 . 
3.2.2.3 Bifunctional Cross-Linkers 
There are a large variety of commercially available cross-linkers, which 
makes them attractive prospects for functionalising surfaces with peptide 
sequences. In addition the cross-linkers contain a spacer arm that may be useful 
to distance a peptide from the bulk of the substrate. 
Homo-bifunctional cross-linkers consist of molecules that have been 
derivatised with two of the same active functional group. Disuccinimidyl cross-
linkers are utilised to derivatise surfaces containing amine functionalities with 
peptides via an amine in the peptide. Different spacers can be utilised to form the 
cross-linker, disuccinimidyl suberate54 and its sulfonated analogue bis(sulfo-
succinimidyl) suberate contain a (CH2)6 hydrophobic spacer between the two 
NHS activated esters. Ethylene glycol bis(succinimidyl succinate)18.25 and its 
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sulfonated analogue26 contain a hydrophilic spacer between the two activated end 
groups. The structures of some disuccinimidyl crosslinkers are shown in Figure 
3-8 below. 
a) disuccinimidyl suberate 
b:o~:t( 
o 
c) Ethylene glycol bis(succinimidyl succininate) d) Ethylene glycol bis(sulfosuccinimidyl succininale) 
Si~O~o~p 
o 
·,~o 
·~Si~·~o~}-~~ 
o?\ 
Figure 3-8 Disuccinimidyl homo-bifunctional cross-tinkers. 
Hetero-bifunctional cross-linkers contain two different functional groups 
activated to react with different functionalities in the substrate and peptide. Most 
of the hetero-bifunctional cross-linkers contain a succinimide activated ester that 
reacts with amines on the peptide or substrate. 
N-succinimidyl 3-(2-pyridyldithio)-propionate (SPDP) and succinimidyl 
6-(3-[2-pyridyldithio ]-propionamido )hexanoate (LC-SPDP) contain a 
succinimide activated ester to react with amines on the surface of the substrate 
and an activated disulphide bond that is displaced by the SH functional side 
chain of cysteine42,44,196-198. The LC-SPDP contains a longer spacer arm that 
distances the peptide from bulk. Both derivatives are also available as their 
sulfonated analogues and these have also been utilised to attach ROD peptides to 
surfaces 199. The structures of succinimidyl and dithio based crosslinkers are 
shown in Figure 3-9 below. 
ON •• 
N -Succinimidyl 3-(2-pyridyldithio)-propionate Succin imidy I 6-{ 3-[2-pyridyldith io )-propionamido )hex anoatc 
Figure 3-9 Succinimidyl and dithio based hetero bifunctional crosslinkers. 
32 
N-succinimidyl-3-maleimidopropionate (SMPioO,201. N-succinimidyl 
trans-4-( maleimidylmethyl)cylcohexane-l-carboxylate (SMCC) and N-
succinimidyl-4p-maleimidophenyl-butirate (SMPB) and their sulfonated 
analogues43 ,74,80,I20,I21,l24 also react with thiols from cysteine but in a Michael-
type addition reaction as discussed in section 1.2.3.3. Structures of crosslinkers 
with succinimidyl activated ester and reactive groups for Michael-type addition 
reactions are shown in Figure 3-10 below. 
)fo~,~ 
o )J 
o 
N-Succinimidyl 3-maleimidopropionatc N-succinimidyl trans-4-(maleimidylmethyl) 
cyclohexane-l-carboxylate 
N -sue eini midyl-4p-malc imidophcnyl-hul irale 
Figure 3-10 Hetero bifunctional cross-linkers with a succinimidyl activated ester and a 
reactive group for Michael-type addition reactions. 
N-Succinimidyl-6-[4' -azido-2' -nitrophenylamino] hexanoate (SANPAH) 
contains an NHS activated ester that reacts with free amines in a peptide and a 
phenyl azide photo reactive group that can utilised to immobilise the peptides 
onto a surface50.106. 
FNIIhlO was attached to BSA coatings using various homo-bifunctional 
or hetero-bifunctional linkers and the relative amounts of accessible ligands were 
assessed by ELISA202 . The cross-linkers investigated were dimethyl 3,30-
dithiobispropionimidate (DTBP), 3,30-dithiobis[ sulfo-succinimidyl propionate] 
(DTSSP), N-[e-maleimidocaproyloxy]sulfosuccinimide ester (sulfo-EMCS), 
sulfosuccinimidyl-4-(P-maleimidophenyl) butyrate (sulfo-SMPB), N-[K-
maleimidoundecanoyloxy] sulfosuccinimide ester (sulfo-KMUS) and 
sulfosuccinimidyl 6-[3 '(2-pyridyldithio)-propionamido] hexanoate (sulfo-LC-
SPDP). The ELISA determined amount of FNIIhlo for coating concentrations of 
20l-lg/ml of each cross-linker divided by the background levels of protein were 
found and designated as the coupling indexes. It was found that the homo-
bifunctional amine reactive cross-linkers (DTSSP) and dimethyl 3,30-
dithiobispropionimidate (DTBP) produced surfaces with much greater 
concentrations of accessible peptides than the other cross-linkers. The coupling 
index determined to be 83 and 44 for DTBP and DTSSP respectively whereas the 
coupling index for the other crosslinkers was found to be 8.2 or lower_ The 
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coupling index as determined by ELISA probably refers to a combination of 
peptide immobilisation and peptide accessibility. 
3.2.2.4 Distribution of Surface-Modified RGD 
The majority of modification procedures are carried out with non-
protected peptides. In some cases, it appears that the amino acid side chains of 
RGD will react with the activated substrate or other peptide molecules. There is a 
general convention to assume that the determined amount of peptide is evenly 
distributed over the surface of the substrate whereas in fact the peptide may in 
fact have reacted to form oligo-peptides and be localised into clusters of repeat 
sequences (see section 4.2.2.1). This clustering usually occurs when coupling 
reagents are utilised and the peptide is present at the same time as activating 
agents. The clustering of RGD peptides on a surface through a modification 
procedure was observed by Senyah et a1 119• The clusters can be seen through 
con focal laser microscopy and scanning electron microscopy in Figure 3-11 
overleaf. 
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SEM x 20000 
Figure 3-11 Immobilisation of fluorescent RGD-peptide onto glass, observed by A) confocal laser scanning microscopy and B) scanning electron microscopy. 
Reproduced from Senyah et alt, 119 
t Reproduction of Figure I from "Senyah, N., Hildebrand, G. & Liefeith, K. Comparison between RGD-peptide-modified titanium and borosilicate surfaces. Analytical & 
Bioanalytical Chemsitry 383, 758-762 (2005)" with kind permission of Springer Science and Business Media 
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Whilst materials like glass and metals do not allow the access of peptides 
and reagents into the bulk of the material many polymers are made as cross-
linked gels or blends and they contain pores25 as shown in Figure 3-12. The 
depth of the surface modification will therefore depend on the size of the pores , 
which can be a function of the concentration of monomers203 or the phase-
separati ton characteristics85 . Consequently many of the reported concentrations 
for RGD pep tides immobilised onto polymers by modification methods should 
be treated with caution. 
Figure 3·l2 Left· Depth of surface modification to PLGA blend films. Reproduced from 
Yoon et al t ,25. Right· Open porous structure of a HMPA hydrogel. Reproduced from Plant 
et al*,85. 
t Reproduction of Figure 3 from "Yoon, 1. 1. , Song, S. H. , Lee, D . S. & Park, T . G. 
Immobili zati on o f cell adhesive RGD peptide onto the surface of highly porous biodegradable 
po lymer caffolds fabricated by a gas foaming/salt leaching method , Biomaterials 25,56 13-5620 
(2004)" with permi ssion from Elsevier Ltd. 
t Reproduction o f Figure 2 from "Plant, G. W ., Woerly, S. & Alan R. , H. Hyd rogels Containing 
Peptide or Aminosugar Sequences Implanted into the Rat Brain : Influe nce on Cellular Migration 
and Axonal Growth. Experimental Neurology 143, 287-299 ( 1997)" with permiss ion from 
Elsevier Ltd. 
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3.2.2.5 Comparison of Strategies 
The coupling efficiency of a peptide to a substrate is affected by the 
peptide, the material, coupling reagents and the conditions under which the 
coupling is performed. If the material on which a peptide is being immobilised is 
altered the coupling efficiency may also be altered as shown by Yamaoka et al 
who derivatised poly(L-lactides) containing various p-alkyl a-malate-units with 
ROD under the same conditions I 79. The amounts of immobilised peptide in 
J..lg/cm2 was analysed and it was found that the alkyl group had a large effect on 
the amount of peptide. (R = H, 7.7 J..lg/cm2; R = CH2Ph, 3.0 J..lg/cm2; R = C I2H25 , 
1.7 J..lg/cm2; PLLA alone, 0.95 J..lg/cm2). This may also have been the case in a 
situation where N-isopropylacrylamide was copolymerised with different 
carboxylic acid containing monomers, namely 2-carboxyisopropylacrylamide 
(CIPAAM) and acrylic acid (AA)76. RGDS was reacted with both polymers 
under identical conditions (2mM RODS plus 2mM EDC in PBS, pH 7.4, 24 
hours, RT). However, those polymers synthesised with CIPAAM were 
significantly better at promoting cell adhesion and spreading than those 
synthesised with acrylic acid. As the amount of ROD that had been immobilised 
was not quantified it is difficult to tell whether this effect is due to a change in 
ROD concentration or a change in integrin binding induced by the changing 
conditions. 
Bouhadir et al investigated the immobilisation of ROD peptides to 
sodium poly(guluronate) and poly(aldehyde guluronate) with varymg 
conditions48 • The same amounts of radio-labelled ORGDY were used without 
reagents, with carbodiimide/sulfo-NHS coupling and with a reductive amination 
procedure. Slightly higher amounts of peptide were incorporated via the sodium 
cyanoborohydride (NaCNBH3) reductive amination. 
Different methods of modifying surfaces give different coupling 
efficiencies and the efficiency can be dependent on the concentration. Patel et al 
created poly(methyl methacrylate) peptide modified surfaces with identical final 
chemistries via hydrolysis or aminolysis8o• At low concentrations «0.5J..lM) the 
relative efficiencies of the two methods were similar. However at higher 
concentrations the coupling efficiency of the aminolysis method was higher. 
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Even when the method utilised to derivatise a material with RGD is kept 
constant the sequence in which the steps are performed may affect the amount of 
peptide, accessibility, or binding strength. This was shown by Irvine et al who 
modified comb polymers with a methyl methacrylate backbone and PEO side 
chains79 • The combs were modified in solution, activated in solution and coupled 
in situ, or both activated and coupled in situ. Coupling efficiencies were 
approximately 30% lower when the combs were activated and coupled in situ in 
comparison to the other two methods, which is likely to be due to steric 
hindrance in the activation step. 
3.2.3 Chemical Methods 2: Incorporation 
Peptides can be incorporated into polymers by including a polymerisable 
group such as a carbon double bond into a peptide-containing species (PCS) and 
then copolymerising the PCS with other monomers. Alternatively gels can be 
produced from proteins or polymers containing active functional groups that can 
be cross-linked with enzymes or bifunctional cross-linkers such as those detailed 
in section 1.2.3.3. 
3.2.3.1 Chain-growth Polymerisation 
The creation of the PCS is often achieved by one of the chemical 
strategies utilised for modification (see section 1.2.3). Polymerisation is achieved 
by use of an initiator that can be activated by the use of heat, visible light, UV 
light or chemical reaction. Examples of polymerisation initiators that have been 
utilised to form RGD-containing biomaterials include azobisisobutironitrile 
(heat)83,84, 2-hydroxy-2-methyl propiophenone (UV)31, 2,2-dimethyl-2-phenyl-
acetophenone (UV)30,94,98, 2,2-dimethoxy-2-phenyl-acteophenone (UV)41,lI2 and 
ammonium persulfate (chemical)68-71. These initiators have been chosen because 
they are non-toxic towards cells when immobilised in a polymer and / or when in 
solution so that cells can be encapsulated in polymers as they are formed. 
The concentration of the peptide in a polymer can be controlled by 
altering the ratio of PCS and other monomers. When copolymerised with other 
monomers the amount of PCS incorporated into the polymer will be dependent 
on the relative polymerisation rates of the components. Acrylamidohexanoic acid 
was derivatised with an RGD-containing peptide and copolymerised with 
acrylamide and bisacrylamide to form cross-linked gels68. Using this method 
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75 ± 2% of the added peptide was incorporated over a concentration range 50-
260 nmol/cm2• The acryl-containing PCS was not purified prior to use so part of 
the loss of peptide may be due to inefficient coupling of the peptide to 
acrylamidohexanoic acid prior to copolymerisation. The coupling was performed 
via NHS chemistry and a 20-fold excess of activated ester was utilised. Other 
investigations with 25-fold excess of activated esters have reported coupling 
efficiencies of 84% w.r.t. the peptide41 . 
The incorporation of different PCS into PEG-DA hydrogels was 
investigated by Hem et al who found that acryloyl-YRGDS was incorporated 
with 51-75% efficiency and that acryloyl-PEG-YGRGDS was incorporated with 
81-97% efficiency41. This reflects the relative polymerisation rates of the two 
PCS species investigated. However it should be noted that the PCS were not 
purified after synthesis and the efficiency of the PCS synthesis was only 84% so 
that actual peptide concentrations were only 40-81 % that of the nominal 
concentrations. Polymerisation methods can also be utilised to create gradients of 
peptide within a gel by the use of micro-fluidic commercial gradient makers31 •69 . 
Biesalski et al polymerised self-assembled amphiphiles at an interface l72. 
Polymerisation was achieved via UV irradiation activation of alkyne bonds. The 
polymerisation of vinyl containing PCS can also be utilised to add RGD 
functionality to pre-formed polymers by making use of non-polymerised double 
bonds contained in the material77 • However it seems likely that the PCS will 
polymerise to form oligo-peptides and the surface distribution of the peptide will 
be uneven. 
3.2.3.2 Cross-linking 
Alginate can be ionically cross-linked by calcium sulphate and this 
strategy was used to form gels from alginate pre-modified with RGD blended 
with non-modified alginate45 . 
Gelatin can be cross-linked with trans-glutaminase and RGD peptides 
containing glutamine have been incorporated into gelatin gels via this method204 . 
Interestingly when RGD peptides without glutamine were treated by the same 
system they also promoted cell adhesion and proliferation, although to a lesser 
extent, indicating that the peptides were probably immobilised in part by physical 
entrapment as well as cross-linking. 
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Factor XIIIa can cross-link fibrin and the peptide sequence LNQEQ and 
this methodology was utilised to form fibrin gels with ROD incorporated through 
a peptide sequence containing both LNQEQ and ROD27,35,205. Maximum peptide 
incorporation was achieved at 1 mM input concentrations and declined at higher 
concentrations, which was attributed to limited amounts of cross-linking enzyme 
being available. As the input concentration of peptide increased the amount of 
free peptide that was not cross-linked into the gel also increased with 
implications for competition for integrins between immobilized and solubilised 
peptides. 
3.2.4 Assessment of RGD Concentration 
In many of the references cited a variety of RGD concentrations are 
studied in order to optimise the cell response. Altering either the input amount of 
the peptide containing species (PCS) or the amount of active functionalities 
present on each PCS can generally control the concentration of RGD. However 
the actual amount of peptide presented towards cells may depend on a number of 
other factors such as the incorporated / deposited amount of peptide, the spatial 
arrangement and the accessibility of the peptide. 
3.2.4.1 RGD Concentration: Notations and Implications 
In addition there are a number of different forms in which the amount of 
ROD present can be expressed in terms of the mass or molar amount of the 
peptide and the surface area, volume, mass or molar amount of the substrate in 
question. The most appropriate notation for each material is utilised and 
generally depends on the synthesis method however this means that it is difficult 
to compare ROD concentrations from different synthesis methods as the units of 
the concentration or density may be different. Where units have been converted 
from one type to another assumptions are made such as the depth of a 
modification procedure or the density of a cross-linked polymer which may not 
be accurate and may be misleading unless all assumptions and calculations are 
publicized. 
The amount of peptide immobilised on a surface by physical methods and 
incorporated onto a surface or into a material by chemical methods will depend 
on the input amount of peptide relative to other species and the efficiency of the 
immobilisation procedure. Assessment of ROD-concentration should be 
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performed qualitatively to discover the effects of peptide incorporation at a 
known surface density on cell behaviour. Non-porous systems such as glass or 
TCP will present ligands towards cells in a quasi-2D system. In these 20 systems 
the amount of peptide available for binding is dependent on the concentration of 
peptide in terms of number of active moieties per unit surface area. The amount 
of peptide available for binding in 3D systems such as cross-linked gels is 
dependent on the density of peptide and the depth that integrins can penetrate to 
access \igands, which is often assumed to be IOnm. 
Coatings are usually 2 dimensional as the peptide forms a layer on the 
surface; the units used reflect this. If the extent of peptide coating has been 
quantified (see section 1.3) the concentration can be expressed as mass per unit 
area42,206, moles per unit area206,207 or distance between peptide molecules42,113. If 
the coating forms a multi-layer coverage instead of a monolayer or less this 
notation may no longer be appropriate as there will be a non-accessible ROD 
content in the bulk. It is worth noting that fibronectin forms a monolayer coating 
at a concentration of -350ng/cm2, equivalent to O.692pmo\/cm2 of ROD 
species l70• Coatings of peptides or peptide containing species onto surfaces are 
often designated by the amount of peptide in the coating solution expressed as 
either moles per unit volume42,53,90,118,162 or weight per unit volume51 combined 
with a volume of coating solution per unit area. Where comparisons between 
different peptide-containing species are being made care must be taken to ensure 
that the units are converted to moles per unit area to ensure that the numbers of 
active moieties are comparable. For example a poly (l-lysine-graft-ORODS) will 
have significantly less active moieties per mass unit than a short amino acid 
sequence. 
Blends of materials deposited as coatings or processed into a shape often 
express the amount of ROD present as a function of the amount of non-peptide 
containing material present. This can be done as a mass per mass (weight 
%)78,79,167,168, mass per volume (w/v %)55, moles per mass, moles per volume or 
moles per mole (mol %)110. Where the peptide amount is measured in mass it 
must be noted that the mass will be of the entire peptide containing species, 
which may mean that very different amounts of active moieties are present in 
systems that purport to have similar concentrations. Where the peptide amount is 
measured in moles it must be noted that the molar masses of the other 
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components in the system may have a large effect on the density of the active 
moieties. Possibly the most relevant notation for this type of system would be 
moles per effective volume of solid as this notation reveals the peptide density 
and spacing. 
Attachment of PCS to a pre-formed solid is generally assumed to be a 
surface only modification as many solids, such as glass, do not allow access of 
reagents into the bulk. The assessment of RGD concentration in materials formed 
by modification procedures usually assume that the reagent penetration depth is 
the same as the integrin accessible depth of 10nm and treats the results in a 20 
manner. This may not be appropriate where the material being modified is 
porous as shown in section 3.1.3. It should also be noted that the majority of the 
assessment protocols are performed on the materials in a dried state and many 
polymeric materials may expand in aqueous environments as they adsorb water. 
The units of concentration for a modified surface are generally moles per unit 
area and reflect the assumption that the immobilization of the PCS occurs only to 
a depth of IOnm, which is also assumed to be the depth that integrins can have 
access to the peptide. However this may not be true in all cases and where the 
concentration of peptide has been assessed in a 3D material the peptide 
concentration may be spread over a greater depth of material than the integrins 
are able to access. Rowley et al estimated the penetration depth of modification 
reagents to be 50nm 46. 
The units of peptide concentration that are utilised for incorporation 
methods are usually in terms of the total mass of the substrate or the fraction of 
monomeric components containing peptide. Analysis of the peptide 
concentration will give an amount of peptide per mass of substrate which can be 
converted to moles per unit area if assumptions are made as to the depth that 
cells can perceive ligands, the density and swelling characteristics of the 
substrate under culture conditions. However in many cases the swelling 
characteristics of a substrate are not measured and the peptide concentration 
quoted is usually that of the amount of peptide in the dry weight of material. 
The implications of the different notations utilised for RGD 
concentrations impact heavily on the capacity to make comparisons between 
different systems containing RGD peptides. In addition many researchers do not 
carry out analysis of the actual peptide concentration and rely on the assumption 
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that the amount of active peptide moieties presented towards cells is proportional 
to the nominal peptide concentration utilised in the synthesis. This leads to 
further confusion over the peptide concentration required to effect a significant 
response from cells. 
3.2.4.2 Quantification Methods 
Radio labelling can be utilised to quantify the amount of RG D present by 
incorporating 1251, 14C, or 35S into a peptide sequence. 1251 is usually incorporated 
into a peptide sequence by oxidative iodination of tyrosine 
(y)40,4 1,45,46,48,68, 1 14,121,207,208. 14C can be incorporated into a peptide sequence by 
reductive methylation of lysine l71 ,I95 or by reaction of radio-Iabellcd 
phenylglyoxal with arginine side chains 117, 35S is incorporated by utilising radio-
labelled cysteine in the peptide synthesis2ol . Radio-labelling can also be utilised 
to estimate the efficiency of peptide incorporation by replacing the peptide in the 
coupling step with a chemical species that contains the same reactive functional 
group and is commercially available as a 14C radio-labelled species l9o. 
Amino acid analysis is a general technique that can be conducted on any 
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hydrolysed, usually with 6M HCI at 11 aoc and the molar amounts of each amino 
acid per sample can be determined. The amount of peptide included in a material 
is calculated from the average molar amount of each amino acid divided by the 
mass of the sample which gives a peptide concentration in units of mol g-I. 
Where the material being derivatised with RGD is a protein the background 
substrate will contain amino acids and the amount of RGD-containing peptide 
incorporated can be determined as the increase in amounts of the amino acids 
that are included in the pes. The analysis of RGD concentration after 
degradation of a substrate can also be performed using the ninhydrin assay for 
amines by degrading the substrate by acid l79 or base hydrolysis26,86. 
The incorporation of a dye or fluorescent into a peptide sequence can be 
used to quantify the amount of immobilised peptide79,80,165,167.210 and visualise the 
localisation of the peptide 1 19. Assays for specific functional groups can be 
utilised to determine the ROD concentration from the Sakaguchi assay for 
guanidine groups on the arginine side chain211 or Ellmans reagent for thiols96 . 
Methods of analysing the amount of ROD in solution from either the coupling 
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solution or substrate degradation products include HPLC50,73,128,181, UV 
spectroscopy175, gel permeation chromatographl05, NMR75 ,212,213 and SIze 
exclusion chromatography27,35. The efficiency of a coupling reaction can be 
assessed indirectly by the quantification of peptide concentration in the reaction 
solution before and after coupling however this may lead to reduced reliability. 
Semi-quantitative assays for the amounts of RGD present can be performed 
using ELISA to determine the binding of antibodies to immobilised 
ligands44,89,166,214. This procedure has the advantage that it quantifies the amounts 
of accessible ligands but the disadvantage that the assay only shows the relative 
amounts of peptide not the actual concentration. 
Spectroscopic ellipsometry analysis can be utilised to determine the 
thickness and the molar refractivity index of coatings or modification procedures 
and can be used to calculate the surface density of immobilised species 124,206. The 
mass of adsorbed peptide containing species can be used to determine the RGD 
concentration if the moles of peptide per mass unit are already known. The mass 
of adsorbed coatings can be determined using optical waveguide lightmode 
spectroscopy (OWLS)ll3. It should be noted that the majority of the assessment 
protocols are performed on the materials in a dried state and many polymeric 
materials may expand in aqueous environments as they adsorb water. 
3.3 Assessment Methods and Their Effect on Outcomes 
After an RGD-containing material is synthesised it must be assessed to 
determine whether it is fit for purpose. These biomaterials are generally utilized 
for two main purposes; investigation into cellular behaviour or for use in tissue 
engineering. The majority of the research is performed on cells cultured on the 
material in vitro either as an investigative study or as an initial evaluation method 
to generate an indication of the suitability of the material for tissue engineering. 
The criteria for whether a material is fit for purpose is highly dependent 
on the intended use and the initial assessment as to its suitability can be measured 
in a number of different ways. Usually the measure of success of the material is 
determined by its ability to improve an aspect of cellular behaviour above that of 
a non-peptide control. The aspects of cellular behaviour that have been used as 
assessment methods include adhesion (cell spreading, cell number, cytoskeletal 
organisation), attachment strength, viability, proliferation, motility, secretion 
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(DNA, RNA, cell specific functions) and differentiation. Note that disparate 
properties can be desirable dependent on the usage of the material; extracellular 
matrix deposition can be a desirable feature indicating the successful adhesion 
and function of cells or it may be an undesirable feature on non-fouling materials 
as the surface becomes remodelled and allows protein adsorption and non-
specific interactions. The outcome of the assessment, in terms of whether the 
material is deemed successful, may depend on which aspect of cellular behaviour 
is examined and also the methodology used for evaluation. For example a 
material may be successful at promoting cell adhesion but not spreading so an 
assay based method may report an increase in cell number or function whereas a 
visual based method would show the lack of cell spreading. In addition there are 
a number of experimental parameters involved in in vitro cell culture that may 
have an effect on the reported outcomes; these include cell type, seeding density, 
time of analysis, culture conditions and pre-treatment of the material. The aspects 
of the required cell behaviour, experimental design and analysis methods that 
may affect reported outcomes are analysed in more detail below. 
3.3.1 Cell Behaviour 
ROD moieties that bind to integrins can be found in a large number of 
ECM proteins including fibronectin, vitronectin, fibrinogen, osteopontin, 
collagen, Von Willebrand factor, laminin and thrombospondin215. The ROD 
sequence in each protein has different affinities for the various integrins 
produced by cells. Integrins are a family of transmembrane proteins that control 
various aspects of cell behaviour such as cell adhesion, cytoskeletal organisation 
and migration. The majority of mammalian anchorage-dependent cells produce 
integrins capable of binding to ROD peptides. However, the integrin expression 
profile and the activation of the integrins varies between cell types and the local 
environment of the cells216.217. The binding of the ROD motif to integrins 
regulates a large number of cell responses of which the best known are the 
adhesion, spreading and re-organisation of the cytoskeleton to form focal 
contacts. However the binding of the ROD motif can also regulate cell migration, 
proliferation and differentiation218. Different integrins can produce different 
cellular responses and have variable affinity for ROD sequences which leads to 
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the behaviour of cells on peptide-containing surfaces being affected by the nature 
of the peptide sequence and its micro-environment. 
The ability of an ROD-containing surface to promote the different facets 
of cellular behaviour is likely to depend on the binding affinity of the peptide in 
its current environment to a selected integrin that regulates that function219 . For 
example an ROD peptide may be able to bind to the integrin that regulates 
adhesion and promote this function but may not be able to bind to the integrin 
that regulates migration. Consequently when ROD biomaterials are analysed the 
aspect of cellular behaviour that is examined will have a large effect on whether 
the material is reported to be fit for purpose. 
The assessment of cells cultured on biomaterials will gIve different 
results depending on the time after seeding that the analysis is conducted as cell 
behaviour is time-dependent and different aspects of the behaviour will be 
analysed at different time points. Adhesion is the first stage and occurs in the 
first 1-2 hours after seeding followed by spreading, which can develop up to 24 
hours after seeding but is more usually established in the first 4 hours. Focal 
contacts and adhesions also develop up to 24 hours after seeding220. The degree 
of cell survival (viability) is an ongoing process, non-adhered cells are likely to 
die within the first hour however adherent cells may not have access to the 
requisite signals for survival and may die at later time points. Proliferation is also 
an ongoing process but no reports of proliferation up to 4 hours have been made 
and proliferation up to 12 hours is low. Metabolic activity of cells is a continual 
process as is the secretion of cellular products (DNA, RNA, proteins, enzymes) 
and these may be up or down-regulated dependant on the local cellular 
conditions and signals. 
3.3.1.1 Adhesion and Spreading 
Studies on the adhesion kinetics of cells plated onto ROD-containing 
materials have reported various rates of attachment with some studies finding 
maximal cell adhesion (cell number) within 60 minutes61.197 and others reporting 
increasing cell numbers up to 2 hrs 42.61.68.167 or even 5 hours54.179. Many of these 
studies assume that cell adhesion occurs within 60 minutes and the assessment 
terminates at this time point although a maximum in cell number has not been 
observed however this is partly due to trying to assess cell adhesion without 
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contamination from proliferation 189. Drumheller et al reported increasing cell 
numbers up 10 hours for high ROD concentrations and up to 50 hours for lower 
ROD concentrations although it seems likely that some proliferation will have 
occurred during this time4o. 
Average cell area has been shown to increase with time up to the 
maximum time tested (4 hours)221 and the percentage of cells that are spread can 
increase up to 80 hours after seeding41. 
In general the measured adhesion and spreading events increase with time 
as does the magnitude of the differences between peptide containing materials 
and negative controls. In some cases at short time points there is no significant 
improvement gained from the inclusion of an ROD peptide but this may develop 
at a later time point. For example the adhesion of fibroblasts onto plasma-
deposited acrylic acid was greater than the adhesion to the ROD-modified 
surfaces after 3 hours but after 24 hours the peptide surfaces were significantly 
better than the control surfaces67. Differences between various peptides may also 
be more clearly observed at longer time points. Osteoprogenitor cells attached to 
titanium surfaces modified with RODC and cylco-DtKRG in equal amounts after 
I or 3 hours culture time but after 24 hours the cell numbers were clearly higher 
on the substrates containing the cyclic peptide than the linear peptide201 . It is not 
always the case that spreading increases with time as Yang et al found that some 
concentrations of peptide coating produced greater cell spreading at 5 hours than 
at 24 hours56• 
3.3.1.2 Focal Contact Formation 
Streeter et al showed that rates of cell attachment to fibronectin and BSA-
ROD coatings were similar (see earlier) but that the rates of cell spreading were 
lower on the ROD coatings. In addition the actin organization on the ROD 
surfaces was much less pronounced than on the fibronectin coatings and 
displayed spot-like adhesion structures instead of typical focal adhesions. Singer 
et al also examined the formation of focal contacts on fibronectin or BSA-ROD 
coating and found that normal rat kidney fibroblasts formed focal contacts 
between I and 4 hours after seeding I96,207. The focal contacts on the peptide 
coated surfaces were unusually associated with fibronectin fibres as well as the 
usual micro filament bundles that were seen on fibronectin coated surfaces. 
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3.3.1.3 Viability and Proliferation 
It is evident that proliferation has an effect on cell number present at time 
points less than 24 hours as shown by Varani et al who incubated cells on 
coatings of poly-L-lysine and PronectinF for 15 minutes and then removed any 
non-adherent cells prior to continuing cell culture for a further 18 hours91. After 
18 hours the numbers of cells present on the materials was higher in most cases 
than after 15 minutes, showing cell proliferation. This means that any studies 
where the initial or only time point where the cell behaviour is examined is over 
approximately 12 hours will be examining a mixture of adhesion, viability and 
pro 1 iferati on 193 . 
A rise in cell number over time is due to proliferation and the 
proliferative index (initial cell number divided by cell number at time t) is often 
used to describe the cell proliferation. A proliferative index of less than I 
indicates that cell death occurs more frequently than cell division. A proliferative 
index of 1 probably indicates that cell death occurs at the same rate as ceIJ 
division rather than implying that no cell division occurs. 
There are numerous studies where the proliferation of cells on RGD-
materials has been investigated and in many cases there appears to be a definite 
time point at which proliferation starts. The onset time of proliferation is usually 
2-3 days after the seeding of cells63,I89,204 but can be later49 and the cell number 
remains fairly constant until this point. Proliferation may not be enhanced by the 
incorporation of ROD containing peptides even though the initial cell adhesion 
was promoted 126. 
There appears to be some evidence that some ROD-containing materials 
that can promote cell adhesion are unable to sustain long-term viability of cells. 
A number of investigations have found that the ROD-containing materials were 
significantly better than the controls at short time periods but over longer time 
periods the controls were as good as the peptide-modified materials and there 
was no statistically significant improvement in cell behaviour23,26. Other 
investigations have found that the viability of cells on ROD-containing materials 
declines with time such that lower numbers of live cells are found as the time of 
the experiment increases and that the cell death is greater than cell 
proliferation)3I,46,59,73,ll2. In some cases an initial proliferative spurt can be 
observed before cell number starts to decline46.162. 
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Hsu et al modified PLLA/PLOA scaffolds with collagen and then coated 
the scaffolds with a ROD-containing fusion protein24 . At a 12 hour time point 
there were more chondrocyte cells on the ROD containing materials however 
after 24 hours their number had declined. The culture on the scaffolds was 
continued for 6 weeks and the presence of the ROD coating inhibited the cell 
proliferation and extracellular matrix production. It may be that the fusion 
protein containing ROD de-adsorbed from the surface and reduced the cell 
number present over that of the controls by providing soluble competition for 
integrin receptors. 
It has been found that the number of cells present on SAMs containing 
ROD declined after 12 hours such that, after 24 hours the number of cells was 
equivalent to that on the scrambled peptide control, even though there had been 
an initial increase in cell number (1, 4 and 12 hour time points)17o. Cells cultured 
on fibronectin coatings under the same conditions maintained their viability. The 
loss of cell adhesion was attributed to the failure of the cells to secrete 
fibronectin. However this implies that the adhesion, after a 12 hour time point, is 
due to adhesion onto synthesised proteins, which seems unlikely. Kao et al found 
that the cell number dropped between 1 and 24 hours of culture, stabilised and 
then proliferation occurred after 180 hours in culture lOI • Park et al found that 
although the viability of hepatocytes encapsulated in ROD-containing hydrogels 
declined with time the rate of loss of viability was less than that observed with 
the non-modified hydrogels212 • 
Studies that investigated both the proliferation by counting cell numbers 
and the viability via tryphan blue showed that the total cell number in ROD-
containing hydrogels increased over time but that the relative viability of the 
cells decreased7s , Another study that investigated the viability of cells over time 
showed that the viability of insulinoma cells encapsulated in poly(Nipaam-co-
PE~) hydrogels declined steadily up to 7 days at which point the levels of 
viability remained constane3, This implies that there is a certain population of 
the cells that have not successfully grafted into the material and it is a matter of 
time before they die whilst the remaining population is successful. A similar 
result was also found by Phillips et al who investigated the monocyte cell 
numbers on ROD-modified PEO hydrogels and found the decline in cell numbers 
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was similar to that of tissue culture plastic and reached a plateau after 
approximately 100 hoursl12. 
It should be noted that some peptide sequences are more likely to 
promote proliferation than others as shown by Verrier et al who compared the 
number of osteoprogenitor cells over time on cyclo-DFKRG modified surfaces 
and GRGDSPC modified surfaces92 • After 24 hours the numbers of cells on each 
material were similar showing similar promotion of attachment by both peptides 
but after 48 hours the numbers of cells on the cyclic peptide modified surfaces 
were significantly greater than on the linear peptide modified surfaces. 
3.3.1.4 Differentiation 
Hepatocytes were grown on polystyrene coated with different peptides 
(P-2, PronectinF and fibronectin) and it was shown that all peptides promoted 
similar levels of cell attachment and that some promoted high levels of DNA 
synthesis but low levels of albumin secretion (differentiation marker)93. 
Conversely those that were not as successful at promoting DNA secretion 
maintained a higher degree of differentiated function showing an inverse 
relationship between growth and differentiation. Other studies have found that 
the incorporation of RGD in Nipaam-co-PEG hydrogels leads to enhanced 
hepatocyte albumin and urea synthesis32,212. It has also been shown that insulin 
secretion of insulinoma cells is also upregulated by the presence of RGD in 
poly(Nipaam-co-PEG) hydrogels33. 
~ Experimental Design 
The experimental parameters involved in the assessment of RGD-
materials to determine whether they are fit for purpose are self-evidently 
determined by the purpose for which the materials are designed. As a 
consequence of the wide range of purposes there are a wide range of 
experimental parameters that are utilised in the analysis of the biomaterials. 
However alterations in these experimental parameters can produce large effects 
in whether a material is deemed successful and some of the decisions made on 
how to conduct a biological evaluation of RGD-containing materials may be 
significant. 
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3.3.2.1 Cells 
A large number of different cell types and sources have been utilised to 
assess RGD-containing biomaterials. These include primary cells derived from 
animal or human sources and immortalised cell lines. The responses of primary 
cells are more likely to be similar to cells in their natural in vivo environment. 
However generating reproducible data from these cells can be more difficult than 
with cell lines as the source of the cells, passage number and culture conditions 
alter the cellular responses. Examples of cell types that have been investigated 
include fibroblasts, osteoblasts, epithelial cells, endothelial cells, keratinocytes, 
chondrocytes, hepatocytes, neurites, macrophages, melanoma, mesenchymal 
stem cells and osteoprogenitor cells. It should be noted that, due to the wide 
range of cells expressing RGD-binding integrins, the incorporation of an ROD 
peptide into a non-fouling material will also mediate the adhesion of immune/ 
inflammatory cells such as macrophages ll2 . 
Cell Type 
Different cell types express different integrin expressIon profiles and 
consequently the behaviour of separate cell types to the same RGD-containing 
material may be changed. Studies that have investigated the behaviour of various 
cell types have shown differences between the cell adhesion in terms of cell 
number and spreading and also in the magnitude of improvement caused by the 
incorporation of the peptide over the negative control 81 • 
This is illustrated by the attachment of various cells to RGD-modified 
and non-modified collagen/GAG matrixes222 . Fibroblasts attached well to the 
non-modified surface whereas keratinocytes and endothelial cells did not. The 
immobilisation of RGD on the matrixes caused a significant improvement in the 
numbers of keratinocytes and endothelial cells adhered but the extent of the 
improvement was much smaller with fibroblasts. In addition, despite the same 
numbers of each type of cell being seeded, the amount of adhered fibroblasts is 
twice that of the other cell types on all materials. 
Kurihara et al investigated the adhesion of fibroblast, cancer and neuronal 
cells to coatings of multiple RGD repeat sequences (2, 21, or 43 repeats) or 
fibronectin. Only the neuronal cells adhered better to (RGD)43 coatings than 
fibronectin coatings and they also displayed better responses to lowering the 
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coating concentration than the other cell types. Fibroblast cells showed improved 
cell adhesion to all peptide coatings whereas the cancer cells only responded to 
the longer repeat sequences and the neuronal cells only responded to the (RGD)43 
coating. 
Cell Source 
Even within a cell type the source of the cells may affect the reported 
results although the responses of the cells cultured on the material usually follow 
the same trends the magnitude of the response can be altered. This was shown by 
Singer et al who cultured various fibroblast cell lines on surfaces coated with 
BSA that was subsequently modified with ROD-containing peptide207 . The 
formation of focal contacts of various fibroblast cell types on BSA-RGD and 
fibronectin coatings was investigated and it was found that Balb/c 3T3 (mouse 
clone A31) cells were incapable of forming focal contacts on the peptide coated 
surfaces. NRK (normal rat kidney) and Nil 8 (normal hamster) fibroblasts formed 
numerous focal contacts on the same surfaces and produced significantly more 
focal contacts on fibronectin coated surfaces than the Balb/c 3T3 cells. 
In cases of primary cells the donor source may affect the reported results 
as Marletta et al showed when they investigated the cell adhesion of primary 
osteoblasts derived from patients of different ages. Cells derived from younger 
patients tended to cover a larger percentage of the area of poly(caprolactone) 
coated with ROD and also tended to show a larger increase on the ROD coated 
materials over the non-coated materials57• In addition the length of time that 
primary cells are cultured for affects their integrin expression and hence their 
affinity for ROD peptides223 . The trends in integrin expression as passage 
number increases for human chondrocytes are shown in Figure 3-13 below. 
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Figure 3-13 Trends of integrin expression during monolayer cultivation of human articular 
chondrocytes. Reproduced from Jeschke et al t.m . 
From Figure 3-13 it can be seen that the a v integrin expression decreases 
as the passage number increases. leschke et a1 also investigated the effect of 
increasing passage on cell adhesion to RGD-peptide coated surfaces. The seeding 
efficiency increased with increasing passage number from passage 10 to passage 
18 but then fell dramatically for passage number 20 as shown in Figure 3-14. 
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Figure 3-14 Adhesion of human articular chondrocytes on RGD-peWide coated surface in 
the course of monolayer cultivation. Reproduced from Jeschke et alt. 23. 
t,:): Reproductions of Figure 3(t) and Figure 6 (:):) from "Jeschke, B., Meyer, 1., Jonczyk, A., 
Kessler, H., Adamietz, P., Meenen, N. M .. Kantlehner, M., Goepfert, C. & Nies, B. ROD-
peptides for tissue engineering of articular cartilage. Biomalerials 23 , 3455-3463 (2002)" wi th 
permission from Elsevier Ltd. 
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Similar trends in increasing cell adhesion for increasing peptide-coating 
concentration were observed but the magnitude of the effects varied dependent 
on the passage number. It is evident that there is a critical passage number 
threshold above which the RGD-coatings can no longer promote effective cell 
adhesion. As the expression of many of the integrins decreases with increasing 
passage number on TCP it appears as though the ROD-peptide either stimulates 
integrin expression or is able to function with any of the integrins that are 
expressed by the cells. 
3.3.2.2 Seeding Density 
Cell seeding densities ranging from 5 x 103 cells/cm2 to 1.8 x 106 
cells/cm2 have been employed to test the effectiveness of ROD-containing 
biomaterials. There is some evidence showing that the seeding density may have 
an effect on the reported outcome. High cell seeding densities may produce a loss 
of viability due to confluency promoting contact-mediated cell death73 . 
High cell seeding densities have been shown to reduce the secretion of 
endothelin-l on PronectinF coatings due to contact inhibition as the cells form a 
monolayer214. In addition high cell seeding density may have an effect on the 
reported cell number and cell area if confluency is observed. It may be that cells 
form confluent monolayers and a reported increase in cell number necessarily 
refers to a decrease in cell area as there is not enough surface space for larger 
numbers of cells to fully spread. An example of this type of behaviour is shown 
in Figure 3-15 by Yamauchi et al who took photomicrographs of fibroblasts 
adhered to glass, 0.14 mg/cm2 and 0.64 mg/cm2 coatings ofkeratin-RGD52 . 
54 
Figure 3-15 Photomicrographs of fibroblasts adhered to glass (a), O.14mg/cm2 (c) and 
O.64cm2 coatings ofkeratin-RGD (e) after 24 hours. Note that the seeding density was 2xl06 
cells per dish of diameter 3.Scm (equivalent to -2.08xl0s cells/cm2). Reproduced from 
Yamauchi et al t .s2• 
3.3.2.3 Culture Conditions 
The manner in which cells attach to surfaces can be altered by the 
conditions under which they are cultured. One of the most common variables that 
can be altered is the presence or absence of serum in the media. There is a 
growing awareness of the need to minimise the use of animal-derived products in 
the production of biomaterials seeding with cells and consequently the behaviour 
of cells in serum-free media is often investigated. 
Serum-Containing vs. Serum Free Media 
The presence of serum in the media can alter the cell adhesion profile 
over time as shown by Lin et a161• In serum-containing media maximal cell 
adhesion is seen after 40 minutes in comparison to the same materials in serum-
free media where the number of attached cells rises steadily over the time period 
assessed (up to 240 minutes). Consequently in serum-containing media the 
effects of RGD can be seen more clearly at short time points than in serum-free 
media where longer times will emphasise the differences between substrates. 
t Reproduction of Figure 4 from "Yamauchi , K., Hojo, H., Yamamoto, Y. & Tanabe, T. 
Enhanced cell adhesion on RGDS-carrying keratin film. Materials Science & Engineering C 23, 
467-472 (2003)" with permission from Elsevier Ltd. 
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The magnitude of the effect caused by the inclusion of a peptide may be 
altered by the presence or absence of serum. The presence of serum can increase 
the effect observed due to increased cell viability73 or decrease the effect due to 
protein effects obscuring the effects of the peptide. In some cases the positive 
effects of the inclusion of an ROD sequence can only be seen in serum-free 
media. OUmU~derelioglu et al observed a significant improvement in the cell 
attachment to non-woven polyester fabric when it was modified with ROD only 
when the cells were adhered in serum-free media and not when serum was 
present54. In addition the dependence of the cell adhesion on the ROD 
concentration is more clearly shown in serum-free media as shown by Brandley 
et a169 . The cell attachment appeared to show no dependence on ROD 
concentration in serum-containing media but a clear dependence was shown in 
serum-free media. In addition low concentrations of peptide appear to be less 
effective in serum-free media than in serum-containing media 121. 
In addition serum may alter the expression profile of extracellular matrix 
components, proteins or other cell secretion products. The presence of serum 
appears to inhibit the production of proteins as shown by Malek et al who 
investigated the production of endothelin-l by endothelial cells on PronectinF 
coatings when cultured with serum concentrations ranging from 0 - 10%214. 
Dynamic Cell Culture 
As well as the increased attachment of cells in terms of cell number and 
the increased spreading the incorporation of an ROD peptide can improve the 
adhesion strength. Cells are more likely to be retained in dynamic environments 
where stresses are placed on the cells such as fluid pressure in replacement of 
blood vessels65,I88,205,224,225 or mechanical flexing l20,121. The presence of ROD 
peptides has been shown to increase the force necessary to detach cells from a 
substrate 123,175,176. 
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3.3.3 Analysis Methods 
There are two main types of analysis methods for determining the ability 
of biomaterials to promote various aspects of cellular behaviour, visual methods 
and assay-based methods. Assay based methods are quantitative and show the 
relative activities of cells whereas visual methods can be used in a qualitative or 
quantitative manner and show the relative morphologies or numbers of cells. 
3.3.3.1 Visual Methods of Analysis 
Image Generation 
Images of cells can be generated by phase contrast microscopy, immuno-
fluorescent microscopy, confocal microscopy and scanning electron microscopy 
(SEM). Phase contrast and immuno-fluorescent microscopy require the substrate 
on which the cells are adhered to be optically transparent. 
Image Analysis 
When images of cells grown on substrates have been captured the images 
are often analysed to try to provide a quantitative measure of the success of the 
material. The information that can be gained from images of cells includes cell 
number, cell area, cell shape (including filopodia formation and neurite 
extension) and the area of material covered by cells. From this information the 
data can be collected and summed up in a variety of ways. 
The number of cells per unit area and the percentage adhesion (cells per 
unit area divided by applied number of cells per unit area) are in common use as 
measures of cell behaviour on novel biomaterials. However this information does 
not give an indication of the viability of the cells and does not differentiate 
between healthy cells and rounded cells that are likely to die soon. 
The morphology of the cells on the substrates gives a better indication as 
to the viability and normal behaviour of the cells however it is more difficult to 
represent this as numerical data. Percentile area charts have been used to indicate 
the numbers of cells that fall into various categories of cell area96 however this 
method does not indicate the numbers or densities of cells adhering to a 
substrate. 
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In references where data is presented containing only one aspect of the 
image such as cell number or the cell shape the results should be treated with 
caution. The general trends shown by the image analysis will probably be 
accurate however the differences between substances may be magnified or 
reduced dependent on the analysis as shown by Massia et al in Figure 3-16 
below. In this case endothelial cells appear to respond poorly to the linear peptide 
as the cell numbers are ~50% of the control but when the cell area is analysed the 
I inear peptide appears to promote good cell spreading. 
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Figure 3-16 Comparison of EC, 3T3 and SMC adhesion on substrates containing surface 
grafted linear and cyclic RGD I)eptides. Left - % cell adhesion. right - % cell spreading. 
Reproduced from Massia et al t. 87 
In addition artefacts can be produced from the experimental conditions 
utilised such as the seeding density. If cells are confluent or over-confluent the 
mean cell area will be reduced as cells will not have enough space in which to 
fully spread (see section 2.2.2). 
3.3.3.2 Assay Based Methods of Analysis 
Assay based methods provide a quantitative measure of the amount of 
cellular components, products or the activity of cellular process. The cellular 
products generated can be found in the cell culture media or deposited on the 
material's surface. The amount of cellular products deposited on a surface will be 
dependent on the characteristics of the substrate as well as the rate of production. 
The rate of production can be assessed by analysing the amount of cellular 
products generated at various time points. 
t Reproductions of Figure 6 and Figure 7 from "Massia, S. P. & Stark, 1. Immobilized RGD 
Peptides on Surface-Grafted Dextran promote Biospecific Cell Attachment, Journal of 
Biomedical Materials Research 56, 390-399 (200 I)" with the pennission of John Wiley & Sons 
Ltd. 
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Assays for cellular components cannot distinguish between live cells and 
dead cell material deposited on a surface. Examples of cellular components that 
have been utilised to assess the amounts of cells on RGD-containing biomaterials 
include total DNA25,30,167, nucleic acid assay (CyQuant)59,78,93,170, total RNA34 
and total protein assay120,226. 
Assays that depend on the current activity of cellular processes include 
Alamar blue, CCK-8, hexosaminidase and MTT assays. The Alamar blue assay 
incorporates resazurin and resarufin as colorimetric redox indicators that change 
in colour in response to chemical reduction resulting from cell metabolism57,224. 
The MTT assay utilises the purple colour from formazan formed from the 
oxidation of 3-( 4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) by the action of mitochondrial reductase enzymes31 ,50,87,181,227. CCK-8 
develops an orange formazan product on reaction with cellular 
dehydrogenases26,89,I62, The hexosaminidase assay quantifies the activity of the 
lysosomial enzyme N-acetyl-p-D-hexosaminidase using p-nitrophenyl N-acetyl-
P_D_glucosaminide43,44,9o,92,228. Other assays for cellular processes include lactate 
dehydrogenase activity68-70,212 and chromogenic substrate solution2ol . 
Some assays can show the levels of cell differentiation as the cellular 
process is only present in certain cell types and the activity of the process or the 
amount of products can be quantified, Urea synthesis in hepatocytes can be 
quantified by the Berthelot method88,229,23o and alkaline phosphatase production 
in osteoblasts can be assessed with p-nitrophenyl phosphate25,34,73. Dopamine 
secretion in pheochromocytoma cells was measured by HPLC with an 
electrochemical detector using 5% buffered methanoI 17!!. Hydroxyproline content 
is a marker of collagen synthesis and can be determined by oxidation with 
chloramine and development with p-dimethylaminobenzaldehyde30,23 I , 
Enzyme-linked immunosorbent assay (ELISA) can be used to determine 
amounts of cell products for which there is an antibody. A peroxidase-
conjugated antibody is bound to the cell product and the amount of peroxidase is 
quantified with a calorimetric assay. Albumin synthesis93,212, endothelin-l 
production214 and osteocalcin34 have been quantified on RGD-containing 
substrates using ELISA. 
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3.3.3.3 Comparison of Methods 
In general the trends observed by varying the method of analysis are 
similar however the magnitude of the effects observed may be different. This 
was shown by Smith et al where the trends in increasing peptide concentration 
were similar however by MTT assay the highest concentration of ROD gives a 
result comparable to TCP whereas by cell count the material is clearly poorer 
than TCP as shown in Figure 3-17 below73 • 
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Figure 3-17 24 bour adbesion of C2C12 cells to RGD-modified Nipaam-co-NASI films. 
Reproduced from Smith et alt ,7l 
Similar observations where assay based methods and visual based 
methods have been compared show that this IS a fairly common 
phenomenon I2o,227,232. In particular the MTT assay gives an elevated response for 
some materials compared to the cell number probably due to an increased 
respiration rate for loosely adhered cells. 
t Reproduction of Figure 3 from "Smith, E., Yang, J., McGann, L., Sebald, W. & Uludag, H. 
RGD-grafted thermoreversible polymers to facilitate attachment of BMP-2 responsive C2Cl2 
cells. Biomaterials 26, 7329-7338 (2005)" with the permission of Elsevier Ltd. 
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A total protein as ay conducted on myocytes seeded onto RGD-modified 
silicone membranes or fibronectin coated surfaces showed equivalent cell 
numbers on both surface . However immuno-fluorescent staining with phalloidin 
for actin showed that the fibronectin surface clearly promoted actin filament 
organisation but the RGD-modified surfaces did not a shown in Figure 3-18. 
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Figure 3-18 Adhesion of cardiac neonatal myocytes to peptide-modified silicone and 
fibronective coated silicone (48 hours) asses ed by total protein assay (above) and phalloidin 
staining (below). Reproduced from Boateng et alt , 12o. 
t Reproduction of Figure 2 from "Boateng, S. Y., Lateef, S. S., Mo ley , W. , Hartman , T. J., 
Hanley, L. & Russell, B. RGD and YIGSR synthetic peptides facilitate cellular adhesion identical 
to that of laminin and fibronectin but alter the phy iology of neonatal cardiac myocytes. 
American }oumal of PhysioLogy - CeLL Physiology 288, 30-38 (2005)" used with permission from 
APS. 
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3.4 Effects of RGD Design on Cell Behaviour 
As shown in section 3.2 there are numerous strategies for immobilising 
RGD peptide sequences on a wide assortment of materials with different intrinsic 
abilities to promote various aspects of cell behaviour. In addition there is 
considerable variety in the peptide sequence containing RGD that can be 
presented towards cells with respect to the choice of peptide length, sequence 
and local organisation as well as the concentration and immobilisation strategy. 
These peptides have different affinities for integrins as determined by the 
flanking residues, conformation and accessibility towards integrins. More affine 
ligands are likely to require a lower density of peptide to achieve the same effect 
on cellular behaviour. The effects of the design parameters for the synthesis of 
the RGD-containing materials are discussed here. 
3.4.1 Material Design Effects 
The analysis of ROD-containing biomaterials usually refers to the 
improvement of an aspect of cellular behaviour obtained from the inclusion of 
the peptide over that of a negative control. The negative control is usually a 
substrate that is similar to the peptide-modified substrate but lacking the active 
ligand. The controls can include a scrambled or substituted peptide or can be 
devoid of any peptides. The improvement that can be obtained from the inclusion 
of the peptide can be dependent on the background substrate to which the peptide 
is added. In addition the presence of the peptide can alter the physical and 
chemical properties of a material and affect the biological properties of the 
material through non-specific means. This section deals with the effects that the 
background materials and the synthesis methods have on the ability of ROD to 
promote cell attachment. 
3.4.1.1 Proof of ROD Specificity 
The inclusion of RGD in a biomaterial may have effects on the biological 
properties by means other than the binding of the peptide to integrins. The 
peptide may change the chemical and physical properties of the material (surface 
roughness, phase separation, water content, electrostatic properties etc) and 
through them the biological properties by a modified protein adsorption profile. 
Consequently the assessment of the biomaterials often includes a methodology to 
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determine whether the effects of the peptide are due to specific integrin binding 
or more generally through other means. 
Peptide-Containing Controls 
One method of determining whether the presence of the peptide has 
altered the properties of the biomaterial is to compare the RGD-containing 
material to one containing a peptide sequence with a substituted peptide or a 
scrambled peptide. A substituted peptide is one in which one of the amino acids 
has been replaced with another amino acid with similar properties such as the 
replacement of D (aspartic acid) with E (glutamic acid). A scrambled peptide is 
one in which the amino acids remain the same but the order of the active 
sequence is scrambled. This method has the advantage of categorically 
confirming whether any increase in cell adhesion is due to integrin binding but 
the disadvantage of requiring synthesis of additional peptide and materials. 
According to Olbrich et al there does not appear to be any differences in cell 
behaviour observed between the substituted peptide RGE and the scrambled 
peptide RDG 128. 
In the majority of cases where a substituted or scrambled peptide has 
been investigated the cell behaviour is not improved over the non-peptide 
containing control however there are some exceptions. Park et al incorporated 
GCGYGRGDSPG or GCGYGRDGSPG into halouronic acid and PEG based 
hydrogels in amounts approximating to 60~mollg. Cell activity was promoted on 
the networks derivatised with the scrambled peptide although not to the same 
extent as on the networks derivatised with the active peptide. 
Soluble Peptides 
Another method to determine the specificity of cell adhesion is to utilise a 
soluble peptide that blocks the integrin binding sites and hence prevents cell 
adhesion by RGD-integrin specific routes. The soluble peptide may be added to 
the cells prior to seeding, to the media as the cells are seeded, or to the media 
after a set time period has elapsed. 
It should be noted that a high concentration of soluble peptide may be 
required for competitive binding as shown by Porte-Durrieu et ai, who incubated 
endothelial cells with soluble RGDC for 30 minutes immediately prior to seeding 
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the cells on silica grafted with RGDC. It was found that 5llg/ml of the soluble 
peptide was insufficient to compete with the immobilized peptide however 
lOOOllg/ml of the oluble peptide caused a significant decrease in the cell 
adhesion. The inhibition of cell adhesion appears to be proportional to the 
amount of soluble RGD utilised99 . This was confirmed by Hayman et al who also 
showed that different cell type can respond differently to equivalent 
concentration of soluble RGD peptide l 6 1. 
The remodelling of urface by cells wa illu trated effectively by Ebara 
et al who used so luble RGD to detach cells from urfaces they had been cu ltured 
upon for varying length of time. After 4 and 24 hours of culture the cells 
detached more rapidly and to a greater extent than after longer periods of 
culture76 . 
Integrin binding sites can also be blocked using antisera that can be 
h I b· d ... 53 129 169 Th· h h c osen to on y m to certa10 10tegnn . ' . IS sows t e integrin 
pecificity a well as the electivity of the RGD-integrin binding effects. 
L.l.!.1 Substrate Effect 
Alteration in the abi lity of the control sub trate to promote that aspect of 
cellular behaviour may modify the level of improvement gained from the RGD 
peptide. For example control ub trate may be able to promote high level of 
cell attached through protein adsorption but the proteins may hinder the integrin 
binding to peptide and decrease their effectiveness. The abi lity of the control 
ubstrate and the effect of the peptide on an a pect of cell behaviour cou ld be 
competitive, cumulative or cooperative. 
'+-< 
o 
Competitive Cumulative Cooperati ve 
Figure 3-19 Effect of ability of control substrate and RGD-peptide inclu ion on the cell 
behaviour. Black lines - ability of control to promote an aspect of cell behaviour, red line _ 
improvement in cell behaviour caused by the inclusion of an RGD-peptide. 
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The ability of the RGD-peptide to promote an aspect of cell behaviour is 
considered in terms of the improvement over a control substrate and the overall 
level of the cell behaviour. Significant improvements in an aspect of cell 
behaviour from the inclusion of an RGD-peptide can still result in materials that 
behave poorly in comparison to other materials if the control substrate gave poor 
levels of cell behaviour. There is only a limited amount of literature wherein the 
effect of changing the background substrate on the effect caused by RG 0 
inclusion has been investigated. 
Chemical Effects 
It is likely that the chemical composition of a substrate will affect the 
ability of an immobilised peptide to promote cell adhesion and other aspects of 
cell behaviour as the environment that the peptide is in will affect the peptide 
conformation as well as the approach of cells and integrins. In addition the ability 
of the peptide to perform may be affected by the ability of the bulk substrate to 
adhere proteins. 
Drumheller et al synthesised semi-interpenetrating networks from PEG-
DA, acrylic acid and trimethylolpropane triacrylate and derivatised the surfaces 
with GRGDS in concentrations that could be controlled by altering the % of 
acrylic acid incorporated4o • At 1% AA (and theoretical 1% RGD modification) 
the percentage cell adhesion was ~83% when 0.1 gig PEG-DA was utilised but 
the percentage cell adhesion decreased to 75% and 64% when the PEG-DA 
concentration was increased to 0.2 and 0.4 gig respectively. This shows that the 
effectiveness of a given concentration of peptide can be modified by the nature 
of the background substrate. It also implies that the minimum RGD concentration 
required to be effective is dependent on the nature of the background substrate. 
However at higher AA concentrations of 6 and 10% (and therefore higher 
theoretical RGD concentrations) the percentage cell adhesion was determined to 
be 100% and was not decreased by increasing PEG-DA concentration. This 
implies that there a maximum effect that increasing the RGD concentration can 
have on the cell adhesion and further increases in peptide concentration will not 
improve the cell behaviour but may protect the ability of the peptide to work in 
adverse conditions. The concentrations of peptide in the materials were assessed 
to be 12, 66 and 110pmol/cm2 by radiolabelling. However these figures denote 
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the amount of peptide immobilised per square centimetre of network. It seems 
likely that the surface accessible concentration of RGD is significantly lower as 
this amount of peptide will be spread throughout the bulk of the porous network. 
The thickness of the networks was not stated so it is not possible to determine the 
surface concentration. There are other severe limitations of this work as well; the 
percentage cell adhesion was determined to be 100% after 24 hours culture. This 
figure seems unrealistic as it seems unlikely that 100% of cells would have 
adhered and during a 24 hour period some proliferation will have occurred such 
that the percentage adhesion should be slightly higher or lower than the 100% 
point. In addition as the amount of PEG-DA was altered the overall mass of the 
network was also altered such that the amount of RGD was diluted over a larger 
area. This makes it difficult to tell whether the decrease in cell adhesion is due to 
a decrease in effective RGD concentration or due to the change in background 
substrate. 
In one system self-assembling mono layers were created where the 
amount of peptide could be precisely controlled and the micro-environment 
could be altered by using different lengths of oligo( ethylene glycol) chains on the 
non-modified species forming the monolayersl7l. It was found that as the chains 
grew longer the cell number and average cell area decreased linearly. In addition 
at the shortest PEG chain length the three different concentrations of RGD 
performed equally well whereas at longer chain lengths greater concentrations of 
ROD promoted higher levels of cell attachment. This appears to support the work 
of Drumheller et al in which it was implied that the ROD concentration only 
affects the cell behaviour below a critical threshold of substrate effects on cell 
behaviour. It appears that increasing the chain length of ethylene glycol units has 
hindered the access of peptide sequences towards integrins such that the 
concentration of accessible peptides is lowered below a critical threshold and 
becomes crucial to the extent of cell adhesion and spreading. The change in 
micro-environment has altered the accessibility of the peptides and consequently 
the peptide concentration required for maximal cell response has increased. 
Lee et al produced self-assembling monolayers with various surface 
chemistries, modified these with RGD and found that the peptide incorporation 
produced a small improvement in the cell adhesion strength regardless of the 
background surface as shown in Figure 3-20 below 176. This implies that the 
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effect ofRGD-inclusion on cell detachment strength is cumulative with the effect 
of the control substrate. 
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Figure 3-20 Cell adhesion strength to self-assembling monolayers with various chemistries 
(A) and the self-assembling monolayers with RGD attached (8). Reproduced from Lee et 
al t •176, 
Hydrogels of PEG and HEMA have been derivatised with RGD or the 
charged monomer species 2-sulfoethyl methacrylate (negative) or 2-
methyacryloxy ethyltrimethyl ammonium chloride (positive) incorporated 81• The 
concentration of the charged species was fixed at 200mM and the peptide den ity 
was not analysed. The incorporation of both charged pecies and RGD increased 
the levels of cell attachment over the neutral control hydrogel. The positive ly 
charged species increased the levels of cell attachment more than the peptide 
modification. It is not known whether an increased concentration of RGD could 
produce a level of cell adhesion equal to or greater than that produced by the 
positively charged monomer. It would be interesting to see whether the addition 
of RGD to charged hydrogels would promote an additional increase in ce ll 
adhesion when the two strategies are utilised in combination. 
t Reproduction of Figure 3 from "Lee, M. H. , Brass, D. A., Morris, R., Composto, R. J. & 
Ducheyne, P. The effect of non-specific interactions on cellular adhesion using model surfaces. 
Biomalerials 26, 172 1-1730 (2005)" with permission from Elsevier Ltd. 
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Polyethylene surfaces were oxidised by ion-beam irradiation with Ar t or 
Kt and then modified with RGD233 • The water contact angle of the surfaces 
decreased with increasing irradiation due to oxidised species and was not altered 
significantly by the addition of the peptide. The adhesion of fibroblasts to the 
surfaces was dependent on the fluence (amount of irradiation) and the 
modification of a surface with RGD produced a similar improvement over the 
non-modified surfaces in all cases implying that the effects of increasing 
oxidised species on the surface and addition of peptide were cumulative as 
shown in Figure 3-21. 
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Figure 3-21 Water contact angle (A) and fibroblast adhesion numbers (B) on polyethylene 
irradiated with Ar+ or Kr+. Reproduced from Ro~kova-Hlava~kovat.233. 
Physical effects 
Surface roughness has an effect on the ability of surfaces to adhere cells 
and also an effect on the ability of RGD to promote the cell adhesion. Schuler et 
al showed that on poly(lactic acid-graft-polyethylene glycol) suhstrates smooth 
surfaces coated with RGD were more effective than rough surfaces coated with 
RGDI13. The effect of the surface topography and the addition of the active 
peptide sequence appeared to be cumulative when compared to the scrambled 
peptide sequence. 
t Reproduction of Figure 2 and Figure 4 from "Rockova-Hlavackova, K., Svorcik. V .• Bacakova. 
L., Dvorankova, B., Heitz, J. & Hnatowicz. Bio-compatibility of ion beam-modified and RGD-
grafted polyethylene. Nuclear Instruments and Methods in Physics Research B 225, 275-282 
(2004)" with the permission of Else vier Ltd. 
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Nano-amorphous calcium phosphate, nano-crysta lli ne hydroxyapatite and 
conventional hydroxyapatite were all modified with R 0 and the adhes ion or 
osteoblasts to the surfaces was examined20o • As can be seen in Figure 3-22 the 
modification of the conventional hydroxyapatite wi th RGD produced an increase 
in cell adhesion which gave ri se to a ce ll density comparable to that produced by 
the non-modified nano-amorphous material. The addition of RGD increased the 
ce ll adhesion in all cases and it is interesting to note that the largest increase was 
obta ined on the materials that performed best without the modification . Thi 
implies that the effects of substrate and the effects of RGD-inclu ion were 
cooperative in determining the numbers of adhered ce ll s per cm2 in thi s case. 
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Figure 3-22 Osteoblast adhesion to calcium phosphate and hydroxya~a tite materials with 
differing levels of crystallinity. Reproduced from Balasunduram et ul t •2 0. 
t Reproduction of Figure 5 from "Bala undaram, G., Sato, M. & Webstcr, T. J. sing 
hydroxyapatite nanoparticles and decreased crystallini ty to promote osteoblast adhesion imi lar 
to fu nctionalizing with RGD. Biomaterials 27, 2798-2805 (2006)" with permiss ion from Elsevier 
Ltd. 
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The rigidity of a material will also have an effect on some aspects of the 
cellular behaviour such as the motility as the stiffer a material is the more ea il y 
force can be transduced through a migrating ce11234 . ell attached to electrosplln 
polymers containing RGD deformed the fibres by exerting a contractile force on 
the fibres26 . It is likely that cells would be unable to migrate on these materi als as 
applied force provides deformation of the substrate rather than ce ll movement. 
SEM images of the electrosplln polymer before and after deform ation by ce ll arc 
shown in Figure 3-23. 
Figure 3-23 RGD-modified PLGA electrospu lI mesh (8) and the same mesh after 8 hours 
adhesion of fibt'ob lasts (D). Reproduced from Kim et alt .26• 
Coating Effects 
The background substrate on which a coating i formed may affe t the 
accessibility or orientation of ligands and produce different ce ll behaviours ~ r 
coatings of the same peptide on different background . When the hepatocytes 
were grown on coatings of a 2.3kD peptide on different types of po lystyrene it 
was shown that the type of polystyrene that the coating was form ed upon alt red 
the response of the cells from a growth mode to a differentiated phenotype both 
in morphology and secretion of DNA or albumin. The authors believe that the 
alteration in behaviour may be caused by different orientation and conformation 
of the peptide on the different plastics93 . 
t Reproduction of Figure 1 and Figure 6 from "Kim , T. G. & Park, T. . Biomimicking 
Extracellular Matri x: Cell adhesive RGD Peptide Modified , lectrospun Poly(D,L-lacti -co-
glycolic acid) Nanofiber Me h. Tissue Engineering 12, 22 1-233 (2006)" with permi sion from 
Liebert Publishing. 
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When streptavidin engineered to contain peptide sequences from 
fibronectin or vitronectin was coated on polystyrene or biotin-BSA the levels of 
cell adhesion were reduced on the biotin-BSA coatings especially at low coating 
concentrations and a greater dependence on the peptide sequence was observcd53 • 
3.4.1.3 Comparison of Synthesis Methods 
Coating vs. Modification 
Poly(Nipaam-co-NASI) have been prepared and either reacted with the 
peptide and then deposited as a film or the film prepared first and the peptide 
subsequently reacted with the film73 • It was found that the first method (coating) 
did not promote cell adhesion whereas the second method (modification) did. 
The authors assumed that this was because the majority of the ligands were 
buried in the bulk-phase of the film when the coating was formed after the 
attached of the peptide. 
Irvine et al produced combs that were modified in solution (followed by 
coating), activated in solution and coupled in situ (modification procedure), or 
both activated and coupled in situ (modification procedure). They showed that 
the levels of peptide immobilisation were 30% lower by the last method than the 
others (see section 3.2.2)79. The amount of peptide contained in the final 
substrate was reflected in the adhesion of cells to the substrates prepared by the 
various methods. There was no reduction in the amount of cell adhesion on 
peptide containing coatings that had been cast onto a preformed solid indicating 
that peptides were accessible towards ligands which has been attributed to a 
quasi-2D confinement of the comb polymer at the water interface to minimise 
interaction of water with the backbone and maximise interactions with the 
chains. 
Similar levels of cell adhesion were observed on substrates of BSA-RGD 
regardless of whether the protein-peptide conjugate was synthesised in solution 
and adsorbed or the protein was adsorbed first and then the peptide covalently 
attached in situ43 • 
A study of focal adhesions on cells adhered to fibronectin coated or 
fibronectin immobilised surfaces showed two distinct types of cell-matrix 
adhesions235 • On coated surfaces the cells formed "fibrillar adhesions" enriched 
71 
in tensin but lacking paxillin and vinculin. On the surfaces where fibronectin was 
covalently linked to the material the cells formed "classical" focal contacts 
containing high levels of paxillin and vinculin. The study associated the change 
in focal adhesion type with the rigidity of the substrate although by this they 
probably meant that the binding ligand was rigidly fixed to the substrate and 
unable to move. 
Incorporation vs. Modification 
Acrylamide gels have been prepared with varying concentrations of RGD 
via the copolymerisation of either a pes or an NHS activated ester that was later 
displaced by the peptide68 • Similar levels of RGD concentration were 
immobilised into the gels by both methods however the cellular response was 
dependent on the synthesis method. When the peptide was copolymerised the 
numbers of cells adhering to the surface were approximately half the numbers 
attached to the gels with equivalent peptide concentrations but synthesised via a 
modification route. This may be due to the localisation of peptide at the surface 
with the modification route but this seems unlikely as the activated ester will 
have been copolymerised throughout the bulk and the gels should be porous 
enough to allow access of reagents. It appears that the copolymerisation of a 
peptide adversely affects the activity of the peptide, possibly through reactions of 
the side chains of the peptide. 
3.4.1.4 Distance of Peptide from Bulk 
It is known that to achieve the promotion of cell adhesion the ligands 
must be spatially accessible towards ligands. This forms the requirement for a 
certain minimum spacing between the bulk of the material and the active peptide 
sequence. The distance can be achieved via additional amino acids in the peptide 
chain or through the incorporation of a "spacer arm". The distance that the 
peptide is required to be from the bulk material depends on the physical 
properties of the bulk such as openness of a network or water content in swollen 
materials that affect the accessibility of the bulk. 
It has been shown that PEG-DA based materials synthesised by 
incorporating a peptide require a long spacer arm between the bulk and the 
peptide in order to promote cell adhesion41 • This is not surprising as the PEG-DA 
contains two acrylate groups and hence forms a highly cross-linked network with 
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long chains extending from the backbones in a manner similar to a brush 
polymer. A peptide incorporated into the backbone by polymerisation would be 
buried inside the brush unless it was itself attached to a long chain. An 
interesting study was made on the accessibility of IgG attached to a PEG spaccr 
arm in hydrogels composed of PEG-DA and poly(propylene fumarate-co-
ethylene glycol) copolymers with varying molecular weights (CP 2000 and 
CP5000)236. The results showed in all cases a surface concentration lower than 
that predicted from the bulk measurements with the longer copolymer tending to 
reduce the amount of available ligands. Similar materials utilising PEG but with 
a modification method do not require a spacer arm because the immobilisation 
occurs only at accessible sites95.IOI-104. 
In a system that utilised the residual double bond in poly(methyl 
methacrylate) to polymerise a coating of acrylate-containing RGD onto the 
surface it was found that the shortest spacer arm tested did not effectively 
promote cell adhesion except at very high concentrations as shown in Figure 
3-24 below77 • The longer spacer arms were all equally effective at promoting cell 
adhesion. 
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Figure 3-24 Cell plating efficiencies of osteoblasts on P-MMA modified with RGD-acrylate. 
Acrylate spacer 1 (star), acrylate spacer 2 (circle), acrylate spacer 3 (square, acrylic spacer 
4 (triangle). Reproduced from Kantlehner et alt ,77. 
t Reproduction of Figure 2 from "Kantlehner, M .• Finsinger. D .• Meyer. J., Schaffner. P., 
Jonczyk, A., Diefenbach, B., Nies, B. & Kessler, H. Selective ROD-Mediated Adhesion of 
Osteoblasts at Surfaces of Implants. Angew. Chem. Int. Ed. 38, 560-562 (1999)" with permission 
from Wiley-VCH. 
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Beer et al synthesised Gn-RGDF with 1 to 19 glycine spacers and coupled 
these peptides to polyacrylonitrile beads with efficiencies of ~ 74% for 1-9 
glycines and -91 % for 10-19 glycines 19. The agglutination of platelets was 
assessed and it was found that as the length of the spacer arm increased up to 9 
glycine residues the agglutination increased however as the length was increased 
further the agglutination dropped off. In competition with soluble peptide the 
concentration of the soluble RGD required to abolish agglutination was higher 
for the longer spacer arms, 41l-lmol for n = 1, 400l-lmol for n = 3 and 4mmol for n 
> 7. The decline of agglutination at longer spacer arm lengths is probably due to 
the increasing entropy with the flexible arms that prohibits strong binding to 
integrins. 
The crystal structure of the a.v~3 integrin has been determined237 and the 
binding site for RGD peptides identified238 • From these it appears that the 
binding site is located very close to surface of the integrin and that long spacer 
arms should not be required for access as shown in Figure 3-25. It appears that 
the spacer arm is required to prevent steric hindrance and adverse electrostatic 
effects between the integrin and the bulk of the material. This would explain why 
the length of the spacer arm required is substrate specific. 
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Figure 3-25 Structure of av/33-Mn complexed with cyclo(RGDf-N(Me)V). Ribbon drawing, 
the carbon, nitrogen and ox-ygen atoms of the cyclo-peptide are shown in yellow, blue and 
red respectively. Reproduced from Xiong et a1238,t . 
t Reproduction of Figure I.from "Xiong, I. -P. , Stehle, T., Zhang. R., Ioachimiak, A., Frech, M., 
Goodman, S. L. & Arnaout, M. A. Cry tal Structure of the Extracellular egment of [ntegrin 
a v/33 in Complex with an Arg-Gly-A p Ligand. Sciel/ce 296, 151- 155 (2002)" reprinted with 
permi ion from .AAA 
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3.4.2 RGD Sequence 
A large number of different sequences and lengths of RGD-containing 
peptides have been utilised to form biomaterials, these range from the minimum 
sequence RGD to entire proteins. Much of the analysis of the binding affinity of 
various RGD containing peptides has been performed on the detachment of cells 
from coatings offibronectin or vitronectin by the soluble peptidesI61.239.24o. It has 
been shown through these methods that the relative affinities of a series of short 
peptides for the fibronectin integrin receptor went in the order 
GRGDSP>RGDS>RGD-NH2>ROD241. In this study the minimal sequence ROD 
had very little ability to detach cells from fibronectin coatings. In addition it was 
shown that ORODPPC had very little ability to detach cells from fibronectin or 
vitronectin coated surfaces but GRGDSPC and GRGDNPC were active on both 
coatings but had increased preferences for the vitronectin and fibronectin 
integrins respectively. This shows that, as well as the length of the peptide 
sequence, the flanking amino acids around the RGD peptide can alter the affinity 
and selectivity of the sequence. 
Despite the reported inability of the minimal RGD sequence to bind to 
integrins there are a number of studies that have utilised this sequence and shown 
improved cell attachment54,59,65,67,169, spreading57.227, attachment strength 176, or 
viability and proliferation63 although it is likely that more significant 
improvements could have been obtained with more affine peptides. The ability of 
the minimal sequence to bind to integrins when immobilised on surfaces but not 
in solution is probably due to increased binding energy in immobilised peptides 
due to entropy loss on binding being minimised when the peptide is covalently 
linked to substrates. The effect of entropy on the binding abilities of peptides has 
also been observed when ROD-containing peptides have been linked to long 
flexible polymer chains (see section 3.4.1). 
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3.4.2.1 Length of Peptide Sequence 
Rapuano et al. showed that the fibronectin fragments P2 and P4 (shown 
below) adsorbed to polystyrene in equivalent molar amounts such that each 
coating presented the same number of active moieties9o . The fragments were 
systematically chosen such that the longer peptides contain the same sequences 
of amino acids as found in the shorter peptides. It was found that the longer 
peptide sequence P3 and P4 promoted a higher degree of cell adhesion indicating 
that flanking residues at some distance from the ROD sequence can affect the 
strength of binding to integrins, probably through effects on the conformation of 
the tripeptide. The peptide sequences and their ability to promote cell adhesion 
when utilised as a coating are shown In Figure 3-26 below. 
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Figure 3-26 Adhesion of osteoblast-like cells to coatings of various peptides (shown to the 
left). Reproduced from Rapuano et alt•90• 
t Reproductions of Figure 1 and Figure 3 from "Rapuano, B. E., Wu, C. & MacDonald, D. E. 
Osteoblast-like cell adhesion to bone sialoprotein peptides. journal of Orthopaedic Research 22, 
353-361 (2004)" with permission from.1ohn Wiley & Sons 
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Lanza et al created an immunoglobulin human/mouse chimeric heavy 
chain gene with a single or three repeat RGD tripeptide sequence inserted in the 
third hypervariable loop termed yl RGO and yl (RGO)3 antibodies242. Melanoma, 
osteosarcoma and fibroblastoma tumour cells did not adhere to coatings of the 
ylRGD but did adhere to yl(RGD)3 coatings. It is unlikely that the adsorption of 
the large gene will be affected by the length of the inserted sequence and so this 
shows that the repeat RGD sequence either provides more accessible active 
moieties or has a greater affinity for the osteosarcoma and fibroblastoma 
integrins. 
3.4.2.2 Affinity 
The flanking residues surrounding an RGD sequence can alter its 
conformation and affinity for various integrin receptors. A bent conformation has 
been shown to be more selective for the av~3 receptor. Lin et al modified 
polyurethane with GRODVY and GRGDSY at the same concentration of 100 
f..lmollg of polymer61. When endothelial cells were grown on the polymers the 
GRGDVY peptide promoted significantly higher levels of cell adhesion than the 
GRGDSY peptide. This demonstrates the higher affinity of the former for the 
integrins expressed by the endothelial cells. Cyclic peptides have been shown to 
have a greater affinity for integrins than linear peptides. Linear peptides and 
cyclic RGOfK have been compared and the cyclic peptide shown to provide a 
greater increase in cell attachment when immobilised201 and to be more effective 
at detaching cells from RGD-modified surfaces when in solution243 . This was 
confirmed by Verrier et al who also showed that an increase in cell adhesion to 
cyclo-DFKRO modified surfaces compared to GRGDSPC over a range of 
peptide concentrations92• 
3.4.2.3 Integrin Selectivity 
In addition to having a greater affinity for integrins some cyclic peptide 
have also been shown to selectively bind to certain integrins and not others. The 
selectivity is obtained via control of the peptide conformation through cyclisation 
and by utilisation of flanking residues that increase binding to the integrin in 
question. 
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The cyclic peptide cyclo(-RGDfK) has been shown to se lectively bind to 
the integrins UvP5 and UvP3 integrins expressed by osteoblasts77.243 .244. The 
peptide 's affinity for Uv P3 is 10-fold greater than that of the analogous linear 
peptide245.246. When cyclo-DFKRG was compared with GRGDSPC it was 
shown that the adhesion of osteoprogenitor ce ll s to the cyclic peptide was 
inhibited by monoclonal antibodies to UvP3 and UvP5 whereas the linear peptide 
was inhibited by P 1 antibodies as shown in Figure 3-2792 • 
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Figure 3-27 Inhibition of osteoprogenitor adhesion to surfaces modified with cyC\o-DFKRG 
(dark grey) or GRGDSPC (light grey) by monoc\onal antibodies to integrin subunits. 
Reproduced from Verrier et a lt •92• 
The study also showed that the expre sion of integrins was altered by the 
nature of the peptide surface on which the cells were plated. GRGDSPC coating 
appears to reduce the expression of PI , Ps and Us subunits, while cyclo-DFKGR 
promoted the Uv and U5 subunits, PI mRNA expres ion being slightly 
reduced and P3 was poorly expressed on both surfaces. The regulation of integrin 
expression by the substrate on which cells are cultured has significant 
implications on the use of RGD in tissue engineering. ell s may be encouraged 
to produce the integrin that is most affine for the peptide utili sed. 
t Reproduction of Figure 7a from "Verrier, S., Pallu, S., Bareille, R. , Jonczyk, A., Meyer, J., 
Dard, M. & Amedee, J. Function of linear and cyclic RGD-containing peptides in osteoprogenitor 
cells adhesion process. Biomaterials 23, 585-596 (2002)" with permi ss ion from Elsevier Ltd. 
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Massia et al found that the binding of fibroblasts to ORODY-modified 
glass was mediated primarily by the (lvP3 integrin. a vitronectin receptor. rather 
than the (lSPI integrin (fibronectin receptor)l29. It has been shown that melanoma 
adhesion to streptavidin engineering with ROD sequences was also mediated by 
the (lvP3 integrin53 . It has also been shown that cyc1 ic peptides with the general 
formula ROD-Ar-R (with Ar being a hydrophobic residue) have high affinity and 
selectivity for the platelet integrin (lllbP3240 . It has been shown with smooth 
muscle cells that (lvPI mediates adhesion and (lvP3 controls migration219• 
The changing effects of ROD on the various aspects of cell behaviour 
may be due to the control of these aspects by different integrins and the relative 
affinity of the peptide used for the diverse integrins. 
3.4.2.4 Peptide Arrangement 
Integrins are known to be found in clusters and the clustering of the 
Iigands is believed to have wide-reaching effects on the adhesion, spreading and 
migration of cells through altered integrin binding effects247 . In addition cells are 
known to align with and migrate along gradients of ROD peptide. Consequently 
the local arrangement of peptide moieties can affect and control the adhesion and 
migration properties of cells on peptide-containing materials. 
Clustering 
Albumin derivatised with 3.5-20.8 ROD moieties per protein molecule 
and coated in varying concentrations onto TCP has been used to create surfaces 
where the total amount of ROD moieties was constant but the distances between 
active groups varied. It was found that the higher numbers of peptide moieties 
per albumin molecule were more effective at promoting cell adhesion42 • This 
implies that the distance between moieties may be more important that the actual 
peptide concentration. 
Star shaped polymers have been employed to form ROD clusters that 
were blended with non-derivatised polymers to form surfaces with equivalent 
overall densities of RGD but different localised densities. It was found that 
clusters of ligands increased cell adhesion, motility and the formation of stress 
fibres compared to materials with the same peptide concentration208 . 
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Lee et al formed alginate hydrogels from a blend of alginate and alginate 
modified with varying numbers of ROD moieties per molecule and consequently 
varied both the overall ligand density and the spacing between clusters of 
ligands45 • It was shown that the proliferation of preosteoblasts was linked to the 
spacings between islands of ROD and not to the overall ROD concentration or 
number of ROD ligands in each cluster. In contrast to this the secretion of 
osteocalcin (an osteogenic bone marker) was increased on materials with smaller 
cluster spacings but the same overall ROD density (i.e. smaller numbers of 
Jigands in each cluster and less distance between clusters). 
Gradients 
Brandley et al created acrylamide gels with ROD-peptides incorporated 
in either uniform concentrations or gradients and showed that the uniform 
concentrations of peptide all promoted the same level of cell adhesion69 • 
However when plated onto gels containing a gradient of ROD (linear or 
exponential) cells migrated along the gradient towards the higher peptide 
concentration. 
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3.4.3 RGD Concentration 
3.4.3.1 Effect on Cell Adhesion and Spreading 
It has been definitively reported that "An RGD Spacing of 440 nm is 
Sufficient for Integrin avB3-mediated Fibroblast Spreading and 140 nm for Focal 
Contact and Stress Fiber Formation" by Massia et al in 1991 129• This study 
derivatised glass with GRGDY at concentrations varying from 0.1-100 fmol/cm 2. 
The study showed that a concentration of I fmol/cm2 promoted cell spreading 
and a concentration of IOfmol/cm2 also promoted the formation of focal contacts 
(ROD spacing of 440nm and 140nm respectively). 
A logarithmic relationship between the RGD concentration and the 
average cell area with increasing ROD concentration was shown by Reinhart-
King et al who derivatised polyacrylamide gels with YA VTORODS in 
concentrations ranging between 0.001 and I mg/ml of peptide (approx. 1.2x 10-3_ 
1.2 J.lmol/cm2 assuming a surface depth of lOnm)I75, There was no indication that 
the average cell area had reached a maximum over the concentration range 
tested. In addition to the cell area increasing with ROD concentration the 
morphology of the cells changed to include pseudopodia and present a stelate 
contour. 
The average cell area was also found to increase with increasing ROD 
density in poly(vinyl alcohol) hydrogels86 • At the maximum concentration of 
2.8J.lmol per ml of polymer (equivalent to 2.8pmollcm2 assuming an accessible 
surface depth of lOnm) there was no indication that a maximum cell area had 
been obtained. 
Drumheller et al modified a non-adhesive semi-interpenetrating network 
formed from PEO-DA, TMPT A and acrylic acid with GRGDS and found that 
concentrations of 66 and 110 pmol/cm2 promoted 100% cell adhesion and that 12 
pmol/cm2 promoted up to 83% cell adhesion40. Another system using PE~, this 
time as a diacrylamide, studied the areas of cells adhered to ROD-containing 
hydrogels and found that the cell area increased with peptide concentration 96. 
However the cells were not as fully spread as on TCP at the maximum 
concentration investigated was 3.8pmol/cm2 implying that further improvements 
in cell spreading could have been made by larger peptide concentrations. 
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The concentrations required to achieve maximal cell spreading in these 
systems are much greater than those reported by Massia et al. This may be in part 
due to differences in experimental parameters such as cell type and peptide 
sequence utilised but part appears to be due to the nature of the material into 
which RGD is included. This may be because part of the cells' ability to spread 
comes from the background material or because the ability of the ROD peptide to 
function effectively is altered by the substrate on which it is immobilised. The 
PEG chains, which resist protein adsorption, may have sterically hindered the 
binding interactions between peptides and integrins thus requiring a much larger 
nominal peptide concentration to achieve the same perceived concentration. 
Alternatively the flexibility of the polymer chains to which the RGD peptides are 
attached may have reduced the binding strength of the peptide to the integrin 
through entropic considerations. 
In addition the study by Massia et al did not investigate the cell density or 
attachment efficiency onto the surfaces. Since this work these parameters have 
become the main methods that have been used to quantify the efficacy of ROD-
containing biomaterials (see Section 3.3.3). Observation of cell spreading and 
quantification of cell numbers may lead to different reported effectiveness of a 
given RGD concentration. Senyah et al investigated a similar system to Massia et 
al where GRGDSP was immobilised on borosilicate or titanium surfaces. A 
peptide input concentration of 40nmol/cm2 obtained the best adhesion in terms of 
cell number. 
Herbert et al found that a plateau of maximal cell attachment was 
achieved with concentrations of KGYSORGDSPAS of I pmol/cm2 or greater 
immobilised onto ethylene glycol SAMsI95 • It seems likely that the long length of 
the peptide sequence has increased the binding affinity for integrins and a smaller 
amount of peptide is therefore needed to obtain maximal cell response. 
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Pakalns et al found that self-assembling mono layers conta ining 5 to 100 
mol % of RGD-containing amphiphiles produced a linear increase in the number 
of attached cells (note: 50 mol % = 94.5pmol/cm2)1 69. However it has been 
shown that the cell number is not necessarily an indication of the degree of cell 
spreading as Roberts et al reported similar numbers of cells on self-assembling 
monolayers containing 10.5 to 1 mole fractions of RGD but the morphologies of 
the cells were very different as shown in Figure 3-28 below248. 
Figure 3-28 Adhesion of endothelial cells to SAMs presenting RGD and ethylene glycol 
groups. Reproduced from Roberts et alt•248 
t Reprinted with permission from "Roberts, C. , Chen, C. S., Mrksich, M., Martichonok, V., 
Ingber, D. E. & Whitesides, G. M. Using Mixed Self-Assembled Monolayers Presenting RGD 
and (EG)30H Groups to Characterize Long-Term Attachment of Bovine Capi llary Endothelial 
Cells to Surfaces. Journal of the American Chemical Society 120, 6548-6555 ( 1998)" Copyright 
1998 American Chemical Society 
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An increase in peptide concentration is not always guaranteed to increase 
cell adhesion and spreading as shown by Yang et al who found the greatest cell 
spreading when the minimum concentration investigated of PLL-GRGDS 
(0.03flM) coated onto PLA was utilised56 • The coating of PLL-GRGDS 
significantly increased the average cell area when applied in concentrations of 
0.3 and 0.03mM but not at the higher concentrations of 3 and 30flM. It seems 
likely that an improvement over the PLA could be obtained by the use of RGD 
but that the use of PLL in peptide-containing species meant that the active 
moieties were blocked when large coating concentrations were used. In a similar 
investigation60 it was found that coating concentrations of 1 % (w/v) did not 
promote cell adhesion but coatings of 0.01% did. Increasing the numbers of 
ligands per PLL monomer allowed the promotion of a degree of cell adhesion to 
1 % coatings but the 0.01% coating supported the adhesion of a greater number of 
cells. Clearly in this situation the inhibitory effects of increasing the PLL density 
outweigh the adhesive potential of the peptide at high concentrations but not at 
lower concentrations. 
A decrease in cell attachment with increasing RGD concentration was 
also noted by Sawyer et al who coated E7GPenGRGDSPCA or 
GPenGRGDSPCA onto hydroxyapatite disks l65 . The decline in cell adhesion as 
the peptide concentration increases has been attributed to the ligands being too 
closely packed at high concentrations and hindering the access for integrins. 
However this might also be attributable to de-adsorption of the peptide from the 
surface at high coating concentrations creating soluble competition for integrins. 
Biesalski et al showed that the maximum cell attachment was achieved 
with self-assembling monolayers containing 10 mol % of the RGD-containing 
species 172. This is in contrast to the report by Pakalns et al discussed earlier 
where the increasing mole percentage of the peptide in self-assembling 
monolayers increased the cell adhesion up to 100 mol %. It is known that 
packing effects can trouble SAMs at high peptide concentration and it seems 
likely that the reduction in cell attachment at high concentrations is in fact due to 
lowered accessible ligand concentrations. 
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3.4.3.2 Effect on Viability and Proliferation 
Some researchers have found that the inclusion of RGD reduces the rate 
of proliferation or even decreases the viability of cells over time (see section 
3.3.1 Cell Behaviour). This has also been observed at varying concentrations of 
RGD as shown by the relative numbers of fibroblasts on keratin and keratin-
RGD coatings of different concentrations after 1 hour and after 24 hours52 . 
Initial cell attachment to coatings of O.2-0.8mg/ml keratin-RGD were the same 
independent of the coating concentration. The relative number of cells on the 
peptide containing surfaces compared to glass after 24 hours is lower than at the 
I hour time point. Although cell numbers at the later time point were higher than 
that of glass the fact that the numbers of cells were closer to that of the control 
substrate than at an earlier time point indicates that the proliferative rate was less 
than that of glass. The extent of the reduction in proliferative rate was 
ameliorated to some extent by the utilisation of a stronger coating concentration 
but the use of the keratin-ROD peptide containing species appears to have had a 
negative effect on proliferation. 
When proliferation has been examined as a function of the concentration 
an increase in ROD concentration tends to increase the growth rate45.249-251. 
Holland et al also found a clear link between the rate of endothelial cell 
spreading in the first hour of attachment and the rate of proliferation over 4 days 
as a function of the ROD concentration l89 . 
3.4.3.3 Effect on Motility 
Cell migration occurs via the extension of lamellae from the cell followed 
by a contractile force exerted on the lamellae and the retraction of lamellae on 
the opposing side of the ce1l252 . The formation and the retraction of the lamella 
are governed by integrin binding to the substrate. At low levels of cell attachment 
migration is slow because weakly attached cells do not generate enough traction 
to move significantly234,253. At high levels of cell attachment cells display 
impaired motility, presumably due to an inability to cycle between adherent and 
non-adherent states because the ligand binding is too strong. The levels of cell 
attachment and migration rates are dependent on the ligand density, Jigand-
integrin binding energy, integrin density and activation state of the 
integrins254,255. 
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There is evidence to show that the migration of cells on ROD-containing 
surfaces is dependent on the ROD peptide as well as the integrin profile and is 
affected by the sequence utilised, the binding energy (affinity) and the 
concentration. The presence of RGDS has been shown to decrease the ability of 
cells to migrate in terms of random motility coefficient, migration differential or 
persistence time 127. The highest migration rates have been found at intermediate 
peptide concentrations in polyvinyl amine coatings249.25I and through PEG-DA 
hydrogels98 
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Figure 3-29 Theoretical bell curve for the dependence of cell migration rate on Iigand-
integrin binding. 
A theoretical bell-curve graph such as that shown in Figure 3-29 has been 
experimentally proven to fit the motility of cells on collagen with respect to the 
amount of GRGDSPC present28. In contrast Maheshwari et al found a plateau at 
which cell speed stabilised and did not decrease on substrates formed from 
clusters of PEO-YGRG028. The cell speed was dependent to a greater extent on 
the cluster sizes rather than the overall average density of peptide indicating a 
cooperative effect of clustered Jigands on the assembly of regulatory and 
structural proteins. It is possible that the cell speed would decrease if the peptide 
concentration was increased further. However Maheshwari et al estimate 100 
integrins/llm2 compared to 200,000 peptide moieties/llm2. It appears that the low 
affinity of the peptide YGRGO for integrins results in a modified migration 
profile wherein the cells are always able to de-adhere sufficiently to migrate. 
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3.4.3.4 Extracellular Matrix Production 
Rezania et al found that extracellular production was increased on glass 
surfaces derivatised with concentrations of 0.01, 0.62 and 3.8 pmollcm2 of 
COONOEPRODTYRA yl25. The matrix produced by osteoblasts was 
significantly improved over the ROE control for the 0.62 and 3.8 pmollcm2 
concentrations. However the increase was the same for both of the higher 
concentrations implying an on/off relationship between ROD concentration and 
extracellular matrix production. 
In contrast to this Mann et al found that ECM production was reduced on 
glass surfaces modified with RODS (2nmol/cm2) compared to ROES and non-
modified glass even though the original cell adhesion was promoted 131 . It has 
been suggested that the ROD-ligand interactions may initiate signal transduction 
events to regulate ECM synthesis. 
The adsorption of extracellular matrix produced by cells to surfaces is 
dependent on the nature of the surface. Roberts et al produced self-assembling 
monolayers of non-fouling ethylene glycol units and ROD that showed cell 
attachment and spreading but resisted the deposition of newly formed 
extracellular matrix248 . 
3.4.3.5 Differentiation 
ROD-modified surfaces appear to be able to promote differentiation of 
cells as shown by the secretion of various proteins. Increasing the concentration 
of a PronectinF coating upregulates the production of endothelin-I by endothelial 
cells214• Dopamine production in pheochromocytoma cells is increased by 
increasing ROD concentration178• PEO-DA hydrogels containing varying 
concentrations of ROD were synthesised to encapsulate marrow stromal cells and 
the expression of bone related markers was examined34 • Whilst the total DNA 
content of the hydrogels remained independent of the ROD concentration the 
expression of alkaline phosphatase and osteocalcin were increased as the ROD 
concentration increased showing that larger amounts of active moieties 
promoted differentiation towards osteoblast-like cells. 
Connelly et al cultured bone marrow stromal cells on ROD and ROE 
modified alginate surfaces and attempted to differentiate the cells toward 
chondrocytes through use of dexamethasone and TOF-P 1256. The differentiation 
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as determined by chondrocytic gene expressIOn and matrix production was 
significantly inhibited by RGD but not RGE. 
3.4.3.6 Other Aspects of Cell Behaviour 
Schense et al measured the neurite outgrowth rates from dorsal root 
ganglia encapsulated in RGD-modified fibrin gels27•35 . Intermediate ROD 
concentrations promoted the extension but higher concentrations inhibited the 
neurite outgrowth in a similar manner to that shown for migration of cells in 
other systems. The intermediate concentration at which growth was promoted 
was lower for a cyclic peptide than a linear peptide. This supports the theory that 
neurite outgrowth is governed by the same bell curve type behaviour as 
migration as the binding strength of cyclic peptides tends to be greater than the 
binding strength of linear peptides. 
Reinhart-King et al showed that the cell area was proportional to the 
amount of peptide incorporated over the concentration range tested and that the 
endothel ial cell traction forces generated were proportional to the cell area 175. 
Ferris et al reported that the thickness of new bone formed in apposition 
to RGDC coated implants compared to plain titanium implants in rat femurs was 
28% greater after 2 weeks and 45% after 4 weeks 118. Schliephake et al found 
only limited evidence that RGD peptides linked to collagen coatings increased 
periimplant bone formation in the alveolar creseS7 • Woerly et al found that a 
poly(hydroxypropyl methacrylate) hydrogel containing RGD peptides was 
suitable for guiding the repair of spinal cord but the effects of RGD inclusion 
over a control substrate were not examined83 . 
3.4.4 Other Peptide Sequences 
In fibronectin the effect of the RGD peptide sequence is synergistically 
linked to the PHSRN site. When films of amphiphiles containing GRGDSP, 
GRGDSP and PHSRN, or sequences containing both moieties were constructed 
it was found that the inclusion of PHSRN increased initial cell attachment. The 
viability of cells on films containing only RGD or RGD and PHSRN at 
randomised distances declined over a 72 hour period whereas viability was 
maintained when RGD and PHSRN were contained in the same sequence with an 
(SG)s linker between the two active sequences 170. 
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Neurite outgrowth was measured by Saneinjad et al on glass/gold 
surfaces modified with 447 fmol/cm2 of various adhesion peptides including 
CGRGDS258• Whilst RGD was shown to improve the number and length of 
neurites the other peptides SIKV A V and YIGSR were shown to be more 
effective at this concentration. Levasque et al modified dextran hydrogels with 
CRGD or a combination of CPDGYIGSR and CQAASIKVAV at concentrations 
of -2J..lmoI/cm3 and found that the YIGSR I KV A V materials promoted slightly 
greater numbers of neurite and dorsal root ganglia cells attached than to RGD 
materials259. This is not particularly surprising as the RGD sequence utilised has 
a low affinity for integrins and is being compared to substrates with two active 
peptides. 
Mann et al prepared glass surfaces modified with 0.5 or 2 nmol/cm2 
RGDS and cultured smooth muscle cells, endothelial cells and dermal fibroblasts 
on the surfaces. The numbers of adherent smooth muscle cells on the RGD-
containing materials were not significantly different from the RGES control 131 • 
Both Santiago et al and Gumusderelioglu et al compared the modification of 
materials with the minimal tripeptide RGD and other proteins and peptide 
sequences and found that whilst RGD promoted cell attachment it did not 
perform better than IKVAV59 or insulin87 • It was shown in section 3.4.1.2 that 
the strategies of altering crystallinity in hydroxyapatite or including charged 
species into hydrogels have proved more effective than the incorporation of 
RGD-containing peptides. 
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3.5 Conclusions 
There are numerous different ways to immobilise ROD containing 
peptides onto surfaces for the purposes of tissue engineering. 
The amount of immobilised reactive moieties when formed by physical 
methods is dependent on the adsorption efficiency, the relative adsorption 
efficiencies of the peptide-containing species (peS) and other species, the 
amount of pes in solution compared to the surface area and the retention 
efficiency. However in all cases the amount of accessible peptide may not be the 
same as the amount of immobilised peptide. The accessibility of the peptide can 
be reduced by an adverse orientation and conformation of the peptide, the 
masking of the active moiety by other chemical groups and the embedding of 
ligands in the bulk where the access for integrins is hindered. 
The amount of immobilised peptide formed by chemical methods of 
synthesis can be controlled by the relative amounts of input peptide or amounts 
of functional groups available for derivatisation compared to the non-active 
volume or surface area of the substrate. Reaction efficiencies can vary 
dramatically between the various synthesis methods and can also vary over a 
range of input peptide concentrations. The efficiency of a modification reaction 
and the depth of modification can also be dependent on the material being 
derivatised due to accessibility of reactive groups at the surface and in the bulk 
through penetration of reagents in porous materials. Overall the amount of 
immobilised ROD will be dependent on the synthesis method, input 
concentration of peptide, reaction efficiency and the volume of inclusion. The 
amounts of active moieties perceived by integrins will further be dependent on 
the accessibility of the peptides and the swelling characteristics of the material. It 
should be realised in all situations that the amount of input peptide does not 
always correlate to the amount of immobilised peptide and furthermore that the 
amount of active moieties perceived by integrins may not be the same as the 
amount of ROD present in the system. 
The effectiveness of ROD-containing peptides to improve the cellular 
behaviour on a substrate is dependent, in part, on the background substrate. The 
chemical and physical properties of a material can affect the ability of the peptide 
to bind to integrin and transmit the effects of integrin binding into cellular 
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behaviour. The rigidity of a substrate affects the ability of a cell to transmit force 
through focal adhesion and consequently alters the migration abilities. The 
surface topography or crystallinity of a material can also affect the ability of 
ROD peptides to improve aspects of cell behaviour. The biological properties of 
the background material can affect the extent of improvement gained from the 
incorporation of ROD as the peptide-integrin based system may be in 
competition with other mechanisms of cell attachment and spreading. 
The effectiveness of an ROD-peptide immobilised onto a surface on 
cellular behaviour is basically dependent on the strength and extent of integrin 
binding to ROD peptides. However this is controlled by a number of other 
variables. The affinity of ROD-containing peptides for integrins in general is 
controlled by the strength of electrostatic interactions and overall entropy change 
when the peptide binds to the integrin. The entropy loss on binding can be 
reduced by constraining the ROD sequence into an accessible conformation by 
selective use of flanking residues or cyclisation and will be increased by long 
flexible spacer arms. The binding strength can be increased by the selection of 
flanking residues or constrained conformation that is specific to a particular 
integrin. Binding strength can also be increased by clustering of ligands. The 
extent of integrin binding will be dependent on the concentration of ligands and 
the concentration and types of integrins. The concentration of ligands is 
dependent not on the amount of immobilised ROD-containing peptides but on 
the amount of these peptides that are available for binding in terms of 
accessibility. The concentration and the types of integrins available in a cell are 
dependent on the cell type, cell source and conditions the cells are cultured 
under. Most cells express more than one type of integrin capable of binding to 
ROD and the different integrins can control different aspects of cell behaviour. 
The integrin expression profile and the affinity of the integrins expressed for the 
particular peptide utilised will affect the various aspects of cell behaviour. 
Whilst Massia et al set a benchmark by reporting that an ROD 
concentration of lOfmol/cm2 was sufficient to promote maximal cell spreading 
and focal contact formation this has not been reproducible in other systems. The 
majority of other studies that have investigated the effects of increasing ROD 
concentration involve flexible polymeric systems and it seems likely that the 
increase in entropy loss upon binding of integrins has formed the need for a 
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greater RGD concentration to offset the decreased affinity. In addition the 
amount of accessible peptides in polymeric systems may not be the same as the 
nominal or found peptide concentrations. In polymeric systems maximal cell 
adhesion and spreading is usually observed at concentrations between 1 and 100 
pmol/cm2. 
Virtually all of the literature concerning RGD-containing materials shows 
that the peptide improves at least one aspect of the cell behaviour that was 
examined. It has been shown in this review that some materials may produce 
significant improvement in certain cell responses and conditions but not others. 
Some literature that compares RGD-modified surfaces to other peptide 
derivatised materials reports no significant change in the cell response from the 
inclusion of RGD over the controls. For example Mann et al prepared glass 
surfaces modified with 0.5 or 2 nmollcm2 RGDS and cultured smooth muscle 
cells on the surfaces. The numbers of adherent smooth muscle cells on the RGD-
containing materials and their extracellular matrix production were not 
significantly different from the RGES control l31 . It appears likely that there may 
be a considerable amount of research that has not been published wherein the 
ROD peptide has not been successful within the experimental parameters 
examined. This will limit the applications of ROD-inclusion for use in tissue 
engineering to situations where the experimental parameters determined by usage 
factors match those in which the peptide inclusion is successful. It has also been 
shown through comparison of RGD-incorporation with other strategies that the 
peptide incorporation may be less successful than other methods of promoting 
cell adhesion. 
It appears that the majority of literature wherein RGD is unsuccessful at 
promoting cell attachment and spreading relates either to coatings24•82 , instances 
where a short peptide sequence with low integrin affinity is utilised or where a 
low concentration of peptide is accessible for interaction with integrins. However 
there is sufficient evidence to conclude that ROD-containing materials may not 
be able to promote long-term viability, proliferation and normal cell function 
without additional assistance from, for example, adsorbed proteins or cell-
derived ECM. 
In conclusion biomaterials designers should design RGD-containing 
materials with care as to the choice of peptide sequence, immobilisation strategy 
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and accessible concentration of the peptide. In addition researchers should be 
aware of the effects experimental variables can have on the reported success of 
ROD-incorporation and be aware of the limitations of ROD-incorporation as a 
strategy for promoting the various aspects of cell behaviour. Long-term use of 
ROD as a tool for tissue engineering will probably see the sequence being used 
in conjunction with synergistic sites, other active peptide sequences and other 
methods of promoting or directing different aspects of cell behaviour. 
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~ Experimental Design 
As shown in the introduction there are numerous ways of creating RGD-
containing biomaterials and the synthesis and analysis methods can have a large 
effect on the reported outcomes. Consequently it is important that the synthesis 
and analysis methods utilised are carefully selected to ensure that the results 
obtained do in fact answer the questions posed in the original aims. The selection 
of the methods utilised are therefore imposed by the criteria created by the 
objectives, which must be clearly identified in advance. 
4.1 Objectives 
RGD is a popular sequence used for derivatisation of biomaterials to 
promote cell adhesion and spreading through binding to integrins. The ROD 
peptide sequence binds to a wide range of integrins and its affinity for certain 
integrins can be increased by selection of flanking amino acids and cyclisation to 
promote integrin selective cell adhesion. The integrin selective binding of RGD 
can be useful in promoting the adhesion of selected cell types such as osteoblasts. 
However many cells do not express integrins that can be targeted with a selective 
RGD peptide. For the purposes of promoting non-integrin selective cell adhesion 
in tissue engineering there are strategies other than the incorporation of RGD 
peptides that can promote cell adhesion and spreading at a reduced cost. This 
leads to questions over whether the incorporation of ROD-containing peptides is 
useful in non-integrin selective cell adhesion. 
The main aim of this research is to determine whether the incorporation 
of ROD peptides into polymeric biomaterials is a useful tool for promoting non-
selective cell adhesion for tissue engineering purposes. To determine whether 
RGD-incorporation is a useful strategy in tissue engineering it is important to 
determine the experimental parameters under which the peptide functions and 
produces maximal beneficial cell responses. Consequently the main aim of this 
research becomes an investigation into the parameters that control the extent of 
effects caused by RGD-incorporation. This main aim can be divided into several 
more specific questions that, if answered, can help to determine the role of RGD 
incorporation in tissue engineering. 
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1. If the adhesion of cells to the substrate is non-integrin selective is 
there value to be obtained in combining the two strategies of 
supporting cell adhesion, namely in promoting cell adhesion by RGD 
and supporting normal cell behaviour by protein adsorption to the 
substrate? 
2. Does the ability of RGD to promote cell adhesion hold in the case 
where protein adsorption is present, i.e. are the processes competitive 
or cumulative? 
3. Does the use of RGD peptides in a non-specific manner confer any 
value on the substrate that is not obtainable by other methods? 
4.2 Design Criteria 
The answers to these questions can be obtained by the synthesis and 
analysis of a library of materials which is designed to show the effects of 
changing background substrate composition and RGD concentration. The design 
of this library should ensure the following design criteria are met to allow logical 
and meaningful conclusions to be drawn from the data: 
1.) The library should contain materials that possess the following properties: 
a) Does not adsorb proteins 
b) Does not adsorb proteins and contains RGD sequences 
c) Does adsorb proteins 
d) Does adsorb proteins and contains ROD sequences 
2.) The source of the ability to support cells should be elucidated: 
a) The properties of materials that contain peptide should be as similar as 
possible to those that do not contain peptide. 
b) The peptide used should be known to promote cell adhesion in at least 
one situation. 
c) The minimal peptide concentration required to promote cellular 
properties should be determined. 
d) The ability of a known concentration of peptide to promote cellular 
properties in different polymers should be determined. 
3.) Experiments performed on the materials should: 
a) Ascertain ability of polymers to support cell attachment 
b) Ascertain ability of polymers to support cell viability 
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c) Ascertain ability of polymers to support normal cell growth and 
functions. 
4.3 Experimental Design 
As shown in section 4.1 there are many different ways to incorporate 
RGD peptides into polymeric substrates. The synthesis method used to create the 
polymers should reflect the requirements imposed by the design criteria. 
The first criterion is that materials that do and do not adhere proteins and 
do and do not contain RGD should be synthesised. These materials should be 
synthesised in a manner as similar as possible to each other to ensure that 
features of the synthesis do not affect the analysis of the materials. Features of 
the synthesis that may affect different monomers in different ways such as the 
adsorption of coatings or the presence of additives should be avoided. Synthesis 
of random cross-linked polymer networks from vinyl-containing monomers 
provides an ideal method for the creation of materials with varying properties as 
they provide materials that are easily tunable and easy to handle and the 
processing variables are limited. Methacrylates make a good candidate for 
monomer choices as some have been approved by the federal drug agency (FDA. 
USA) and the medicines and healthcare products regulatory agency (MHRA. 
UK) for use in medical devices. In addition to this a range of methacrylates with 
different hydrophilicities are readily available. Polymers made from glycerol 
methacrylate are known to promote minimal cell attachment whereas polymers 
containing alkyl methacrylates (e.g. butyl, lauryl) are known to promote 
reasonable levels of cell attachment. 
The requirement that the source of the ability to support cells should be 
elucidated means that the polymers containing RGD should be as similar as 
possible to the polymers without RGD. This means that additional functional 
groups such as acids or amines should not be included in the polymer to allow 
the attachment of RGD. The best way to incorporate RGD into a polymer 
without the unnecessary inclusion of functional groups is to copolymerise a 
vinyl-containing peptide with the other monomers. This also gives the added 
advantage that the peptide concentration can be precisely controlled to obtain 
various concentrations and also to ensure that different substrates contain the 
same RGD concentration. 
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Whilst the peptide utilised should be known to stimulate cell adhesion it 
should also have the least possible effect on the properties of the polymer. In 
many circumstances it has been found that there is a certain minimum distance 
between the peptide and the substrate that is required to allow the peptide to 
work. However this "spacer arm" may have a large impact on the properties of 
the polymer and so peptides with and without a spacer arm will be investigated. 
The minimal sequence needed to promote cell adhesion is ROD however the 
tripeptide has a much lower activity than slightly longer peptide sequences and 
the lower activity means it is unlikely to promote cell adhesion to a significant 
degree or that the concentration of peptide required to have a significant effect 
will be high. Consequently the peptide sequence GRGDS was chosen to be 
investigated. The reported minimal peptide concentrations required to promote 
cell adhesion on different backgrounds differs widely and it is not known what 
concentration IS required to promote cell adhesion under these conditions. 
Consequently it was decided to investigate a range of different peptide 
concentrations over 4 orders of magnitude, these being 10, I, 0.1 and 0.0 I 
pmollcm2 (equivalent to 10, 1, 0.1 and 0.01 J.lmol/g assuming an integrin 
penetration depth of 10nm and a swollen hydrogel density of 1 g/cm\ 
In vitro culture of cells is generally the first stage of analysing the 
efficacy of materials intended for tissue engineering purposes. Fibroblasts are a 
good choice of cell type for the first stage of analysing the material as they are 
easy to culture in large numbers and are able to show a large range of behaviour 
as they can survive in moderately hostile conditions. Primary human dermal 
fibroblasts were selected as the cell type for the analysis of the library of 
polymers as it is known that immortalised cell lines can respond differently to 
biomaterials than the primary cells that would be utilised in tissue engineering. 
There are many different techniques that have been utilised to analyse the 
cellular functions on the materials under investigation. RGD acts by promoting 
the cell adhesion via integrins and the adhesion has many knock-on effects as 
anchorage-dependent cells cannot perform any other functions without adhesion. 
The quantification of the adhesion can therefore be performed by analysing a 
different function of the cells. It was decided to utilize the MTT assay, which is a 
calorimetric assay based on the purple colour from formazan formed from the 
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oxidation of 3-( 4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) as shown in Figure 4-1 below. 
mitochondrial reductase 
.. 
Figure 4-1 Oxidation of MTT by mitochondrial reducatase enzymes. 
The MTT is oxidised when mitochondrial reductase enzymes are 
functioning and so the intensity of the formazan is directly proportional to the 
activity of these enzymes. Consequently the assay gives a response based on the 
cell number and viability thus generating a value that denotes both the number of 
cells present and their ability to function. It was also decided to visualise the 
cells to determine their morphology as abnormal morphology is an indication of 
cellular distress. The visualisation can be achieved by visual light microscopy or 
by immunofluorescent microscopy. The light microscopy can be performed at 
any time point but the contrast obtained is often not high enough to properly 
distinguish cell morphology. The ROD-mediated adhesion of the cells is known 
to have a large effect on the cytoskeleton and hence immunofluorescent staining 
for F-actin to visualise the cytoskeleton is the ideal method to investigate the 
morphology of cells adhered to ROD-containing materials. 
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5 Results & Discussion 
5.1 Polymerisation Techniques 
The first step towards the production of a polymer library was to was to 
investigate the polymerisation techniques that could be utilised to synthesise the 
biomaterials and investigate the effect of the synthesis method on the cell-based 
analysis of the materials. The requirements of this project were that polymers 
that both did and did not adsorb proteins should be synthesised. The simplest 
method of producing such substrates is to free-radically polymerise vinyl-
containing monomers as these are cheap, easy to obtain in a wide range of 
properties and can easily incorporate cross-linkers. Additionally there is a large 
amount of published material on the biological properties of these types of 
polymers. 
5.1.1 AIBN Initiation 
Thermal initiation utilising AIBN at 60°C is a common technique that has 
been much utilised for the synthesis of biomaterials. Random cross-linked 
polymers can be synthesised by placing monomer solutions containing 1% AIBN 
into a mould followed by curing at 60°C. The resultant gel will be the same 
shape as the mould although its dimensions can alter if the solvent is changed 
reflecting the ability of a network to adsorb that particular solvent. 
Hydrogels containing 2.5 wt % ethylene glycol dimethacrylate (EGDMA) 
and varying ratios of glycerol monomethacrylate (OMMA) and butyl 
methacrylate (BMA) were synthesised by thermal polymerisation in moulds. The 
moulds were created from 2 sheets of PET laminated onto glass with a PTFE 
gasket and held together with an aluminium frame that held the array together 
tightly through butterfly screws. 
Moulds were made with a PTFE gasket of 1.5mm so that the needle 
diameter could be incorporated into the depth of the gasket and polymerisation 
occurred without significant monomer leakage. Sheets of poly(GMMA-co-
EGDMA-co-BMA) were synthesised, cut into discs with a cork borer and 
analysed for their ability to support cells. 
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Figure 5-1 Human dermal fibroblast adhesion and survival on thermally initiated random 
copolymers of GMMA and BMA (percentages shown are wt %) containing 2.5wt % 
EGDMA. Cells (F tS33, passage 7) were cultured on the substrates for 24 hours in media 
containing 10% FCS and were assessed by the MTT assay. Results shown are the mean of 
3-6 replicates and error bars show standard deviation divided by number of replicates. 
Students non-paired T -test was performed on the data , all polymers were significantly 
different to TCP (p<O.OI) and 0 indicates that p<O.Ol compared to 100% glycerol 
methacrylate hydrogels. 
A shown in Figure 5-l above the abi lity of the e polymers to support 
cells increases a the percentage of BMA (the more hydrophobic component) 
increa e . For the homopolymer of GMMA and BMA the relative viab ility of 
cell remains the same, proportional to the TCP control, over both the one and 
seven day time periods. The copolymers of GMMA and BMA appeared to be 
better at promoting initial attachment and viability of cell s than at u taining 
viability and promoting proliferation long term when compared to TCP. Viability 
and proliferation wa ob erved on the e hydrogels but thi wa not a 
pronounced a that produced on TCP resulting in the apparent decline of cell 
viability over 7 days cell culture in the graph above. 
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The thick sheets of polymers were found to cause problems in the cell 
culture experiment. The discs that were cut from the polymer sheets were 
uniform in size and shape but they did not entirely fill the wells in which they 
were placed due to the limited sizes of cork borers available. Consequently when 
cells were applied to the surfaces there was the potential for cells to "fall off' the 
edges of the polymer or migrate onto the TCP underneath. The migration of cells 
could be reduced by the use of sterile but non-treated multi-well plates. This was 
considered as a culture method but was not utilised as comparison of the cell 
number and viability on experimental materials with TCP is a useful benchmark. 
The amount of cells that "faH off' the polymer discs can be reduced by 
applying the same number of cells in a smaller volume and allowing them to 
adhere to the surface for a set amount of time before adding media. This method 
creates its own problems, the cell count is less accurate, the cell viability is 
lowered by spending a significant amount of time in inadequate amounts of 
media and the space available to the cells is significantly affected by the 
wettability of the polymers. Even with this method the cells can be washed onto 
the TCP by the addition of media and the cells can also migrate onto the TCP. 
MTT assays of the wells in which the polymers were cultured showed that the 
cells attached to the TCP ranged from 20 to 90% that of the TCP control, 
indicating that significant amounts of cells had moved off the polymers and that 
the amounts varied indiscriminately between wells. 
Another problem with this method of polymer synthesis was that large 
amounts of monomers and consequently large amounts of peptide are required to 
synthesise enough polymer to carry out the analysis. This method required 5g of 
monomers to produce enough surface area of one hydrogel type for one 
experiment. Due to the expense of the peptides and the importance of controlling 
the peptide concentration the reduction of monomer usage is important. As a 
consequence of this other alternatives for initiating the free-radical 
polymerisation were investigated. 
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5.1.2 UV Initiation 
UV free-radical initiation has been extensively used for many years in 
coating applications however it is only in recent years that it has been used for 
biomaterials (see Section 3.2.3.1 Chain-growth Polymerisation). 2-hydroxy-2-
methylpropiophenone (HMPP) has been approved by the FDA and the MHRA 
for use in biomaterials and so appears to be a good candidate for the 
photo initiation of these materials. 
5.1.2.1 Sheets 
Monomer solutions were purged with nitrogen for a minimum of 20 
minutes and then injected into a mould similar to that used for thermal initiation. 
Modifications that were made to the mould were to use quartz plates to allow 
passage of UV radiation, to use the thinner PTFE gasket and to leave a small gap 
at the top for injection. The gap at the top to allow injection was possible because 
the shorter polymerisation time involved with photo-initiation meant that solvent 
loss would not be significant and consequently much thinner sheets could be 
formed. 
It was found that poly(GMMA-co-EGDMA) polymerised easily after 40 
seconds exposure on each side. Polymers with 25 wt % BMA also polymerised 
but only after a further 40 seconds exposure. Polymer solutions with greater than 
25 wt % BMA did not polymerise even after a total exposure time of 5 minutes. 
Greater exposure times were not investigated because the polymer mould became 
hot during 5 minute exposure times. It was believed that the lack of 
polymerisation in the BMA containing polymers was caused by air inhibition 
caused by the gap at the top and that this did not affect the GMMA polymers due 
to the faster polymerisation rate of these solutions. 
5.1.2.2 Formed in situ 
The ideal situation would be for the polymers to be formed in sterile 
conditions in a container that could also be utilised for cell culture. Monomer 
solutions were placed in a 24 well culture plate and then placed inside a purging 
box where oxygen was removed by repeated cycles of applying vacuum and 
introducing nitrogen. Poly(GMMA-co-EGDMA) was synthesised in the wells of 
24 well plates with 1 wt % HMPP and 50 wt % ethanol. However it was found 
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that compositions with more than 25% BMA degraded the plastic. This was the 
case with a number of different solvents (methanol, ethanol, IPA, OM SO) and 
also in the absence of solvent. In addition the mixture did not polymerise, it is 
possible to replace the plastic multiwell plates with glass multiwell plates if the 
polymerisation can be performed. It was believed that the lack of polymerisation 
of butyl methacrylate at high concentrations might be due to the absorption of 
UV radiation by butyl methacrylate at the wavelength required to excite the 
photoinitiator HMPP. Consequently other initiators with different excitation 
wavelengths were investigated as were photoinitiators that were likely to give 
higher rates of polymerisation. The structures and absorption spectra of these 
photoinitiators are shown in Figure 5-2 below. 
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Figure 5-2 Structures and UV spectra of the photoinitiators 2-methyl-4'-(methylthio)-2-
morpholinopropiophenone (MMP), 2,2-dimethoxy-2-phenylacetophenone (DPP), 2-
chlorothioxanthen-9-one (CTX) and a 50:50 blend of diphenyl(2,4,6-trimethylbenzoyl) 
phosphine oxide (DPO) and 2-hydroxy-2-methylpropiophenone (HMPP). Spectral data 
reproduced from Aldrich Polymer Products Application and Reference Information26o• 
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The polymerisation of BMA with EGOMA with I wt % of each of the 
initiators above in glass vials after purging in a box a quartz window was 
investigated. All of these photoinitatiors were unable to achieve the 
polymerisation of butyl methacrylate. A range of other monomers were 
investigated to determine whether the polymerisation was unsuccessful due to 
characteristics peculiar to BMA or a common feature of the system being 
utilised. These monomers were lauryl methacrylate (LMA), 
hydroxyethylmethacrylate (HEMA), dimethylaminoethylmethacrylate 
(DMAEM), divinyl benzene (OVB) and styrene. The table below shows the 
compositions that were attempted; all compositions were tested with each 
initiator with concentrations of I wt % and 10 wt % and with methanol and 
DMSO as solvents and no solvent. 
POL YMERISABLE NOT POL YMERISABLE 
EGDMA LMA: EGDMA 50:50 
BMA:EGDMA 50:50 BMA: EGDMA 75:25 
HEMA:EGDMA any ratios DVB 
GMMA:EGDMA any ratios DMAEM: EGOMA 
GMMA:DVB 97.5: 2.5 Styrene: EGDMA 
Table 5-1 Summary of monomer blends polymerisable in situ by uv intitiation 
It appears that only strongly hydrophilic monomers are polymerisable by 
this method. It is believed that this is due to residual amounts of oxygen present 
in the system that acts as a an inhibitor that is only overcome where the mono mer 
polymerises at a high rate. Consequently this technique is not suitable to the 
production of a polymer library. The lack of polymerisation in the other 
monomers is believed to be due to the relative depth of the monomer solution 
and it'was decided to try the synthesis of thin films onto a surface. 
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5.1.2.3 Thin Films 
Use of photoinitiators is an extremely well documented technique for the 
formation of thin films and coatings on a variety of substances. The requirements 
of a base material on which to coat the polymers for this application are as 
follows: optically transparent for visualisation of cells, inert to prevent 
interaction with assays, insoluble in organic and aqueous solvents, obtainable in 
a format whereby cells can be cultured on the surface and capable of retaining 
the coating. Candidates that meet these requirements include glass and PET 
sheets, previously used as disposable sheets laminated onto glass in the moulds. 
PET has the advantage that a coating can be applied to a large area and later cut 
to fit the container utilised for cell culture however it cannot be used with strong 
solvents such as TF A. The coatings formed by this technique should have the 
same characteristics as a sheet of polymer hydrogel as the random cross-linked 
structure can be formed without packing effect such as those formed with self-
assembling monolayer and the film should be thick enough to prevent the base 
material from showing through. 
Monomer solutions containing either GMMA or BMA were placed on a 
PET sheet and the liquid was drawn down the sheet using a 60llm coating bar. 
The sheet was then placed in the purging box where they were repeatedly 
evacuated and purged with nitrogen. All solutions were exposed to UV radiation 
for 5 minutes to ensure the same conditions were experienced by all the 
polymers. The coatings formed by this technique should have the same 
characteristics as a sheet of polymer hydrogel as the random cross-linked 
structure can be formed without packing effect such as those formed with self-
assembling monolayer and the film should be thick enough to prevent the base 
material from showing through. After polymerisation the surfaces were washed 
with ethanol and then analysed to show that the polymerisation had been 
successful and that the polymer had been retained on the PET surface. The 
analysis of the surface was done by roughly ascertaining the surface free energy 
using a Dyne pen test set. The surface energy of uncoated PET was found to be 
38-39 Dynes per cm2 and any other surface energy was considered to have been 
coated successfully. 
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It wa found that methanol, ethanol and isopropyl alcohol were all 
suitable solvents for coating as they were miscible with both glycerol 
methacrylate and butyl methacrylate and the mixtures wetted the PET surface. 
All the initiators trialled for the formation of polymers in situ were utilised to 
make thin film of glycerol methacrylate and butyl methacrylate and all were 
successful except for 2-chlorothioxanthen-9-one. Cell culture was performed on 
the thin films formed with different initiators to investigate the effect of the 
initiator on the cell adhe ion and viability. 
100% 
90% 
80% 
b 70% 
= 8 60% 
~ 50% 
~ 
~ 40% 
b9 
lW' 30% 
20% 
10% 
MMP 
DPO I HMPP 
o DPP 
HMPP 
0% -'---"--
GMMA BMA 
Monorner Used to Make 60J..lm Film by UV Polymerisation 
Including 2.Swt % of EGDMA and 1 wt% of the 
photoinitiator 
Figure 5-3 Human dermal fibroblast adhesion and survival on UV-initiated 60Ilm thin film 
random copolymers of GMMA or BMA containing 2.5wt % EGDMA and 1 wt % of the 
relevant initiator. 2-methyl-4' -(methyIthio)-2-morpholinopropiophenone (MM P), 2,2-
dimethoxy-2-phenylacetophenone (DPP), 2-hydroxy-2-methylpropiophenone (HMPP) or a 
50:50 blend of diphenyl(2,4,6-trimethylbenzoyl) phosphine oxide (DPO) and HMPP. Cells 
(FI833, passage 9) were cultured on the substrates for 24 hours in media containing 10% 
FCS and were assessed by the MTT assay. Results shown are the mean of 3-6 replicates 
with standard errors shown. Students non-paired T-test was performed on the data, all 
polymer were significantly different to TCP (p<O.OI) and 0 indicates that p<O.Ol 
compared to the other polymers of the same type synthesised with different initia tors. 
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The polymers synthesised with the initiator DPO I HMPP were 
significantly better at supporting cell adhesion and viability than the polymers 
with the same monomer synthesised with any of the other initiators. All polymers 
supported approximately the same levels of cell adhesion and viability compared 
to tissue culture plastic as the thick sheets of polymers synthesised with thermal 
polymerisation through use of AIBN. Despite the greater ability of polymers 
made with DPO I HMPP to support cell adhesion and viability it was decided 
that HMPP alone was a better candidate for the synthesis of polymer libraries. 
The reasons for this are that the main aim of this research is not promote 
maximum cell adhesion and viability but to investigate the cell adhesion and 
viability on polymers with a wide range of ability to support cell function and 
that HMPP has FDA and MHRA approval for use in biomaterials. 
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5.1.3 Summary of Advantages & Disadvantages 
Polymerisation Method 
Thermal Curing 
UV Curing: Sheets 
UV Curing: In Situ 
UV Curing: Thin Films 
Advantages 
Any 
possible 
composition 
Well-defined technique 
Large amounts of 
peptide make 
Disadvantages 
Large amounts of 
polymer and peptide 
required 
Cracking caused by 
swelling and shrinkage 
concentration 
determinable 
Some 
by opaque 
polymers are 
elemental analysis Inaccurate cell analysis 
Small 
polymer 
required 
amounts of Limited choice of 
and peptide composition 
Likely to give inaccurate 
cell analysis 
Small amounts of Limited choice of 
polymer 
required 
and peptide composition 
Accurate cell analysis 
Many compositions 
possible (limited by 
wettability of substrate 
on which coating IS 
formed) 
Very small amounts of 
polymer and peptide 
required 
Accurate cell analysis 
Non-uniform surface 
Extensive 
required 
washing 
Difficult to verify 
presence of coating 
Analysis of RGD 
concentration impossible. 
Table 5-2 The advantages and disadvantages of different polymerisation techniques. 
The only two options available from the list above are the thermal 
polymerisation method and the thin-film method as the others do not fulfil the 
criteria that materials should be made by the same method and materials that do 
adsorb proteins should be incorporated into the polymer library. 
The use of small amounts of peptide is not a requirement imposed by the 
design criteria but the basis of the synthesis of a library is that a large number of 
polymers can be included in the library. Whilst the need to minimise peptide 
usage was not a design criteria the thermal polymerisation techniques require 5g 
of monomers (and associated weight % of peptide) to provide I set of disks for 
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cell culture whereas the thin-film uv-initiated techniques requires just 0.2g of 
monomers to create 20 sets of disks for cell culture. The cost of the peptide 
required to create a library of polymers by the thermal polymerisation technique 
would be exorbitant. It was therefore decided to use the thin-film technique 
despite the inability to analyse the ROD concentration by amino acid analysis or 
elemental analysis. 
5.2 Peptide Incorporation Techniques 
ROD sequences containing a vinyl group can be easily synthesised by the 
addition of a species containing a vinyl group and a carboxylic acid group, such 
as methacrylic acid, at the end of the peptide chain in a manner similar to that 
used to form the chain. However the vinyl-containing peptide cannot be 
copolymerised directly with the other monomers as side chains on the peptide 
can react with the monomers. This was shown in section 3.4.1.3 where the same 
concentration of peptide was incorporation by copolymerisation and modification 
methods. When copolymerised the peptide promoted less than half the cell 
response obtained from the same concentration of peptide when immobilised by 
modification. Consequently protecting groups on the side chains of the peptide 
must be utilised to prevent loss of peptide activity. 
5.2.1 Strategy 1: TF A Deprotection of Side Chains 
Standard deprotections of side chains commonly utilised in peptide 
synthesis involves the addition of trifluoroacetic acid (TF A) in concentrations of 
90-100%. This strong acid may affect the methacrylate groups by hydrolysing 
the esters and altering the properties of the polymer. Consequently the effect of 
the TF A on the polymers must be investigated and minimised. 
Glycerol methacrylate hydrogels have been synthesised usmg the 
acetonide protected version of glycerol methacrylate (2-methyl-acrylic acid 2,2-
dimethyl-[1,3]dioxolan-4-ylmethyl ester, GMAc) that was later deprotected with 
selenium dioxide and hydrogen peroxide261 • The acetonide groups should be acid 
labile and could be removed at the same time as peptide protecting groups with 
90-100% TF A. The mechanism for this reaction is shown overleaf in Figure 5-4. 
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Figure 5-4 Mechanism for acid catalysed removal of acetonide protecting groups on 
poly(glycerol methacrylate. 
It is also possible that the methacrylate ester could also be hydrolysed by 
the strongly acidic conditions and so the extent of deprotection and the 
concentration of acid groups in the final product were analysed. 
HO~ 
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Figure 5-5 Acid catalysed hydrolysis of poly(glycerol methacrylate) 
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GMAc was synthesised by the reaction of solketal with methacryloyl 
chloride as shown in Figure 5-6 below. 
HO~>( + Jyo 
Cl 
Hel 
Figure 5-6 Synthesis ofGMAc by reaction ofsolketal with methacryloyJ chloride. 
and a linear polymer was formed by free-radical polymerisation using the 
thermal initiator AIBN. The polymer was then purified, dried and incubated with 
neat TF A for 1 or 4 hours after which time the polymer was re-precipitated and 
analysed. The extent of the deprotection was analysed by IH NMR. 
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Figure 5-8 I" NMR of product of 4 hour reaction between poly(GMAc) and TFA 
As shown by the NMR spectra in Figure 5-7 and Figure 5-8 above the 
peaks corresponding to the acetonide protecting groups at 1.2-1.5ppm were fully 
removed by the treatment with TF A. The extent of the acid catalysed ester 
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hydrolysis was analysed by titration of the treated polymer with aqueous sodium 
hydroxide. The average of three titrations gave a value of 6.6 x 10.6 moles of acid 
per gram of polymer. It was assumed that the entire mass of the polymer 
comprised of GMMA (there is a small percentage of the mass made up from 
initiator but this is assumed to be negligible) and this corresponds to 0.00625 
molar equivalents of side chain functional groups per gram of polymer. This 
assumption in the calculation gave an average percentage of side chains that had 
been converted to carboxylic acid as being 0.105%. As the percentage of acid 
groups formed by the hydrolysis of the ester is extremely low it is assumed at 
this stage that this will not affect the physical or cell-culturing properties of the 
hydrogel. 
Whilst the monomer GMAc can be utilised with TF A deprotection it is 
known that the cross-linker EGDMA is not stable towards acidic conditions. 
Hydrogels made with this cross-linker lose their integrity when exposed to strong 
acid and become difficult to handle in cell-culturing situations. An alternative 
cross-linker that is not degraded is divinyl benzene (OVB). 
5.2.2 Strategy 2: Enzyme Deprotection 
An ideal solution would be to find an alternative protection/deprotection 
method for the side chains of the peptide especially the arginine residue. The 
standard protecting groups on an arginine side chain are normally sulphonamides 
as these are stable to the reaction conditions required for peptide synthesis, 
prevent racemisation and are cleaved by the same conditions as cleavage of the 
peptide from the solid phase resin. A sulphonamide that is deprotected by weaker 
conditions than TF A in the hydrogel but is stable to the peptide synthesis 
conditions would fit the requirements of the synthesis however both strong acid 
and strong base are used in the peptide synthesis. Enzymatic deprotection of the 
sulphonamide group would fulfil all the criteria for the synthesis route if the 
sulphonamide was stable to the peptide synthesis conditions as enzymatic 
reactions generally take place in aqueous media, at neutral pH's and at moderate 
temperatures. 
In 1999 Koeplinger et al and Zhao et al reported that the enzyme 
Glutathione-S-Transferase could deprotect benzyl sulphonamides262 • Whilst this 
research did not show that arginine protecting groups could be removed it did 
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show that the deprotection was not dependant on the amine substitution pattern. 
The substituents on the amine side could affect the rate but the main factor in 
determining whether the deprotection would succeed was the substituents on the 
benzene ring. Electron-withdrawing substituents ortho / para to the sulphonamide 
allowed the deprotection to be accomplished. Some of the compounds that were 
investigated by Zhao et al and indicate the structure-activity relationship of this 
reaction are shown below. 
H ~ H2N" ~N"S02 H2N" ~ " S02 S02 &'~ &'~ N02 
Cl N02 
rate of reaction! min.mM"1 1.67 0.38 0.16 0.08 
Figure 5-9 Structure-Activity relationship of the deprotection of benzylsulphonamides by 
Glutathione-S-Transferase as reported by Zhao et al262. 
The rate of sulphonamide deprotection is increased when the electron-
withdrawing substituent is para to the sulphonamide and decreased when the 
amine is more substituted. Consequently we investigated the potential for this 
deprotection strategy to be utilised with arginine residues as an alternative for the 
construction of a hydrogel library. 
Enzymatically cleavable protecting groups have been investigated 
previously in peptide synthesis to provide orthogonal protecting strategies that 
compliment the existing chemistries available to peptide chemists. These 
techniques have not achieved wide-spread usage as there is insufficient demand 
for additional methods of peptide synthesis. However these show that the 
targeted use of enzymes to deprotect peptide sequences should be successful in 
theory if the protecting group and enzyme are carefully selected. 
Enzymatically cleavable protecting groups have been utilised to 
synthesise model nucleoproteins where a side chain OH from serine in a short 
peptide sequence was linked via a phosphodiester group to a nucleic acid263 . Due 
to the number of different functional groups present in nucleopeptides current 
techniques of orthogonal protecting strategies could not be used to synthesise the 
nucleopeptides. A phenylacetoxy benzyloxycarbonyl (PhAcOz) group (urethane) 
was utilised to protect the amine terminus of a peptide containing serine prior to 
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formation of the phosphodiester bond and was later removed by the enzyme 
Penicillin G Acylase. The enzyme catalysed hydrolysis occurred at RT in PBS 
(pH 6.8) containing 20% methanol and the desired product was isolated with 
yields of 60-69% dependent on the flanking amino acid residues. 
A glucose based enzymatically cleavable group 
tetrabenzylglucosyloxycarbonyl (BGloc) has been used as a protecting group for 
the amine terminus of peptide sequences264 . The removal of the protecting group 
was achieved in two steps by the hydrogenation of the glucose benzyl ester 
followed the removal of the glucose group by a and p glucosidase. Yields of 67-
91 % were obtained from this two-step procedure. 
Phenyl hydrazide groups have been used to protect the carboxyl terminus 
of peptides and can be removed by tyrosinase265 . Yields obtained from the 
enzymatic deprotection were in the order of 64-99% depending on the amino 
acid and / or length of the peptide sequence. 
Although no protection and enzymatic cleavage of arginine side chains 
has been conducted this research shows that enzymes can be utilised to cleave 
protecting groups on peptides in high yields under mild conditions. 
5.3 Amino Acid Synthesis and Deprotection 
The work of Zhao et al showed that virtually any benzyl sulphonamide 
could be cleaved by GST enzymes if there were electron withdrawing 
substituents on the benzene ring ortho or para to the sulphonamide. In order to 
synthesise a peptide containing an arginine protected with the benzyl 
sulphonamide the amino acid must be synthesised with Fmoc protection as the 
peptide will be synthesised on a solid support using Fmoc chemistry266.267. In 
addition the benzyl sulphonamide must be stable to strong acid (TF A for 
cleavage) and strong base (20% piperidine for removal ofFmoc groups). 
The synthesis route to forming protected arginine derivatives usually 
involves the reaction of Z-Arginine with a sulphonyl chloride. The Z group can 
then be removed by hydrogenation and the Fmoc group added by reaction with 
Fmoc-Cl. As this route requires the use of hydrogenation to remove the Z group 
then -N02 cannot be used as the electron-withdrawing substituent as it would be 
converted to -NH2. A survey of commercially available benzyl sulphonyl 
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chlorides identified 4-bromobenzyl sulphonyl chloride as a target. This reaction 
scheme is shown in Figure 5-10 below. 
Fmoc-CI. dio!(lne. 10'/. Na~CO)\MlI 
Figure 5-10 Synthesis of Fmoc-Arg(4-Bbs) from Z-Arg-OH 
5.3.1 Synthesis of Z-Arg(4-Bbsl 
Z-Arg(4-Bbs) was successfully synthesised by the reaction of Z-Arg-OH 
with 4-bromobenzylsulphonyl chloride in acetone and 3M sodium hydroxide 
solution as shown in Figure 5-11. 
CI/~~ 
~. 
lM NaOltlaoj~ Ace!onc, RT, I hours 
Figure 5-11 Reaction of Z-Arg-OH with 4-bromonbenzyl sulphonyl chloride. 
This method was developed as an adaptation of the procedures used to 
synthesize arginine derivatives with different sulphonyl protecting groups268. 
20ml of NaOH(aq) 3M per g of Z-Arg-OH and 1.1 equivalents of the sulphonyl 
chloride were used. The product was found to be a cream-coloured gum that 
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could be converted into a solid by adding cyc10hexylamine (CHA) to form the 
salt. The yield of the reaction was found to be low, approximately 20% and the 
purity of the product (analysed by HPLC with diode array and mass spectrometry 
detection) was also poor. The removal of the CHA by solvent extraction with 
dilute sulphuric acid further reduced the yield of the product to an overall 10%. 
The formation of the CHA was abandoned as this yield was deemed to be 
unacceptable. It was found that the product could also be formed as a solid by not 
drying the solvents and precipitating into ether. It is believed that the product 
formed is hydrated. 
Yields were improved to approximately 50% by utilising 3 eq. of the 
sulphonyl chloride and by utilizing dioxane as the solvent. Attempts to 
recrystallize the product from various solvents (water, ethyl acetate, methanol, 
acetonitrile and combinations thereof) failed, which is not surprising, as the 
natural state of the product appears to be a gum and not a solid. Purification of 
the product could be achieved by repeated precipitation into diethyl ether from 
methanol or ethyl acetate but the yields were reduced by this process to less than 
10%. Extraction of the product into 10% sodium carbonate solution, acidification 
of the solution and then re-extraction back into ethyl acetate had more success. 
Final reaction yields were in the order of 40% and the purity was greater than 
85% by HPLC. This level of purity was deemed insufficient for testing the 
deprotection efficiency of the enzyme and so the product was further purified by 
preparative HPLC. 
5.3.2 Determination of Deprotection by Sulphite Assay 
The reaction of aST with a benzyl sulphonamide produces a benzyl 
group co-ordinated to aSH, an amine and sulphur dioxide. Sulphur dioxide 
dissolves in water to form sulfite and this was utilised by Zhao et. al. to 
determine the rates of reaction of aST with various benzyl sulphonamides. The 
determination of the sulfite concentration was achieved by the reaction of Basic 
Fuchsin (otherwise known as pararosaniline HCI) with the sulfite and the 
spectrophotometric analysis at 590 nm. aSH was known to interfere with the 
spectrophotometry and consequently was precipitated out with mercury 1I 
chloride before the analysis was performed. 
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Stock solutions of sodium sulfite containing 500 IlM GSH were prepared 
and utilised to form a calibration chart. 
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Figure 5-12 Calibration chart showing the concentration of sulfite as determined by the 
basic Fuchsin colorimetric assay. Results shown are the average of 3 replicates with 
standard deviations shown. 
The calibration chart in Figure 5-12 gave a linear fit and showed that the 
sulfite concentration could be accurately determined up to 50llM concentration 
and approximately determined from lOO to 500IlM. It is believed that the loss in 
accuracy at higher concentrations is the result of the adsorption of the sulfite onto 
the GSH precipitate. The concentration of sulfite formed from the reaction of 
varying concentrations of amino acid with varying concentrations of GST were 
examined at 24 and 48 hour time points. 
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Figure 5·13 Deprotection of Z-Arg(4.Bbs) analysed via sulfite Formation and basic fuchsin 
Colorimetric Assay. Results are the mean of 3 replicates with standard deviations shown. 
The result of thi experiment shown in Figure S-13 were di appointing 
as, although the result clearly showed some deprotection the amount of sulfite 
present was very low. The maximum sulfite concentration ob erved wa 7.S J.1M, 
only 1.S% of the total concentration of the amino acid. 
It was believed that the calibration chart may be inaccurate due to the loss 
of sulfite a the ga sulphur dioxide and the experiment was repeated with the 
odium ulfite standards being kept in the ame conditions as the enzyme 
reaction 
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Figure 5-14 Graph showing sulfite concentration generated by deprotection of Z-Arg(4-
Bbs) and remaining sulfite concentration in sulfite standards kept under the same 
conditions. 
In Figure 5-14 the sodium sulfite standards no longer gave a linear plot 
after incubation in the same conditions that the amino acid deprotection solution 
were subjected to and so it was impos ible to determine the concentration of 
sulfite formed in the enzyme reaction from the absorbance. In addition, when the 
absorbances from the sulfite standards are applied to the original calibration 
chart, it appears that ignificant amounts of the sulfite are 10 t as sulphur dioxide. 
This indicates that the sulfite concentration determined in the first experiment 
are a combination of the amount of ulfite formed and the amount of sulphur 
dioxide lost to the atmosphere, and as uch are more indicative of the rate of 
reaction rather than the total amount of amino acid deprotected. 
122 
5.3.3 Determination of Deprotection by "PLC 
An alternative strategy for the analysis of the deprotection of the 4-
bromobenzyl sulphonamide group by GST is to determine the amount of the 
products or starting material by HPLC, which can be a quantitative technique. Z-
Arg-OH precipitated out under the enzyme reaction conditions, which were O.S 
or O.OSmg/ml GST and SOOJlmol dm-3 of GSH in PBS with 0.1 % methanol (from 
stock solution) at 37°C. Z-Arg( 4-Bbs) remained in solution and gave a sharp 
peak when analysed on a C 18 silica column with a gradient of 9S% water 
(containing 0.1 % TF A) to 100% acetonitrile over 2S minutes. Trials of 20, 100 
and SOOJlM of Fmoc-Glycine as a reference amino acid showed that the peaks for 
the arginine species and the Fmoc-Gly were distinct and that 100JlM of Fmoc-
Gly was the most suitable concentration to give roughly equal sized peaks. A 
calibration chart was prepared from a range of Z-Arg(4-Bbs) concentrations with 
this concentration of Fmoc-Gly. Each data point is the average of 3 HPLC traces 
taken from three different solutions to check the accuracy of the volumetric 
composition of the samples. 
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Figure 5-15 Calibration cbart sbowing tbe concentration of Z-Arg(4-Bbs) as determined by 
tbe relative peak area compared to Fmoc-Gly. Results sbown are the mean of 5 replicates 
witb standard errors sbown. 
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The calibration plot in Figure 5-15 shows the expected linear relationship 
between the concentration of the protected arginine species and the ratio of the 
peak area compared to that of the reference amino acid. There are some errors 
introduced through inaccuracies in sample preparation or analysis method and 
these must be taken into account when assessing the reliability of the data. 
Three different concentrations of Z-Arg( 4-Bbs) were reacted with GST at 
two different concentrations at room temperature for 24 hours and then analysed 
by HPLC. In all cases, allowing for errors, there were no detectable reductions in 
the concentration of the arginine species and so the experiment was repeated with 
a reaction time of 7 days. 
Conc. of Z- Conc. Ratio of Conc. of Amount 
Arg(4-Bbs) of OST Z-Arg(4-Bbs) converted 
Percentage 
peak areas 
converted 
used / IlM / mg/ml (%) found / IlM / IlM 
50 0.5 9.93 34.46 15.54 31.08 % 
100 0.5 17.81 61.81 38.19 38.19 % 
200 0.5 33.91 117.67 82.33 41.17% 
50 0.05 10.37 35.99 14.01 28.02 % 
100 0.05 21.30 73.92 26.08 26.08 % 
200 0.05 49.13 170.50 29.50 14.75 % 
Table 5-3 Deprotection of Z-Arg(4-Bbs) by incubation with 0.05 or 0.5mg/ml GST and 500 
J,1mol dm·3 GS" for 7 days at room temperature as determined by "PLC. 
In all cases the concentration of Z-Arg(4-Bbs) had decreased showing 
that the benzyl sulphonamide had been deprotected by the enzyme. The amount 
that had been deprotected appears to be proportional to some degree to the 
concentration of both the amino acid and the enzyme. It is possible to assume 
that these reactions have not reached equilibrium as the percentage conversion 
differs in each case. From this it is a reasonable assumption that the amount 
deprotected at time T is proportional to the rate of the reaction. As these results 
show a linear increase in amount deprotected at time T they imply that the rate of 
the reaction is first order with respect to both the amino acid and the enzyme (see 
Figure 5-16). 
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Figure 5-16 Deprotection of Z-Arg(4-Bbs) by incubation with O.OS or O.Smg/ml GST and 
SOO Ilmol dm·3 GSH for 7 days at RT as determined by HPLC with respect to the reference 
amino acid Fmoc-Glycine 
Whil t these results show that the benzyl ulphonamide species can be 
deprotected by the enzyme the reaction time is too long and the percentage 
conver ion is too low for this to be of use in a synthetic trategy. However the 
physiological conditions under which the enzyme normally function involve a 
higher temperature than used in these experiments. These experiments were 
therefore repeated with the reaction solution being incubated at 37°C. A new 
calibration chart was al 0 prepared with the calibration solutions being kept 
under the same conditions as the reactions. The data from the e experiments can 
be found in Table 5-4 and Figure 5-17 below. 
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Conc. of Conc. of Ratio of Conc. of Amount Percentage Z-Arg(4-Bbs) GST peak Z-Arg(4-Bbs) converted 
converted 
used/ ~M / mg/ml areas (%) found / ~M /~M 
50 0.5 2.71 9.44 40.56 81.11 
100 0.5 4.93 17.18 82.82 82.82 
200 0.5 9.93 34.61 165.39 82.70 
50 0.05 2.68 9.34 40.66 81.32 
100 0.05 5.13 17.88 82.12 82.12 
200 0.05 10.30 35 .90 164.10 82.05 
Table S-4 Deprotection of Z-Arg(4-Bbs) by incubation with O.OS or O.Smg/ml GST and SOO 
Ilmol dm·) GSH for 24 hours at 37°C as determined by HPLC. 
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Figure S-17 Deprotection of Z-Arg(4-Bbs) by incubation with O.OS or O.Smglml GST and 
500 Ilmol dmo ) GSH for 24 hours at 37°C as determined by HPLC with respect to the 
reference amino acid Fmoc-Gly. Results shown are the mean of 3 replicates with standard 
deviations shown. 
These results clearly how that the same level of deprotection is ach ieved 
with both concentrations of GST (0.5 and 0.05 rng/ml). In addition they al 0 
show that the reaction has reached equilibrium over a 24 hour period with a 
percentage conversion of -82%0 Both the time scale and the degree of 
deprotection indicate that this method would be uitable for the protection 
strategy in the peptide. In addition it is po ible that the conversion in the 
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polymer would be driven to completion by the fact the peptide would be tethered 
to the support, removing one of the products from solution and preventing the 
reverse reaction. However the mobility of the solvated polymer chains in 
aqueous media means that the reaction of species attached to swollen hydrogels 
can behave more like species in a viscous solution. It is also possible that the 
incorporation of the arginine residue into a peptide sequence and immobilisation 
into a polymer could hamper the deprotection by steric hindrance of the 
enzyme's access to the protecting group. Consequently it was decided to analyse 
the effect of steric hindrance on the deprotection. As Fmoc-Arg(4-Bbs) is an 
essential part of the peptide synthesis process it was decided to synthesise this 
species and analyse its deprotection by the enzyme. The comparison of the bulky 
fmoc protection with that of the Z group should indicate whether the size of 
groups distant to the benzyl sulphonamide has a significant effect on the 
deprotection. 
5.3.4 Synthesis of Fmoc-Arg(4-Bbs) 
Z-Arg(4-Bbs) was synthesised in bulk and the Z- group was removed by 
hydrogenation with a palladium catalyst. HPLC-MS showed that, whilst the Z 
group had been removed, the bromine on the benzyl substituent had also been 
removed. Alternative ways to remove the Z- group were investigated and it was 
found that 30% hydrogen bromide in acetic acid would remove the Z-group 
whilst leaving the side chain protecting group intact. The stability of the 
protecting group towards strong acids and bases is one of the factors that makes 
it appealing as it can be used as an alternative orthogonal protection strategy for 
other uses as well as copolymerisation of peptides. The extremely corrosive and 
toxic nature of the HBr/ AcOH method however made it unsuitable for use in a 
large scale synthesis of H-Arg(4-Bbs). It was decided to alter the original 
protecting group from Z to Boc as the Boc group is more easily removed by 
TFA. Boc-Arg(4-Bbs) was synthesised and it was found that this strategy had 
additional benefits as the yields were higher (70-90%) and the re-extraction 
process gave a higher degree of purity. The deprotection of Boc-Arg(4-Bbs) with 
TFA was achieved as expected as was the reaction ofH-Arg(4-Bbs) with Fmoc-
Cl269 to form the final protected amino acid to be utilised in both enzyme 
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deprotection analysis and peptide synthesis. Typical overall yields were in the 
order of 40%. 
Boc-Arg 80% )Boc-Arg(4-Bbs) 80% )H-Arg(4-Bbs) bO% )Fmoc-Arg(4-Bhs) 
5.3.5 Deprotection of Fmoc-Ar2(4-Bbs) 
Fmoc-Arg(4-Bbs) of varying concentrations was incubated with 
O.OSmg/ml of GST for 24 hours. Calibration solutions containing varying 
concentrations Fmoc-Arg(4-Bbs), SOO~M GSH and varying concentrations of 
Fmoc-Gly were also prepared and incubated in the same conditions. The extent 
of the deprotection was determined by the average peak areas of the amino acid 
remaining compared to that of the reference amino acid. The initial reference 
amino used was Fmoc-Gly as it was the same as that used in the analysis of Z-
Arg(4-Bbs) deprotection. Trials with Fmoc-Gly showed that a concentration of 
100J-lM was most suitable as it gave reasonable sized peaks relative to those of 
Fmoc-Arg(4-Bbs) at concentrations ranging from 20 to 200J-lM. However when 
solutions using Fmoc-Gly as a reference amino acid were incubated in PBS with 
500)lM GSH the average peak area of the Fmoc-Gly reduced drastically. It is 
unknown why this should be the case when the only change from previous 
experiments was to alter the protecting group on the arginine species. 
Consequently the reference amino acid was changed to Boc-Phe at a 
concentration of 1000J-lmol dm-3• 
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Figure 5-18 Calibration Chart showing the concentration of Fmoc-Arg(4-Bbs) as 
determined by the relative peak area compared to Boc-Phe. Results shown are the mean of 
3 replicates with standard deviations shown. 
With Boc-Phe as the reference amino acid the calibration chart was linear 
as shown in Figure 5-18 even after the standards have been incubated for 24 
hours at 37°C (reaction conditions). 
Conc. of Cone. of 
Cone. of Ratio of Amount 
Fmoc-Arg(4-
GST peak 
Fmoc-Arg( 4-
converted 
Percentage 
areas 
Bbs) used Bbs) found converted 
/ mg/ml (%) /IlM 
filM filM 
50 0.5 7.16 38.29 11.70 23.41 
100 0.5 14.40 77.03 22.97 22.97 
200 0.5 28.77 153.92 46.08 23.04 
50 0.05 7.34 39.27 10.73 21.45 
100 0.05 14.47 77.42 22.58 22.58 
200 0.05 28.86 154.40 45.6 22.80 
Table 5-5 Deprotection of Fmoc-Arg(4-Bbs) by incubation with 0.05 or 0.5mg/ml GST and 
500 IJ.mol dm,l GSH for 24 hours at 37°C as determined by HPLC 
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These results shown in table 5 indicate that deprotection has occurred and 
that, as with the Z protection, equilibrium has been reached after 24 hours 
incubation. However it is clear that the bulky fmoc group has had an adverse 
effect on the percentage deprotection of the side chain reducing it from -82% to 
-22%. This implies that, whilst achievable, the presence of the polymer 
surrounding the protecting group may also have an adverse effect on the 
percentage deprotection. Alternatively, as discussed earlier, the heterogenous 
nature of the reaction when the peptide is incorporated in the cross-linked 
polymer may move the equilibrium position as local regional effects are likely to 
have a large effect on the deprotection. It was therefore decided to proceed with 
the peptide and polymer library synthesis and analyse the deprotection in situ. In 
addition the peptide that has not been deprotected should serve as an adequate 
control sequence similar to a scrambled or substituted peptide that shows the 
effect of the peptide presence on non-specific (i.e. not integrin mediated) cell 
adhesion to a material. 
5.4 Peptide Synthesis 
It is known that the minimal peptide sequence ROD has a low affinity for 
integrins and slightly longer sequences such as RODS, RODY and RODe have 
higher affinities. It has also been shown that in certain polymer systems a spacer 
arm is required to distance the peptide from the bulk of the polymer. However 
the conditions under which the spacer arm is required have not been elucidated 
and it was decided to investigate this requirement in these systems being 
investigated by synthesising peptides both with and without a spacer arm. In 
addition the additional distance between the peptide and the bulk of the polymer 
may reduce steric hindrance and allow better deprotection by the enzyme. It was 
also decided to use the sequence GRGDS as this sequence has been frequently 
utilised in previous publications and is known to promote cellular functions in 
polymeric materials. The target peptides are shown in Figure 5-19 (fully 
protected peptides) and Figure 5-20 (with arginine protected by 4-
bromobenzylsulphonyl group). 
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The first tep of peptide synthesi i to attach the first amino acid to a 
solid support. The peptide with enzyme labile protecting group are ynthesised 
on Wang resins, which can be bought with the first amino acid pre-attached. The 
fully protected peptide are synthe i ed on Rink acid labile resins and the fir t 
amino acid must be attached to the resin by MSNT mediated reaction. Thi 
reaction is hown below in Figure 5-21. 
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Figure 5-21 Reaction scheme for attachment of fir t amino acid to Rink acid labile re in by 
use of MSNT 
The fir t attempt to attach an amino acid to a rink acid labile re in270 
u ing standard MSNT protocolSl 266.271 were un ucces ful a they re ulted in a 
I 5eq of the amino acid, 5 eq . of MS T , 3.75 eq or methyl imidazole and DCM IOml per g or 
re in added to re in pre- wollen in DCM and purged with nitrogen for I hour, allowed to react 
for I hour with 2 agitation then wa hed with 3 aliquots DCM and 3 aliquot methanol. 
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low resin loadings of 0.1-0.4 mmol /g. The nominal loading capacity of the resin 
is 0.6-0.8mmol / g making the functionalised resin unsuitable for further 
synthesis as this requires greater than 70% functionalisation. One of the problems 
appeared to be unsatisfactory errors in the assessment of the resin loadings as one 
sample gave results of 30% conversion and 60% conversion - clearly an 
unacceptable error. The protocol for the analysis of the resin loading was 
modified in the following ways: 
• Instead of weighing the resin directly into a cuvette and adding 3ml of 
deprotection solutions the resin was weighed in 10mg aliquots into 
10ml volumetric flasks to make the weights and volumes more 
accurate. 
• Three measurements of absorption at 290nm from each flask could be 
taken at time intervals ensuring that the deprotection was complete. 
• The Fmoc deprotection time was extended to 4 hours. Although the 
deprotection reaction completes in a few minutes the extra time was 
necessary to allow for resin swelling. 
A number of factors were investigated with respect to improving the resin 
loadings such as the presence of water, time of reaction and ratios of reagents. It 
was found that successful resin loadings could be achieved by swelling the resin 
for a longer period than that recommended by standard protocols. Swelling for a 
minimum of 24 hours produced resin loadings in excess of 90%. The standard 
protocols for the synthesis of the peptide worked efficiently and the desired 
peptide sequences were produced. 
The Fmoc protecting groups were removed by treatment with 20% 
piperidine in DMF for 3 minutes then 7 minutes. The mechanism of Fmoc 
removal is shown in Figure 5-22 overleaf. 
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RNH, 
Figure 5-22 Removal of Fmoc protecting groups with piperidine. 
Standard procedures for effecting the chain elongation of the peptide 
were successful with a PyBOPIHOBt system267,272,· being utilised for protected 
peptides and a HBTUIHOBt systemt266 for non-protected peptides. Standard 
methods of peptide cleavage from the resin were successful with 1% TF A in 
DCM being used for the protected peptide and 95% TFA with 2.5% TFA and 
2.5% water being used for the peptide synthesised on a wang resin. The cleavage 
cocktail successfully removed the side chains of peptides and left the 4-Bbs 
protecting group on arginine intact. 
All target peptides were successfully synthesised and utilised to 
synthesise a polymer library. 
·5 eq. of the amino acid, 4.9 eq. PyBOP, 5 eq. HOBt, 10 eq. DIPEA and lOml DMF per gram of 
resin added to resin pre-swollen with DMF and purged with nitrogen for 24 hours, allowed to 
react for 1 hour and then washed with 3 aliquots ofDMF. 
t 5 eq. of the amino acid, 5 eq. HBTU, 5 eq. HOBt, 10 eq. DIPEA and 10ml DMF per gram of 
resin added to resin pre-swollen with DMF and purged with nitrogen for 24 hours, allowed to 
react for 1 hour and then washed with 3 aliquots of DMF. The mechanism of HBTUIHOBt 
mediated coupling is shown in Figure 5-23 below. 
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11 R'-'--R~N/ Y Bt activated ester R (CP/ H 
R,,/NH2 
Figure 5-23 Reaction Scheme for "BTU mediated coupling of amino acids 
5.5 Polymer Library Synthesis and Deprotection 
5.5.1 Strategy 1: TF A Deprotection of Peptides 
The UV initiation method of creating thin films could not be utilised with 
the TF A deprotection strategy as a suitable material on which to create the thin 
films could not be found. PET and other polymer sheets were not stable to TF A 
reaction and hence could not be used. Glass sheets could be used to make the 
polymers on but could not be cut into suitable shapes for cell culture. Glass 
microscope slides and coverslips of suitable shapes and sizes for placing in 
culture wells were investigated however the thin film could not be properly 
drawn over the glass due to the small size of the glass shapes. Consequently 
polymers containing GMAc and 2.5 wt % DVB were synthesised by the thermal 
polymerisation method described in section 7.2.3. 
Disks were cut out from the sheet polymer and were washed three times 
with ethanol before being placed in 100% TF A for 4 hours. Upon removal from 
the TF A the disks were washed a further three times with ethanol to remove all 
traces of the acid. The transferral of the disks from ethanol to TF A resulted in a 
rapid size change in the polymers and the disks formed multiple hairline cracks 
or broke up entirely. The multiple hairline cracks resulted in a loss of 
transparency making the polymers unsuitable for cell culture as it would not be 
possible to visualise the morphology of the cells. The polymer disks were dried 
in a vacuum dessicator overnight and the experiment was repeated however the 
drying process also caused the polymer disks to break up. As a result of the 
fragmentation of the polymers this strategy of producing polymers incorporating 
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RGD was abandoned and efforts were concentrated on the second strategy of 
producing the peptide with enzymatically cleavable protecting groups. 
5.5.2 Strategy 2: Enzyme Deprotection 
MacAddaGR(4-Bbs)GDS 
Figure 5-24 Target pep tides for use with strategy 2: Enzyme deprotection 
The target peptides (shown above in Figure 5-24) were synthesised as 
described in section 7.5 and stock solutions containing 0.01, 0.1, 1 and 10 !-lmol 
of peptide per mi11ilitre of methanol were prepared. Stock solutions containing 
monomer, 2.5 wt % of EGDMA and 1 wt % of HMPP were also prepared. 
Polymerisation solutions were made by combining a known volume of monomer 
stock solution with known volume of peptide stock solution. The volumes were 
adjusted to allow for the different densities of the solutions such that the weight 
percentages remained constant. Thin films were then created by the techniques 
described in section 7.7. 
Disks of an appropriate size were cut out from the thin films and placed 
inside culture wells in a sterile culture hood. The polymers were washed with 
ethanol three times to sterilize the polymers and to remove soluble impurities 
from the hydrogel such as unreacted initiator. All polymers were then washed 
three times with PBS to remove ethanol from the hydrogel. Those polymers that 
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required deprotection with the enzyme had O.Sml of the GST incubation solution 
added to them and then they were stored for 24 hours in an incubator at 37°C 
with 5% C02. Polymers that were incubated for more than one day had the 
enzyme solution changed at 24 hour intervals. 
Tables showing the polymers synthesised and the deprotection procedures 
are shown below. Each polymer was given a code that referred to its composition 
and treatment with four parts indicating the value of each variable such as G-S-
10-1. The first letter refers to the monomer type CGMMA = G, BMA = B), the 
second letter refers to the peptide sequence CS = short, without spacer arm, L = 
long, with spacer arm), the first number refers to the nominal concentration of 
peptide in l..Imol/g and the last number refers to the number of days pre-treatment 
with GST. 
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Polymers synthesised with the peptide sequence MacGR(4-Bbs)GDS 
Polymer Code Composition wt % Nominal Peptide Enzyme Treatment 
GMMA: BMA: EGDMA Concentration I ~mol g-' 
GE-S-JO-O 100: 0: 2.S 10 No treatment 
GE-S-IO-I lOO: 0: 2.S 10 I day GST/GSH 
GE-S-IO-3 lOO: 0: 2.S 10 3 days GST/GSH 
GE-S-IO-S lOO: 0: 2.S 10 S days GST/GSH 
GE-S-I-O lOO: 0: 2.S I No treatment 
GE-S-I-I lOO: 0: 2.S I I day GST/GSH 
GE-S-I-3 lOO: 0: 2.S I 3 days GST/GSH 
GE-S-I-S lOO: 0: 2.S I S days GST/GSH 
GE-S-O.I-O lOO: 0: 2.5 0.1 No treatment 
GE-S-O.I-I lOO: 0: 2.5 0.1 I day GST/GSH 
GE-S-0.1-3 lOO: 0: 2.S 0.1 3 days GST/GSH 
GE-S-O.I-S lOO: 0: 2.S 0.1 5 days GST/GSH 
GE-S-O.O 1-0 lOO: 0: 2.5 0.01 No treatment 
GE-S-O.OI-I 100: 0: 2.S 0.01 I day GST/GSH 
GE-S-O.O 1-3 lOO: 0: 2.S 0.01 3 days GSTIGSH 
GE-S-O.O I-S 100: 0: 2.5 0.01 S days GST/GSH 
BE-S-IO-O 0: lOO: 2.S 10 No treatment 
BE-S-IO-I 0: lOO: 2.S 10 I day GST/GSH 
BE-S-IO-3 0: lOO: 2.S 10 3 days GST/GSH 
BE-S-IO-S 0: lOO: 2.5 10 S days GST/GSH 
BE-S-I-O 0: lOO: 2.S I No treatment 
BE-S-I-I 0: lOO: 2.S I I day GST/GSH 
BE-S-I-3 0: lOO: 2.5 1 3 days GST/GSH 
BE-S-I-S 0: 100: 2.S I 5 days GST/GSH 
BE-S-O.I-O 0: lOO: 2.S 0.1 No treatment 
BE-S-O.I-I 0: lOO: 2.S 0.1 I day GSTIGSH 
BE-S-0_1-3 0: lOO: 2.S 0.1 3 days GST/GSH 
BE-S-O.I-S 0: lOO: 2.5 0.1 5 days GST/GSH 
BE-S-O.O 1-0 0: lOO: 2.5 0.01 No treatment 
BE-S-O.OI-I 0: lOO: 2.S 0.01 1 day GSTIGSH 
BE-S-O.O 1-3 0: lOO: 2.5 0.01 3 days GST/GSH 
BE-S-O.O 1-5 0: lOO: 2.5 0.01 5 days GST/GSH 
. Table S-6 Polymers synthesised with the short peptide sequence Mac-GR(4-Bbs)GDS and 
treated with the enzyme GST to remove protecting group on arginine. Treatment with 
GST/GSH comprised of incubating polymer disks in individual wells of a tissue culture 
plate with 2S0~1 of a solution of O.OSmg/ml GST and 500~M GSH in PBS (pH 7.4) at 37°C, 
Where the treatment was conducted for more than 1 day the solution was changed on a 
daily basis. 
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Polymers synthesised with the peptide sequence MacAddaGR(4-Bbs)GDS 
Polymer Code Composition wt % Nominal Peptide Enzyme Treatment 
GMMA: BMA: EGDMA Concentration I j.lmol g-
GE-L-IO-0 lOO: 0: 2.5 10 No treatment 
GE-L-IO-I 100: 0: 2_5 10 I day GST/GSH 
GE-L-IO-3 lOO: 0: 2_5 10 3 days GST/GSH 
GE-L-IO-5 lOO: 0: 2.5 10 5 days GST/GSH 
GE-L-I-O lOO: 0: 2.5 I No treatment 
GE-L-I-I 100: 0: 2.5 I I day GST/GSH 
GE-L-I-3 lOO: 0: 2.5 I 3 days GST/GSH 
GE-L-I-5 lOO: 0: 2.5 I 5 days GST/GSH 
GE-L-O.I-O 100: 0: 2.5 0.1 No treatment 
GE-L-O.I-I lOO: 0: 2.5 0.1 I day GST/GSH 
GE-L-0.1-3 lOO: 0: 2.5 0.1 3 days GST/GSH 
GE-L-0.1-5 100: 0: 2.5 0.1 5 days GST/GSH 
GE-L-O.OI-O lOO: 0: 2.5 0.01 No treatment 
GE-L-0.Q1-1 lOO: 0: 2.5 0.01 I day GST/GSH 
GE-L-0.01-3 100: 0: 2.5 0.01 3 days GST/GSH 
GE-L-0.01-5 lOO: 0: 2.5 0.01 5 days GST/GSH 
BE-L-IO-O 0: lOO: 2.5 10 No treatment 
BE-L-IO-I 0: lOO: 2.5 10 I day GST/GSH 
BE-L-IO-3 0: lOO: 2.5 10 3 days GST/GSH 
BE-L-IO-5 0: lOO: 2.5 10 5 days GST/GSH 
BE-L-I-O 0: lOO: 2.5 I No treatment 
BE-L-I-I 0: lOO: 2.5 I I day GST/GSH 
BE-L-I-3 0: lOO: 2.5 I 3 days GST/GSH 
BE-L-I-5 0: lOO: 2.5 I 5 days GST/GSH 
BE-L-O.I-O 0: lOO: 2.5 0.1 No treatment 
BE-L-O.l-I 0: lOO: 2.5 0.1 I day GST/GSH 
BE-L-0.1-3 0: lOO: 2.5 0.1 3 days GST/GSH 
BE-L-O.l-5 0: lOO: 2.5 0.1 5 days GST/GSH 
BE-L-O.OI-O 0: lOO: 2.5 0.01 No treatment 
BE-L-O.O I-I 0: lOO: 2.5 0.01 I day GST/GSH 
BE-L-0.01-3 0: lOO: 2.5 0.01 3 days GST/GSH 
BE-L-0.01-5 0: lOO: 2.5 0.01 5 days GST/GSH 
Table 5-7 Polymers synthesised with the long peptide sequence Mac-Adda-GR(4-Bbs)GDS 
and treated with the enzyme GST to remove protecting group on arginine. Treatment with 
GST/GSH comprised of incubating polymer disks in individual wells of a tissue culture 
plate with 2S0j.l1 of a solution of O.OSmg/ml GST and SOOj.lM GSH in PBS (pH 7.4) at 37°C. 
Where the treatment was conducted for more than 1 day the solution was changed on a 
daily basis. 
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5.6 Analysis of Cell Behaviour on Polymers 
The aims of the cell culture on the polymer are to both qualitatively and 
quantitatively determine the ability of each polymer to promote cell adhesion and 
function. This shall be done in two main ways, the use of the MTT assay to 
quantitatively determine cell activity levels and visual methods to determine the 
morphology of the cells. Cellular adhesion occurs primarily in the first 10 hours 
after the cells are plated on a material however the purpose of this study is to 
analyse both the adhesion and the normal function of the cells so it was decided 
to use a cell culture time of 24 hours prior to analysis of the cells. 
5.6.1 General Information 
The library contained 4 different variables; peptide concentration, peptide 
type, monomer type and number of days deprotection. The peptide concentration 
variable investigated a total of 5 different concentrations 10mmol, I mmol, 
0.1 mmol, 0.01 J.lmol/g and no peptide. The two different peptide types were target 
peptide S (short - without a spacer arm) and target peptide L (long - with a spacer 
arm). The monomer types were butyl methacrylate and glycerol methacrylate. 
The cross-linker concentration was kept constant at 2.5 wt %. As it is unknown 
whether the sulphonamide side chain had been deprotected by the enzyme 
solution it was decided initially to examine the effect of 0, I and 3 days 
deprotection on the library of hydrogels. In total the library consisted of 60 
different polymers. Students non-paired T -test assuming non-equal vanances 
with a one-tailed distribution was utilised to calculate significances. 
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5.6.2 Serum-Containing Media 
The photographs below show the morphology of the cells on the control 
substrates that do not contain RGD; poly(GMMA-co-EGDMA) (abbreviated to 
GE), poly(BMA-co-EGDMA) (abbreviated to BE) and TCP after 4 and 24 hours. 
e.) f.) 
Figure 5-25 Primary human dermal fibroblasts (FI833, passage 10) cultured in media 
containing 10% FCS on a.) GE 4hrs, b.) GE 24 hours c.) BE 4 hrs d.) BE 24hrs, e.) TCP 4 
hrs and f.) TCP 24hrs 
After 4 hours the cells have started to attach to the surfaces but have not 
yet fully spread and obtained their final morphologies. On glycerol methacrylate 
containing surfaces the cells adhere poorly and after 4 hours, still retain the 
unnatural spherical morphology created by the harvesting of the cells from the 
surface on which they were amplified. After 24 hours some of the cells have 
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managed to spread on the glycerol methacrylate surfaces however the majority 
remain rounded and some have aggregated into large cellular bundles. Ce ll s on 
the butyl methacrylate surfaces appear to adhere well after 4 hours but the ce ll 
spreading discontinues and the cells are not much better spread after 24 hour . In 
contrast to this on tissue culture plastic the cells adhere and spread as well to 
begin with and the spreading continues over the 24 hour time period such that, 
with this culture area and cell seeding density, the cells have formed a confluent 
monolayer of elongated cells. The polymers without RGD do exhibit a range of 
cellular behaviours according to whether the substrate can adsorb proteins. 
5.6.2. 1 GMMA Polymers containing Long Peptide Sequence 
The effect of the incorporation of RGD should improve the glycerol 
methacrylate polymers as there are no competing processes of protein adsorption 
and there is a large area for improvement in the cell morphology. 
c.) d.) 
Figure 5-26 Primary human dermal fibroblasts (FI833, passage 7) cultured in media 
containing 10% FCS for 4 hours on poly(GMMA-co-EGDMA-co-MacAddaGR(4-
8bs)GDS) pre-incubated with 0.05 mg/,mt GST and 500 Ilmot dm·J GSH for t day a.) 0.01 
J..lmol/g peptide, b.) 0.1 Ilmol/g peptide, c.) I Ilmol/g peptide and d.) 10 J..lmol/g peptide 
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After 4 hours there are already large differences between the way cells 
behave on polymers containing different concentrations of RGD as shown in 
Figure 5-26 (p 103). At the lowest RGD concentration cells appear very similar 
to those on the blank hydrogel whereas at the higher concentrations the ce ll s 
appear more like those on tissue culture plastic at the same time. 
c.) d.) 
Figure 5-27 Primary human dermal fibroblasts (FI833, passage 7) cultured in media 
containing 10% FCS for 24 hours on poly(GMMA-co-EGDMA-co-MacAddaCR(4-
8bs)GDS) pre-incubated with 0.05 mg/,ml CST and 500 ~mol dm·3 CSH for 1 day a.) 0.01 
~moVg peptide, b.) 0.1 ~moVg peptide, c.) I ~moVg peptide and d.} 10 ~mol/g peptide 
After 24 hours the cells show the same trends in improving cell 
morphologies as the peptide concentration increases. Over the range of 0.0 I to 10 
Ilmol / g there is a continual improvement in cell morphology and cell density. 
The cells cultured on the 0.01 mmol /g polymer (a. in Figure 5-27 above) show 
similar features to those on the blank polymer (d. in Figure 5-26) of cellular 
aggregates with some spread cells. It appears that there may be an improvement 
in cell number per field of view however this is difficult to determine. Both 
polymers with intermediate concentrations of RGD show definite improvements 
in cell morphology and the polymer with the highest concentration appeared 
indistinguishable from the positive control , Tep. These photographs clearly 
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show that there is a definite improvement in the abilities of polymers to adhere 
cells as the concentration of the peptide increases. 
The synthesis route to the incorporated peptide required the use of the 
enzyme Glutathione-S-Transferase to deprotect the sulphonyl group on the 
arginine. The protected peptide will not be able to bind to integrins as the size 
and electrostatic properties of the sequence will have been masked by the 
protecting group. Consequently polymers containing peptide that have not been 
deprotected ought to exhibit cell morphologies similar to that of the background 
substrate glycerol methacrylate. 
The morphologies of cells on polymers containing different leve ls of 
RGD and different number of days deprotection with the enzyme GST was 
investigated. 
a.) b.) c.) 
Figure 5-28 Primary human dermal fibroblasts (FI833, passage 7) cultured in media 
containing 10% FCS for 24 hours on poly(GMMA-co-EGDMA) containing 0.01 flmo1/g 
MacAddaGR(4-Bbs)GDS a.) no GST deprotection, b.) 1 days incubation with 0.05 mg/,ml 
GST and 500 flmo1 dm·l GSH and c.) 3 days incubation with 0.05 mg/,ml GST and 500 flmol 
dm·J GSH 
After 24 hours the morphologies of all cells on polymers containing the 
minimal concentration of RGD of O.OI~mol/g were similar both to each other 
and to the background substrate. 
a.) b.) c.) 
Figure 5-29 Primary human dermal fibroblasts (F1833, passage 7) cultured in media 
containing 10% FCS for 24 hours on poly(GMMA-co-EGDMA) containing 0.1 flmol/g 
MacAddaGR(4-Bbs)GDS a.) no GST deprotection, b.) 1 days incubation with 0.05 mg/,ml 
GST and 500 flmol dm·3 GSH and c.) 3 days incubation with 0.05 mg/,ml GST and 500 flmol 
dm·3 GSH 
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The non-deprotected peptide at a concentration of 0.1 )lmol / g appeared 
to be ineffective at binding cells and the morphologies looked similar to tho e of 
the background substrate with some large cellular aggregates and some pread 
cells. In contrast those polymers in which the peptide had been deprotected by 
GST for either one or three days showed better cell spreading than in that of the 
background substrate. 
c.) 
Figure 5-30 Primary human dermal fibroblasts (FI833, passage 7) cultured in media 
containing 10% FCS for 24 hours on poly(GMMA-co-EGDMA) containing I ~mol/g 
MacAddaGR(4-Bbs)GDS a.) no GST deprotection, b.} 1 days incubation with 0.05 mg/,ml 
GST and 500 ~mol dm-3 GSH and c.) 3 days incubation with 0.05 mg/,ml GST and 500 ~mol 
dm-3 GSH 
a.) b.) c.) 
Figure 5-31 Primary human dermal fibroblasts (FI833, passage 7) cultured in media 
containing 10% FCS for 24 hours on poly(GMMA-co-EGDMA) containing 10 ~mol/g 
MacAddaGR(4-Bbs)GDS a.) no GST deprotection, b.) I days incubation with 0.05 mg/.ml 
GST and 500 ~mol dm-3 GSH and c.) 3 days incubation with 0.05 mg/,ml GST and 500 ~mol 
dm-3 GSH 
With a concentration of 1 or 10 Ilmollg of peptide incorporated into the 
glycerol methacrylate polymer the cells appear similar on all polymers regardle 
of whether the deprotection has been performed on the substrate prior to cell 
culture. 
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The MTT assay results shown in Figure 5-32 support the trends inferred 
by the photographic evidence that the cell culturing ability of the polymers 
increases as the peptide concentration increases. They also show that the pre-
treatment of the peptide with GST does not in fact increase the cell viability as, 
in many cases, the non-treated peptide containing polymers give a higher MTT 
value and a more significant improvement in cell adhesion and viability 
compared to the non-peptide containing control. The MTT assay results confirm 
the visual assessment of the cell adhesion and morphology on the hydrogels 
containing peptide of various concentrations that had been deprotected for 
various amounts of time by GST. It is apparent that the peptide does promote cell 
adhesion and viability even when the protecting group on arginine has not been 
removed by pre-treatment. There appear to be several different explanations for 
this; the presence of the peptide may have altered the hydrophobic and 
electrostatic properties of the polymers and allowed the adsorption of proteins to 
the surface thereby increasing the cell spreading. Alternatively the increase in 
cell adhesion and viability may be due to RGD-integrin binding as the peptide 
might have been deprotected by the culture conditions by GST present in the 
serum or produced by cells or the peptide might be able bind to integrins even 
when the side chain of the arginine residue is blocked with this protecting group. 
5.6.2.2 GMMA Polymers containing Short Peptide Sequence 
The peptide that contains the spacer arm is longer and contains a large 
hydrophobic domain that may affect the hydrophobic characteristics of the 
polymer. The short peptide, if it is able to reach the integrins without steric 
interference, ought to have less of an effect that is due to changing the 
hydrophobicity of the polymer. As the charges on both polymers are the same the 
short peptide may still have an effect due to the electrostatic attraction of 
proteins. It may be that the lack of a hydrophobic spacer arm in the peptide will 
result in cell adhesion being promoted only when the RGD peptide has been 
de protected as protein adsorption is minimised. 
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c.) d.) 
Figure 5-33 Primary human dermal fibroblasts (FI833, passage 7) cultured in media 
containing 10% FCS for 24 hours on poly(GMMA-co-EGDMA-co-MacGR(4-Bbs)GDS) 
pre-incubated with 0.05 mg/,ml GST and 500 Ilmol dm-3 GSH for 1 day a.) 0.01 Ilmol/g 
peptide, b.) 0.1 Ilmol/g peptide, c.) 1 Ilmol/g peptide and d.) 10 Ilmol/g peptide 
After 24 hours culture of cells on polymer containing the short peptide 
sequence the cells appeared to be well spread on those polymers containing high 
concentrations of peptide and less well spread as the concentration decreased. 
This follows the same trends as observed with the long peptide sequence. AS in 
the previous set of results there were no significant differences observed between 
deprotected and non-treated materials. 
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Figure 5-34 Viability of human 
dermal fibroblasts cultured for 
24 hours in media containing 
10% FCS on glycerol 
methacrylate polymers 
containing varying 
concentrations of MacGR(4-
Bbs)GOS. Results shown are 
the mean of 3-6 replicates and 
errors shown are the standard 
deviation divided by the 
number of replicates. 
Polymers were deprotected 
with O.OSmg/ml GST and 
SOOllmol dm,3 GSH in PBS 
and O.5ml per sample for 0, 1 
or 3 days (deprotection 
solution was replaced daily). 
Viability of cells (F1833. 
passage 7) was assessed via the 
MTT assay and compared to 
values obtained for TCP. 
Significance was analysed via 
the Student's non-paired T-
test, each peptide containing 
polymer was compared to the 
non-peptide containing control 
that has been treated with the 
same amount of GST (0 
indicates p<O.Ol and ~ 
indicates p<O.OS). 
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The MTT a ay re ults for polymers containing the short polymer 
equence are le clear cut that those for the long polymer sequence. Certainly 
the incorporation of O. LJ..lmol/g MacGR(4-Bb )GDS followed by L day 
incubation with GST re ulted in a tatistically significant increase in cell viability 
as a e sed by the MTT a ay. There may be a trend towards increasing assay 
value a the concentration increa e however thi i certainly less pronounced 
than previou ly and i not tati tically ignificant. The e re ult do ·how that 
there i no improvement in viability gained when the protected peptide ha been 
pre-treated with GST. However there are some doubts about the veracity of the 
MTT assay result a they did not match up quantitatively with what was 
observed qualitatively by vi ual methods. 
b 
Figure 5-35 MTT stained Primary Human Dermal Fibroblasts after 24 hr culture in media 
containing 10% FCS on poly(GMMA-co-EGDMA-co-MacGR(4-Bbs)GDS) pre-incubated 
with 0.05 mg/,m1 GST and 500 J.lmol dm·3 GSH for 1 day a.) 0.01 J.lIll0Vg peptide and b.) 10 
J.lffioVg peptide 
The MTT re ult mu t be treated with caution as they repre ent a value 
corresponding to the re pi ration rate of the cells. In general the a say provide a 
good correlation between the a ay value and the cell number and viabililY 
because unattached cell are removed by washing procedures and dead cells do 
not re pire. In some circumstances though cells that are loo ely attached and with 
a rounded morphology can remain after the wa hing procedure and may have a 
respiration rate higher than that of spread cell due to the tre imposed by their 
inability to adhere to the substrate. This is illu trated by photograph of cells 
tained by MTT in Figure 5-35 where a clearly how a higher formation of the 
purple formazan colour per rounded cell (photograph a) than per pread cell 
(photograph b). Thi not an uncommon phenomenon a hown in the 
introduction, Section 3.3.3.3, where elevated MTT a say re ult compared to 
other method have reported for other RGD-containing biomaterials. It appear 
that the MTT as ay re ult can be tru ted only where the value reported confirm 
quantitatively the re ult that can be ob erved qualitatively by visual m thod . 
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5.6.2.3 BMA Polymers containing Short and Long Peptide Sequences 
Butyl methacrylate polymers allow the adsorption of protein to the 
surface and consequently the RGD peptide may be masked by the covering 
proteins and its effects invisible or less pronounced than in the glycerol 
methacrylate polymers. 
c.) d.) 
Figure 5-36 Primary human dermal fibroblasts (FI833, passage 10) cultured in media 
containing 10% FCS for 24 hours on poly(BMA-co-EGDMA-co-MacAddaGR(4-Bbs)GDS) 
pre-incubated with 0.05 mg/,ml GST and 500 ~mol dm-3 GSH for 1 day a.) 0.01 ~mol/g 
peptide, b.) 0.1 ~mol/g peptide, c.) I ~mol/g peptide and d.) 1 0 ~mol/g peptide 
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a.) b.) 
c.) d.) 
Figure 5-37 Primary human dermal fibroblasts (FI833, passage 10) cultured in media 
containing 10% FCS for 24 hout's on poly(BMA-co-EGDMA-co-MacGR(4-Bbs)GDS) pre-
incubated with GST for 1 day a.) 0.01 Ilmol/g peptide, b.) 0.1 Ilmol/g peptide, c.) I Ilffiol/g 
peptide and d.) 10 Ilmol/g peptide 
Figure 5-36 and Figure 5-37 above shows no differences in the cell 
morphologies after 24 hours between the polymers containing the long peptide 
sequence with the spacer arm and those with the peptide without the spacer arm 
at the same concentration. There is some evidence that cells are better spread on 
the polymers containing larger amounts of peptides but this is not drastic enough 
to be conclusive. 
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Figure 5-38 Viability of 
human dermal fibroblasts 
cultured for 24 hours in 
media containing 10% 
FCS on butyl 
methacrylate polymers 
containing varying 
concentrations of Mac-
Adda-GR(4-Bbs)GDS. 
Results shown are the 
mean of 3-6 replicates. 
Polymers were 
deprotected with 
O.05mg/ml GST and 
500J.lmol dm-3 GSH in 
PBS and 0.5ml per 
sample for 0, 1 or 3 days 
(deprotection solution 
was replaced daily). 
Viability of cells (FI833. 
passage 10) was assessed 
via the MTT assay and 
compared to values 
obtained for TCP. 
Significance was analysed 
via the Student's non-
paired T-test, each 
peptide containing 
polymer was compared to 
the non-peptide 
containing control that 
has been treated with the 
same amount of GST (0 
indicates p<O.OI and * 
indicates p<0.05). 
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Figure S-39 Viability of human 
dermal fibroblasts cultured in 
media containing 10% FCS for 
24 hours on butyl methacrylate 
polymers containing varying 
concentrations of MacGR( 4-
Bbs)GDS. Results shown are the 
mean of 3-6 replicates. Polymers 
were deprotected with 
O.OSmg/ml GST and SOO J..Lmol 
dm-3 GSH in PBS and O.Sml per 
sample for 0, 1 or 3 days 
(deprotection solution was 
replaced daily). Viability of cells 
(F1833, passage 9) was assessed 
via the MTT assay and 
compared to values obtained for 
TCP. Significance was analysed 
via the Student's non-paired T-
test, each peptide containing 
polymer was compared to the 
non-peptide containing control 
that has been treated with the 
same amount of GST (0 
indicates p<O.Ol and * indicates 
p<O.OS). 
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The MTT assay results for the viability of cells cultured on butyl 
methacrylate hydrogels containing the long peptide sequence MacAddaGR(4-
8bs)GDS (Figure 5-38, pl03) show no trends in increasing cell number and 
viability as the peptide concentration increases. However there is a significant 
decrease in cell number and viability on some of the polymer surfaces that have 
been pre-treated with GST for 3 days (0.1 and 1 ~mol/g). However this reduction 
in cell adhesion and viability appears to be partly due to the adsorption of GST 
to the surfaces as the average reading given for the MTT assay of cells on TCP 
also decreased when it had been pre-treated with GST. 
When the peptide without a spacer arm is incorporated into butyl 
methacrylate hydrogels significant improvements in cell adhesion and viability 
(Figure 5-39, pI 03) are observed for a concentration of 0.1 J..lmol/g and no 
deprotection and a concentration of 1 J..lmol/g and 3 days deprotection with GST. 
There does not however appear to be a direct correlation between increasing 
peptide concentration and increasing cell adhesion and viability. There also does 
not appear to be any differences between polymers containing peptide that had 
been deprotected and those that had. Neither the MTT assay values nor the 
photographic evidence appear to demonstrate any kind of trends in cellular 
behaviour as the concentration of either type of peptide increases, which would 
appear to indicate that the effect of RGD is inhibited by the adsorption of 
proteins to the surface. Again the values of MTT assay results for TCP were 
reduced by pre-treatment with GST, which indicated that the deprotection 
protocol may be adversely affecting the reliability of the experimental procedure 
and that comparison of the effectiveness of RGD compared to TCP may not be 
suitable in this situation. 
5.6.3 Effect of GST on Cell Culture 
Cells were cultured on TCP with varymg concentrations of GST to 
determine whether the presence of residual GST after the washing procedures 
could have reduced the MTT assay value. 
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Figure 5-40 Viability of human dermal fibroblasts cultured in media containing 10% F 
for 24 hours on tissue culture plastic containing varying concentrations of GST/G H in the 
media. Viability of cells (FI833, passage 8) was a sessed via the MTT assay and significance 
was analysed via the Student's non-paired T-test compared to no additive in the media (0 
indicates p<O.Ol and * indicates p<0.05). 
The MTT re ult how that there is a slight decrea e in recorded MTI 
values as the concentration of GST present in the media increases. Thi may be 
due to a reduction in cell number caused by competitive protein adsorption or a 
reduction in cell activity cau ed by interaction of the GST with the cell . A 
significant reduction in viability wa found at GST concentrations of O.OOSmg/ml 
compared to the deprotection olution of 0.05mg/ml. In order for a significant 
effect to be een from the GST deprotection protocol over 10% of the GST 
utili ed in the deprotection tep must have remained on the polymer. Thi eem 
unlikely as the polymer were sterili ed by wa hing with ethanol and then 
wa hed a further three time with PBS after the deprotection and prior to cell 
culture. However the addition of ethanol may have cau d large amounts of 
enzyme to precipitate out and form a coating of the enzyme on the urface thu 
preventing interaction of the peptide with the cell . The effect of the deprotection 
protocols and wa hing procedure on TCP wa examined. 
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Figure 5-41 Viability of human dermal fibroblasts cultured for 24 hours in media 
containing 10% FCS on tissue culture plastic after GST treatment and variou washing 
procedures. Viability of cells (F1833, passage 8) was assessed via the MTT a ay and 
significance was analysed via the Student's non-paired T-test compared to TCP without any 
treatment. (0 indicates p<O.Ol and * indicates p<O.05). 
The analy i howed that neither GST treatment or PBS wa he cau ed a 
significant alteration in the viability of cell grown on TCP. However wa hing 
with ethanol and PBS cau ed a significant reduction in the viability of cell 
grown on the TCP, which was ameliorated by the GST treatment prior to the 
ethanol wa h. It appear that the ethanol wash may have an adverse effect on the 
ability of material to adhere and support viable cell and con equently it wa 
decided to alter the exi ting protocol and perform the deprotection step afler the 
terilisation of the polymer. 
Polymers were sterilized in ethanol a heets, wa hed with PB to 
remove trace of ethanol and cut to ize in a steri le culture hood before being 
placed in terile culture wells. The enzyme deprotection solution was filter 
sterilized prior to use and the deprotection wa conducted in itu with thr e PBS 
wa he and two erum free media wa he prior to cell culture. 
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5.6.4 Reaction of Peptide with Serum 
The previous results do not make it clear whether the increase in cell 
attachment and viability when peptide is incorporated is due to the interaction of 
the peptide with integrins or due to non-specific effect other than integrin binding 
caused by the incorporation of the peptide. The hydrogels that contain peptide 
that has not been de protected by OST in advance show increased cell attachment 
compared to those that do not contain any peptides. This suggests two 
possibilities, firstly that the presence of the peptide has changed the materials 
characteristics enough that the attachment of cells has been increased, perhaps by 
increased protein adsoption. Alternatively the peptide is being utilised as an 
integrin receptor either by being deprotected during cell culture or by the 
protected peptide being able to bind to integrins. It was decided to investigate 
whether the peptide can be deprotected under cell culture conditions. 
The short peptide sequence MacGR(4-Bbs)GDS was added in varying 
concentrations to PBS containing 10% FCS and the GST deprotection solution 
(O.OSmglml OST and SOOJ.1M GSH in PBS). The absorbance of each reaction 
solution at 40Snm was detennined and then the solutions were incubated at 37° C 
and 5% C02. The absorbance of each reaction well was then detennined at set 
time intervals. The change in absorbance values over time was recorded. The 
differences between the change in absorption of the peptide containing solutions 
and the non-peptide containing solutions over 24 hours reflect the concentration 
of the 4-bromobenzyl sulphonamide protecting group in solution. 
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Figure 5-42 Change in Adsorption at 405nm of MacGR(4-Bbs)GDS incubated with various 
solutions over 24 horns. 
The change in adsorption for peptide olutions incubated with GST for 24 
hour shows a decrea e in optical den ity proportional to the ,initial concentration 
of the peptide. This implie that the peptide ha been deprotected and that the 
amount that has been deprotected is proportional to the initial amount and the 
reaction has reaching equilibrium. Thi corroborates the re ult hown earlier 
where the deprotection of the arginine derivative when incubated with GST 
reached equilibrium a hown in Table 5-4, p103. Ad orption reading for 
incubations of the peptide in PBS containing 10% fetal calf serum follow a 
similar trend of decrea ing change in optical den ity a the peptide concentration 
increase. Thi implie that the presence of FCS in the media ha had the ame 
effect on the peptide a the GST deprotection olution and removed the 4-
bromobenzyl ulphonyl protecting group. The compo ition of fetal calf erum ha 
not been fully defined but it is known to contain many different protein and 
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enzymes. It is possible that GST is present in the fetal calf serum or that a 
different enzyme is achieving the deprotection of the sulphonyl protecting group. 
It seems likely that the culture of cells on the RGD-containing polymers 
in serum free media would reduce any effects from accidental deprotection. In 
addition the effects of RGD on cell behaviour can often be seen more clearly in 
serum-free media (see p56). 
5.6.5 Cell Culture in Serum Free Media 
An initial experiment was performed to determine how well materials 
containing the peptide performed after deprotection with GST for 1 day by 
culturing cells on these materials in serum free media. The peptides at various 
concentrations were assessed for their ability to promote cell adhesion and 
viability and the values were compared to those for polymers without peptide. 
These results are shown on the page overleaf. 
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Figure 5-43 Viability of human dermal fibroblasts cultured in serum-free media for 24 
hours on glycerol methacrylate hydrogels containing varying concentrations of 
MacAddaGR(4-Bbs)GD or MacGR(4-Bbs)GDS. Results shown are the mean of 3-6 
replicates with error hown being standard deviation divided by the number of replicate . 
Polymers were deprotected with O.05mg/ml GST and 500J.U1lol dm·] GSH in PB and 0.5011 
per sample for 1 day. Viability of cells (FI833, passage 9) were a se ed via the MTT a say 
and compared to values obtained for TCP. Significance was analysed via the tudent' non-
paired T -test, each peptide containing polymer was compared to the non-peptide containing 
control that has been treated with GST for 1 day (0 indicates p<O.Ol and * indicate 
p<O.05). 
In the glycerol methacrylate contain ing polymers the two I we t 
concentration of peptide (0.01 and O.lllmol/g) how no increa e in the c 11 
number and viability over the background ub trate. At a concentration of I 
Ilmol/g of either peptide there i a mall increase and at the higher concentration 
of 10 Ilmollg of peplide there i a large increa e. Thi indicates that ther i a 
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certain mInimum peptide concentration required to evoke a cellular response. 
Interestingly the short peptide provokes a larger response than the long peptide. 
In a situation where a spacer arm is not required to di stance the peptide from the 
bulk of the polymer the added flexibility of the chain may decrease its ab ility to 
bind to integrins by increasing the entropy loss caused by binding. 
c.) d.) 
Figure 5-44 Primary human dermal fibroblasts (FI833, passage 9) cultured for 24 hours in 
serum-free media on poly(GMMA-co-EGDMA-co-MacGR(4-Bbs)GDS) pre-incubated with 
0.05mg/ml GST and 500 J,Lmol dm-3 GSH for I day a.) 0.01 J,Lmol/g peptide, b.) 0.1 J,Lmol/g 
peptide, c.) 1 J,Lmol/g peptide and d.) 10 J,Lmol/g peptide 
The photographs of the cells corroborate the trends shown in the MTT 
assay results (Figure 5.38) where the lower concentrations of peptide give resu lts 
similar to the background substrate and the higher concentrations of peptide 
promote cell adhesion and spreading. 
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Figure S-4S Viability of human dermal fibroblasts cultured in serum-free media for 24 
hours on butyl methacrylate hydrogels containing varying concentrations of 
MacAddaGR(4-Bbs)GDS or MacGR(4-Bbs)GDS. Re ults shown are the mean of 3-6 
replicates. Polymers were deprotected with O.OSmg/ml GST and SOO ~mol dm·3 G H in 
PBS and O.5m1 per sample for 1 day. Viability of cells (F LS33, pa sage 9) were a essed via 
the MTT assay and compared to values obtained for TCP. Significance was analysed via the 
Student's non-paired T-test, each peptide containing polymer was compared to the non-
peptide containing control that has been treated with GST for L day (0 indicates p<O.Ol 
and * indicates p<O.OS). 
The butyl methacrylate ba ed polymer showed no trends in increa ing 
cell attachment and viability as the peptide concentration increa ed either with 
the long peptide or the hort peptide a hown in Figure 5.39 above. The lack of 
improvement in the cell adhesion and viability in the butyl methacrylate 
hydrogel on incorporation of the peptide equence i likely to be due to the 
competing effects of protein ad orption but there are alternative explanation . 
The po sibil ity exists that the polymer coating may have become delaminated 
and no longer be present and all value refer to the ub trate on which the 
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coatings were made, in this case PET. This seems unlikely as the delamination 
of the coating is likely to 
have been observed. An alternative theory is that the peptide sequence 
has polymerised into domains that are not accessible at the surface. In addition 
the enzyme deprotection of the peptide may not have functioned as successfully 
in the butyl methacrylate hydrogels as in the glycerol methacrylate hydrogels. 
The more hydrophobic nature of the butyl methacrylate means that the network is 
less swollen and this could have caused access problems for the GST enzyme. 
It has been shown that the presence of the peptide in concentrations of I 
to I 0 ~mollg can promote cell adhesion and support cell viability however the 
source of its ability is unknown. It is important to determine whether the peptide 
has been fully deprotected by the treatment with GST such that the actual peptide 
concentration is the same as the incorporated concentration and whether the non-
treated peptide has an effect on the ability of the background substrate to adhere 
and support cells. 
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Figure S-46 Viability of human dermal fibroblasts cultured in erum-free media for 24 
hours on glycerol methacrylate polymers containing varying concentrations of Mac-Adda-
GR(4.Bbs)GDS. Results shown are the mean of 3-6 replicates and error how the tandard 
deviation divided by the number of replicates. Polymers were deprotected with O.OSmg/ml 
GST and SOO GSH 1J.I1101 dm"3 in PB and O.Sml per ample for 0, 1, 3 or S day 
(deprotection solution was replaced daily). Viability of cell was a sessed (FlS33, pa age 9) 
via the MTT assay and compared to values obtained for TCP. Significance was analys d via 
the Student's non-paired T-test, each peptide containing polymer was compared to the non-
peptide containing control that has been treated with the same amount of GST (0 indicates 
p<O.Ol and * indicates p<O.OS). In addition the significance between 1,3 and S day 
deprotection was analysed compared to the peptide containing polymer that had not been 
deprotected (* indicates p<O.OS) 
The e result how that with the low concentration of RGD at 0.1 llmol/g 
there i no improvement in cell number and viability a the time of deprotection 
increa e . It is believed that thi concentration of peptide is too low to upp [1 
cell attachment and urvival. When the maximum RGD concentration of 10 
llmol / g i incorporated in it protected form there is a ignificant increase in cell 
viab ility. The ame compo ition hydrogel that have had the depr t ti n 
removed by GST treatment for 1,3 or 5 day al 0 provide a tati tically 
s ignificant increa e in cell viability over the non-peptide containing contr I. Th 
difference between no GST treatment and 1,3 or 5 day i tati tically ignificant 
with any number of day GST treatment providing an increa e in cell viability 
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however there is no significant change in the ability of the polymer to support 
cells between the 1,3 or 5 days deprotection. This implies that either the entire 
RGD concentration has been deprotected in the first day or that the concentration 
deprotected in the first day provides maximal cell viability response and further 
increases in concentration cannot provoke a higher response. The increase in cell 
viability on the peptide-containing hydrogel that had not been deprotected could 
be due to a number of different factors; the incorporation of the peptide might 
have altered the protein deposition profile on the material, the protected peptide 
may be able to bind to integrins or the culture conditions may deprotect the 
peptide in situ. The possibility that the peptide is being deprotected by the cells 
is a real one as most cells are known to produce GST as the enzymes are a major 
detoxification route. The possibility also exists that the cells can de protect the 
peptide via mechanisms other than GST. 
At a concentration of 1 J.lmol/g there is a linear increase in the cell 
viability on the materials as the number of days deprotection with GST increases. 
This implies that the deprotection by GST is not completed in 1 day and a 
percentage of the total RGD concentration becomes available for each day that 
the peptide is treated with GST. This would imply that at the higher 
concentration there has been a maximal cell response to the RGD concentration 
after 1 days treatment with GST even though the concentration of RGD available 
increases on a percentage per day scale. 
The linear nature of the increase in cell response to number of days 
deprotection allows for some speculation as to the percentage of peptide 
deprotected per day. If the maximal cell response is set to 140% of the TCP 
control the line for the increased cell response per days deprotection for the 1 
mmol/g substrate would intersect it after approximately 13 days. If the 1 J.lmol/g 
had been 98% deprotected after this time then there would be -30% deprotection 
of the peptide remaining each day per day. However it is unlikely that the linear 
response of the cells to the number of days deprotection will continue as it has 
not been shown that cellular response to increasing RGD concentration is linear. 
In addition it is not known whether the peptide would be fully deprotected after 
13 days deprotection. If there was a 30% deprotection of peptide per days 
treatment with GST then the polymer containing 10J.lmol/g of peptide would 
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have an active concentration of 3 Ilmol/g after I day, which appears to be 
sufficient to promote maximal cell adhesion and viability. 
It is apparent that the equilibrium position of the de protection reaction 
has not been pushed towards complete deprotection by the heterogenous nature 
of the reaction between soluble GST and the immobilised peptide. It appears 
likely that the extent of deprotection is equal to or less than 30%. Consequently it 
becomes necessary to analyse the exact amount of peptide that is being 
deprotected each day by GST and hence is available to cells. This required the 
synthesis of bulk modified polymers that contain enough mass to be analysed. To 
determine the actual concentration of peptide that is available towards cells it is 
also important to determine whether the culture conditions can further increase 
the amount of accessible peptide by deprotecting RGD moieties during culture. 
5.6.6 Peptide Concentration Analysis 
Hydrogel sheets containing 5 or 0.5llmol/g of MacGR(4-Bbs)GDS were 
synthesised by UV polymerisation of sheets. The concentration of peptide was 
reduced from the 10 or Illmol/g utilised in previous cell culture experiments to 
allow a greater mass of hydrogels to be synthesised thus enabling a greater 
number of different analyses to be carried out. As this polymerisation method 
does not allow the fabrication of butyl methacrylate polymers then only glycerol 
methacrylate hydrogels were created. Hydrogel samples were incubated with 
PBS, 500llM aSH in PBS or O.OSmg/ml aST and SOOIlM aSH for 3 or 5 days. 
These experiments were also performed on the hydrogel that did not contain 
peptide. The hydrogels were washed with PBS and then distilled water. The 
samples were then weighed and the equilibrium water content (EWC) was 
calculated. 
( wet weight - dry Weight) 
EWC=~------------~ 
wet weight 
This is important as the amount of peptide perceived by cells will be 
affected by the swelling of the hydrogels as the amount of peptide present will be 
diluted over a larger volume as the hydrogel swells. 
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Figure 5-47 Equilibrium water content of poly(GMMA-co-EGDMA-co-MacGR(4-
Bbs)GDS) hydrogels in distilled water after incubation with PB , G H or G HJG T. 
Results are the mean of 3 replicates and the errors shown are the standard deviation. 
The equilibrium water content of the polymer did not change when the 
polymer were pre-treated with GSH or GST/GSH. However the equilibrium 
water contents of the peptide-containing polymers were lower than the EWe for 
lhe non-peptide containing control hydrogel . The amount of water present in th 
hydrogel doe not change when the concentration of the peptide change 0 it i 
not that the peptide that i adsorbing les water than the bulk of the hydrogel . It 
seems likely that the presence of the peptide ha affected the polymeri ation rate 
of the monomers and consequently ales porou and les expandab le netw rk 
ha been formed that i not capable of ad orbing as much water a the blank 
hydrogel. 
After EWe mea urements were taken ample were then dried and then 
ent for elemental analy i . It hould be po ible to determine the amount of 
peptide pre ent in the hydrogel by u e of microanalytical technique to find the 
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concentration of sulphur in samples. The only sulphur present in the non-treated 
hydrogels should be from the sulphonyl protecting group on arginine. 
Consequently it should also be possible to determine the extent of deprotection of 
the sulphonyl group by the drop in sulphur concentration after treatment with 
GST. However the GSH and GST utilised in the deprotection treatment also 
contain sulphur so the amount of sulphur adsorbed into the hydrogels from these 
must be assessed by performing elemental analysis on the non-peptide containing 
hydrogel after treatment. Consequently samples of hydrogel containing 0, 0.5 
and 5J.1mollg were left untreated, treated with 500J.1M GSH for 3 X 24 hours, 
treated with 500llM GSH + 0.5mg/ml GST for 3 X 24 hours or treated with 
500llM GSH + 0.5mg/ml GST for 5 X 24 hours and then submitted for 
microanalytical analysis of the sulphur concentration. The results are detailed in 
Table 5-8 below. 
GE-O GE-S-0.5 GE-S-5 
No Treatment 0.190 0.130 0.377 
3 Days Treatment with GSH 0.563 0.185 0.401 
3 Days Treatment with GST I GSH 0.874 0.185 0.435 
5 Days Treatment with GST I GSH 1.060 0.403 0.487 
. Table S-8: Elemental AnalYSIS for Concentration of Sulphur ID Glycerol Methacrylate 
Hydrogels containing 0, O.S or S~mollg of MacGR(4-Bbs)GDS. Hydrogels were washed with 
PBS, treated with SOO ~mol dm-3 GS" for 3 X 24 hours, treated with SOO~M GSH + 
O.Smg/ml GST for 3 X 24 hours or treated with SOO~M GSH + O.Smg/ml GST for S X 24 
hours. Hydrogels were then washed X 3 with PBS, X 5 with deionised H20 and then X 5 
with ethanol prior to drying and analysis. 
From the sulphur concentrations determined for the non-peptide 
containing hydrogel (GE-O) it can be seen that there is a fairly large 
concentration of sulphur in the non-treated sample. It is not known what the 
source of this sulphur was as the polymer should not have been exposed to 
sulphur at any point in its treatment as the water utilised for washing procedures 
was deionised. It is possible that the polymer has adsorbed atmospheric sulphur. 
The non-peptide containing hydrogel adsorbs and retains large amounts of 
sulphur used in the deprotection treatment of the treatment. More sulphur is 
found in the hydrogels after 5 days treatment with GST/GSH than after 3 days 
treatment with GST/GSH indicating that GST and GSH adsorb strongly to the 
polymer and are not removed by the washing procedures. 
169 
The amount of sulphur found in the polymer containing a nominal 
peptide concentration of O.5j.lmol/g was less than that found in the non-peptide 
containing polymer. In addition the concentration of sulphur found was only 
0.130Ilmol/g that, if it was only due to sulphur from the peptide, would 
correspond to only 25% incorporation of the peptide. It seems likely that at least 
some of the found sulphur concentration will be due to the same source as 
provided the sulphur concentration in the non-peptide containing hydrogel. The 
amount of sulphur in the hydrogels containing a nominal 0.5j.lmol/g of peptide 
increased after treatment with GSH or GST/GSH but the increases were less than 
that found for the non-peptide containing hydrogel. 
The amount of sulphur found in the polymer containing a nominal 
peptide concentration of 51lmol/g was found to be 0.377Ilmol/g. If this 
concentration was only due to sulphur from the peptide it would correspond to 
7.5% incorporation of the peptide. It seems likely that at least some of the found 
sulphur concentration will be due to the same source as provided the sulphur 
concentration in the non-peptide containing hydrogel. Deducting the amount of 
sulphur in the non-treated non-peptide containing hydrogel from the amount of 
sulphur in the nominal 5j.lmol/g of peptide hydrogel gives a sulphur 
concentration due to the peptide of 0.187Ilmol/g - an incorporation efficiency of 
3.7%. 
The amount of sulphur in the hydrogels containing nominal peptide 
concentrations of 0.5 or 5 Ilmol/g increased after treatment with GSH or 
GST/GSH but the increases were less than that found for the non-peptide 
containing hydrogel. It seems likely that the peptide has been partially 
deprotected but the decrease in sulphur concentration corresponding to the 
deprotection has not been observed due to the adsorption of GST and GSH. It 
does not appear as though the adsorption of GST and GSH occurs to the same 
extent in the peptide containing hydrogels as it does in the non-peptide 
containing hydrogel. This is probably linked to equilibrium water content, which 
is much higher for the non-peptide containing hydrogel than for either of the 
peptide containing hydrogels. It seems as though the presence of the peptide in 
the polymerisation mixture results in a different rate of polymerisation that leads 
to a less open structure for the peptide containing hydrogels. These more 
compact hydrogels would be less able to adsorb water and hence the equilibrium 
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water content would be less and the less porous structure would mean that GST 
and GSH would be less able to penetrate into the bulk and hence the 
concentration of sulphur after treatment would be less. 
The amount of sulphur in the polymers with a nominal concentration of 
0.5~mollg is the same where the treatment had been 3 x 24 hours with GSH and 
3 X 24 hours with GST and GSH. The non-peptide containing polymers adsorb 
more sulphur when GST has been used than when just GSH has been used. 
Consequently it appears as if there has been some loss of sulphur from peptide 
deprotection when the polymer was treated with GST and GSH that is obscured 
by the rise in sulphur concentration from the adsorption of GST. 
As it was not possible to determine the peptide concentration from the 
elemental analysis of the polymers it was decided to perform amino acid analysis 
(AAA). The AAA will not be able to determine the amounts of the protected and 
deprotected arginine derivatives but will give a measure of what percentage of 
the peptide in the monomer feed was incorporated into the polymer. The amino 
acid analysis (performed by Alta Bioscience, Birmingham University) showed 
immobilised peptide concentrations of 0.16J..lmollg and 0.68~mollg for nominal 
input concentrations of 0.5 and 5~mollg respectively. This corresponds to 32.0% 
and 13.6% incorporation of the peptide into the cross-linked hydrogel. 
The high EWe of the polymers means that the peptide is spread over a 
larger volume and the actual peptide concentration perceived by cells is even 
lower. At the average EWe of 53% for the peptide containing hydrogels the 
swollen hydrogel contains 47% by volume of the nominal peptide concentration 
assuming that the polymer has a density of 1 glcm3• This gives actual peptide 
concentrations of 0.0752 and 0.3196 J..lmollcm3 for nominal concentrations of 0.5 
and 5 ~mollg respectively. The deprotection efficiency was estimated to be 
-30% per day, which would correspond to active peptide concentrations of 0.022 
and 0.096 ~mol/cm3 for nominal concentrations of 0.5 and 5 J..lmollg respectively 
.Assuming an integrin penetration depth of 10nm this corresponds to surface 
peptide concentrations of 0.022 and 0.096 pmol/cm2• Overall the amount of 
peptide perceived by cells can vary from 3% to 5% of the nominal peptide 
concentration depending on the input concentration and the deprotection 
efficiency. 
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The data shows that peptide incorporation efficiency is dependent on the 
nominal input concentration and it is difficult to determine the exact amount of 
peptide incorporation at different input concentrations. Consequently nom inal 
peptide concentrations will be used throughout the remainder of the di scussion. 
5.6.7 Competition with Soluble RGD 
To determine whether the attachment of the cells to the substrates 
containing peptide was due to the binding of RGD to integrins it was decided to 
challenge the adhered cells with soluble peptide. 
Cells were cultured on TCP and polymers containing varymg 
concentration of MacGR(4-Bbs)GOS for 24 hours in serum free media after 
which time the media was removed and replaced with media containing I mg/ml 
of RGDS. Photographs were taken at 15 minute intervals up to 60 minutes after 
the addition of the soluble peptide. 
a.) 
Figure 5-48 Human dermal fibroblasts cultured in serum-free media on TCP for 24 hours 
a.) prior to addition of soluble RGDS, b.) 30 mins after addition of soluble RGDS and c.) 60 
mins after the addition of soluble RGDS. 
There was no change in the morphology or apparent con fluency of the 
cells on TCP after the addition of soluble RGDS. This shows that the addition of 
the soluble peptide does not affect cells that adhere via mechani sms other than 
integrin binding. The photographs in Figure 5-49, pI 03 show the detachment of 
cells from glycerol methacrylate hydrogels containing lO).lmol/g of peptide that 
had been pretreated with GST for 3 days. 
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Before 
addition of 
soluble 
GRGDS 
15 minutes 
60 minutes 
fier addition 
Figure 5-49 Detachment of human dermal fibropblasts (cultured for 24hours in serum free 
media on GE-S-IO-3 at set time points after the addition of 1 mg Iml RGDS in serum free 
media (2 photographs at each time point) 
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The photographs show that 15 minutes after the addition of RGDS large 
sheets of cells have detached from the surface of the peptide-containing polymer 
but that significant numbers of cells remain attached and fully spread on the 
surface. Later time points show these cells gradually detaching from the surface 
and illustrate cells at all stages of detachment. After 60 minutes some of these 
lifting cells have formed aggregations similar to those seen on the non-peptide 
containing glycerol methacrylate polymers in other experiments. Not all cells 
have detached after 60 minutes however it appears that these cells are still in the 
process of detachment which seems to be gradual and continuous. Cell adhesion 
and viability results from the MTT assay before and after treatment with soluble 
RGD are shown on the page overleaf. 
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Figure 5-50 Viability of human 
dermal fibroblasts cultured in 
serum-free media for 24 hours 
on glycerol methacrylate 
polymers containing varying 
concentrations of MacGR(4-
Bbs)GDS. Results shown are the 
mean of 3-6 replicates and 
errors show the standard 
deviation divided by the number 
of replicates. Polymers were 
deprotected with 0.05mglml 
GST and 500 Ilmol dm') GSH in 
PBS and 0.5ml per sample for 3 
days (deprotection solution was 
replaced daily). After 24 hours 
culture the media was removed 
from all cells and replaced with 
serum-free media containing 
Imglml GRGDS or plain serum-
free media for 1 hour. Viability 
of cells was assessed (F002, 
passage 6) via the MTT assay 
and compared to values 
obtained for Tep. Significance 
was analysed via the Student's 
non-paired T -test, each peptide 
containing polymer was 
compared to the non-peptide 
containing control (0 indicates 
p<O.Ol and * indicates p<0.05). 
175 
The MTT assay results confirm the visual evidence that cells on peptide 
containing hydrogels are detached by the addition of soluble GRGDS. In all 
cases the number and viability of cells on the peptide containing hydrogels were 
significantly reduced to the level of the non-peptide containing control or below. 
Interestingly this was also the case on hydrogels containing 0.1 ~mol/g of peptide 
where no significant increase in cell adhesion had been previously reported. It 
appears as if the same levels of cell adhesion are supported by polymers without 
peptide and with the low peptide concentration but that the mechanisms of cell 
adhesion are different. In the non-peptide containing controls the levels of cell 
adhesion and viability are not affected by the addition of soluble peptide 
indicating that the adhesion is not integrin mediated. In the polymers containing 
0.1 ~mol/g the number and viability of adhered cells was significantly reduced by 
the addition of soluble RGD indicating that the cell adhesion was primarily 
integrin mediated. The number and viability of cells remaining on the 0.1 ~mol/g 
polymers after incubation with soluble peptide was significantly lower than on 
the non-peptide containing controls. This implies that although the polymers with 
low peptide concentration do not produce a significant increase in cell adhesion 
and viability over the control they do promote cell adhesion through integrin-
mediated routes and that this mechanism appears to supersede the cell adhesion 
mechanisms that were in force on the control. 
5.6.8 Peptide Deprotection by Non-contacting Cells 
It appears that the cell adhesion is due to the binding of RGD to integrins 
but these results do not explain why the non-treated polymers can adhere cells in 
quantities greater than the background substrate. The cells may be able to 
deprotect the peptide or the protected peptide may be able to promote cell 
adhesion by other mechanisms that become superseded by the integrin binding 
when the peptide is deprotected. 
Many cells produce GST as the family of enzymes provide a major 
detoxification route. The activity of GST in cells is sometimes used as an assay 
to show the ability of cells to deal with toxins or the activation of this 
detoxification pathway in response to certain toxins. 
The deprotection of the peptide by the cells, if it occurs, may require 
contact between the cells and the polymer or may occur through enzymes that are 
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secreted by cells and are active in the media. To determine whether the cells are 
able to deprotect the peptide without contact the polymers were placed at the 
bottom of wells and cells were placed in co-culture baskets above the polymers. 
The cell adhesion and viability results from the MTT assay are shown on the 
page overleaf. 
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Figure 5-51 Viability of 
human dermal fibroblasts 
cultured in serum-free media 
for 24 hours on glycerol 
methacrylate polymers 
containing varying 
concentrations of MacGR(4-
Bbs)GDS. Results shown are 
the mean of 3-6 replicates and 
errors show the standard 
deviation divided by the 
number of replicates. 
Polymers were deprotected 
with 0.05 Ilmol dm-3 GST and 
5001lM GSH in PBS and O.SmJ 
per sample or incubated with 
50,000 human dermal 
fibroblasts suspended above 
the polymers in a co-culture 
basket for 0,1 or 3 days 
(deprotection solution was 
replaced daily). Viability of 
cells was assessed (F002, 
passage 6) via the MTT assay 
and compared to values 
obtained for TCP. 
Significance was analysed via 
the Student's non-paired T-
test, each peptide containing 
polymer was compared to the 
peptide-containing control 
that had not been pre-treated 
(0 indicates p<0.01 and * 
indicates p<O.05). 
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The adhesion and viability of cells on hydrogels containing 10f,lmollg of 
MacGR(4-Bbs)GDS was not significantly affected by pre-treatment with either 
cells or GST for 1 or 3 days. Previous analysis of hydro gels containing lOf,lmollg 
of this peptide showed a significant increase in cell number and viability when 
pre-treated with GST (see Figure 5-46, pi 03). It appears that in this case the non-
treated peptide containing polymer promotes maximal cell response that cannot 
be improved by incubation with either cells or GST. This maximal cell response 
appears to be -60% of the TCP control, which is much lower than that observed 
previously of -130% of the TCP control. This experiment was conducted with 
human dermal fibroblasts from a different source as there were not sufficient 
cells from the previous cell source to continue with. It is possible that this new 
primary cell source is not as responsive to RGD inclusion as the previous cell 
source. In addition the passage number may have had an effect on the relative 
adhesion and viability of cells as it is known that integrin expression declines 
with passage number. However this experiment was carried out with cells of 
passage number 6 whereas the previous experiment was carried out with cells of 
passage number 9 and consequently the reverse situation would have been 
predicted with this experiment showing higher cell responses c.f. TCP. 
The adhesion and viability of cells on hydrogels containing 1 f,lmol/g was 
significantly increased by pre-treatment with non-contacting cells but the extent 
of the improvement was not as great as that gained from treatment with GST. 
The pre-treatment of the non-peptide containing polymer with non-contacting 
cells did not affect the viability of cells later seeded on the polymers. However 
the pre-treatment of TCP with non-contacting cells significantly increased the 
numbers and viability of cells later seeded on these surfaces. This is believed to 
be due to the non-contacting cells producing proteins that are adsorbed to the 
surface of the TCP but do not adsorb onto the glycerol methacrylate hydrogel 
surface. The peptide-containing glycerol methacrylate hydrogels should have a 
similar protein adsorption profile to the non-peptide containing controls but the 
presence of the peptide may have an effect on the ability of charged proteins to 
adsorb onto the surface. As the adhesion of cells to the polymers containing 
IOf,lmol/g of peptide was not improved by pre-treatment with non-contacting 
cells it can be assumed that all the glycerol methacrylate hydrogels do not adsorb 
proteins regardless of whether a peptide is present. This would imply that the 
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increase In cell adhesion and viability to the polymers containing 
ll..lmol/g of peptide that had be pre-treated with non-contacting cells wa due to 
the deprotection of the peptide by oluble cell product such as GST. 
1.1.2Passage Number 
The results from the prevlOUS experiment on the deprotection of the 
peptide by non-contacting cell were urprising as the relative number and 
viability of cells adhered to the peptide containing hydrogels were much lower in 
comparison to TCP than previously reported. It wa decided to investigate the 
effect of primary cell passage number on the reported cell number and viability. 
120 ~-------------------------------------------' 
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GE-S-O.I-3 
o GE-S-I-3 
• GE-S-1O-3 
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Figure 5-52 Viability of human dermal fibroblasts cultured in serum-free media for 24 
hours on glycerol methacrylate polymers containing varying concentrations of MacGR(4-
Bbs)GDS. Results shown are the mean of 3-6 replicates and errors show the standard 
·deviation divided by the number of replicates. Polymers were deprotected with 0.05mg/ml 
GST and 500 JlI1101 dm'] CSH in PBS and 0.5ml per sample for 3 days (deprotection 
solution was replaced daily). Viability of cells was assessed (F002, passage 6 or passage l2) 
via the MTf assay and compared to values obtained for TCP. Significance wa ana lysed via 
the Student's non-paired T-test, each peptide containing polymer was compared to the non-
peptide containing control (0 indicates p<O.Ol and * indicates p<0.05). 
At passage number 6 there is a small increa e in cell number and viability 
to hydrogels as the peptide concentration increa es. The viability of cells adh red 
to hydrogel wa ignificantly greater than on the non-peptide containing 
polymer when the peptide concentration wa greater than l~rnol/g. The 
maximum cell response obtained was -52% of the TCP control. The viability f 
I 0 
cells adhered to glycerol methacrylate hydrogels without peptide was 
approximately 30% of the TCP control. 
At passage number 12 there is a large increase in cell number and 
viability to hydrogels as the peptide concentration increases. The viability of 
cells adhered to the hydrogels is significantly greater than on the non-peptide 
containing control when the peptide concentration is greater than 1 Jlmol/g. The 
maximum cell response obtained was -110% of the TCP control. The viability of 
cells adhered to glycerol methacrylate hydrogels without peptide was 
approximately 16% of the TCP control. 
The effect of increasing primary cell passage number appears to decrease 
the non-specific cell adhesion to non-peptide containing controls and to increase 
the effectiveness of ROD incorporation over a critical ROD peptide 
concentration threshold. These results are similar to those observed by Jeschke et 
al (see section 3.3.2.1) and it seems that the adhesion of cells to ROD-containing 
materials increases with increasing passage number although this is probably 
limited by a critical passage number above which the cell adhesion would 
dramatically decline. It is possible that the expression of the integrin that is 
responsible for the adhesion of these cells is up-regulated by increasing passage 
number as it has been shown that some integrins are up-regulated by increasing 
passage number (see Figure 3-13, p54). Alternatively the presence of the ROD 
peptide could promote the up-regulation of integrins that normally decline in 
expression as passage number increases. The state of the integrins could also be 
affected such that the amount of integrins present remains constant but are 
present in a more active conformation or state. 
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5.6.10 Histology 
To investigate whether the presence of the RGO peptide had influenced 
the amount of cell spreading and F-actin organisation, cells were cultured on 
hydrogels containing peptide in various concentrations that had been deprotected 
for 3 days with GST/GSH. Cells were fixed after 30mins, 1,2,4 or 24 hours after 
seeding to investigate the progression of the cell spreading and focal contact 
formation. The cell nuclei were stained blue with OAPI and F-actin was stained 
green with FITC-phalloidin. 
As can be seen in Figure 5-53 (pI03) cells adhere and start spreading on 
TCP within the first 30 minutes after seeding seeding. Spreading increases over 
time up to 4 hours after seeding and, during this time, the area that the F -actin 
network around the cells covers increases. At 4 hours after seeding the F -actin 
network forms an orthogonal shape covering a large area surrounding the cell 
nucleus and show signs of actin filament formation. At 24 hours after seeding the 
F-actin has become highly organised and shows highly regulated f-actin fibres 
within the cell and long fillipodia extending out from the cell. 
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Figure 5-53 Adhesion of human dermal fibrobla ts (F002, pa age 6) in erum fr media to 
tissue culture pIa tic after A) 30 minutes, B) 1 hour, C) 2 hours, 0) 4 hour and E) 24 hour, 
Blue repre ents cell nuclei (OAPI) and green repre ents F-actin (FIT -phallodin), 
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Figure 5-54 to Figure 5-59 on the following pages (p 1 03-1 03) show the 
cell attachment to poly(GMMA-co-EGDMA-co-MacGR(4-Bbs)GDS) hydrogels. 
In these images the numbers of cells per unit area may not be representative of 
the entire surface of the polymer but the morphology of the cells is representative 
of the cells that could be found. 
As expected from phase contrast microscopy and MTT assay results, cells 
did not adhere well to the hydrogel without peptide both in terms of cell number 
and F-actin organisation. There was little evidence of F-actin surrounding the 
cells at any of the time points except as a rounded area directly surrounding the 
nucleus showing the cells were not spread. After 24 hours culture the cells 
remaining on the polymer had formed into small clusters as shown in Figure 
5-54, p 103 image D. 
On hydrogels containing 0.1 J.,lmol/g of the peptide there were no cells that 
could be found at the 30 minute time point. However at later time points greater 
numbers of cells could found on the polymer surface than on the negative control 
indicating that this low level of peptide concentration was able to promote cell 
adhesion but that that integrin binding took greater than 30 minutes to become 
effective. These images are shown in Figure 5-55, pl03. There was slight 
evidence of an F-actin network surrounding the cells at the later time points of 4 
and 24 hours but this was much less extensive than for TCP. The F-actin 
surrounding the cells on these hydrogels were in a "spiky" conformation with 
tendrils extending out from the cell nuclei rather than forming an orthogonal 
shape surrounding the nucleus as featured on TCP. The cells on these surfaces 
were usually found in small clusters, which was also observed by phase contrast 
microscopy in section 5.6.2.1 (pl03, GMMA Polymers containing Long Peptide 
Sequence). Image C shows a defect in the structure of the polymer, probably 
caused by rapid swelling or shrinkage when changing the solvent from synthesis 
conditions to cell culture conditions. 
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Figure 5-54 Adhesion of human dermal fibroblasts (F002, pa age 6) in serum fr e m dia to 
poly(GMMA-co-EGDMA) hydrogels after A) 30 minute, B) 1 hour, C) 4 hour and D) 24 
hour . Blue repre ents cell nuclei (DAPn and green represents F -actin (FIT -phallodin). 
Note: no cells were found at the 2 hour time point and 0 no picture i repre ented here. 
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Figure 5-55 Adhesion of human dermal fibroblasts (F002, passage 6) in serum free media to 
poly(GMMA-co-EGOMA-co-MacGR(4-Bbs)GOS) hydrogels containing O.l,...moVg of 
peptide and having been pre-treated with 3 days deprotection with GST/GSH. Cells were 
fixed after A) 1 hour, B) 2 hours, C) 4 hours and 0) 24 hours. Blue represents cell nuclei 
(OAPI) and green represents F-actin (FITC-phallodin). Note: no cells were found at the 30 
minute time point and 0 no picture is represented here. 
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At a peptide concentration of 1 ~mol/g there are still very few cells that 
can be found after 30 minutes of culture as shown in Figure 5-56, p 103. Cells 
show little evidence of an F-actin network up to 4 hours after seeding but at this 
time point some cells shows extensions of the F-actin network from the nucleus 
in the "spiky" conformation observed on the hydrogels containing 0.1 ~mol/g of 
peptide. After 24 hours of culture the F-actin network has formed a more 
traditional network surrounding the nucleus but this is much less extensive than 
that found with cells on TCP. 
At a peptide concentration of 1O~mollg some evidence of an F-actin 
network can be seen at the early stages of cell adhesion and spreading after 1 
hour and 2 hours as shown in Figure 5-57, p103. After 4 hours this has developed 
into the same "spiky" conformation as observed with lower peptide 
concentrations. After 24 hours cells appear to have clustered together and created 
F-actin bridges between neighbouring cells. In these cells the F-actin network 
appears to have formed into a thin linear or broad linear shape. Once again the 
surface area covered by F -actin is much reduced compared to TCP. When the 
hydrogels with lO~mol/g of MacGR(4-Bbs)GDS were not deprotected with GST 
prior to cell culture the F -actin network was less developed than when the 
peptide was deprotected with GST as shown in Figure 5-58, pl03. At the early 
stages after cell seeding there was little evidence of any F -actin network 
formation. At 4 and 24 hours after cell seeding there is some evidence of F-actin 
formation but this was much less extensive than when the peptide had been 
deprotected. The F -actin again showed a "spiky" conformation especially 24 
hours after cell seeding. 
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Figure 5-56 Adhe ion of human dermal fibroblasts (F002, pas age 6) in serum free media to 
poly(GMMA-co-EGOMA-co-MacGR(4-Bbs)GDS) hydrogels containing IllmoVg of peptide 
and having been pre-treated with 3 days deprotection with G T/G H. ell were fixed after 
A) 30 minutes, B) 1 hour, C) 2 hour, 0 ) 4 hour and E) 24 hour. Blue represent cell nuclei 
(OAPI) and green represent F-actin (FITC-phallodin). 
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Figure 5-57 Adhesion of human dermal fibrobla t (F002, pas age 6) in serum free m dia to 
poly(GMMA-co-EGDMA-co-MacGR(4-Bbs)GDS) hydrogel containing 10~moVg of 
peptide and having been pre-treated with 3 days deprotection with G T/G H. ell wer 
fixed after A) 30 minutes, B) 1 hour, C) 2 hours, 0 ) 4 hour and E & F) 24 hour. Diu 
represents cell nuclei (OAP I) and green represents F -actin (FIT -phallodin). 
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Figure 5-58 Adhc ion of human dermal fibrobla t (F002, pa age 6) in erum fr e media to 
poly(GM IA-co-EGDMA-co-MacGR(4-Bbs)GDS) hydrogels containing \()~mol/. of 
peptide and not pre-treated. Cells were fixed after A) 30 minutes, 8 ) l hour, ) 2 hour , 0 
4 hour and E) 24 hours. Blue represents cell nuclei (DAPI) and green r pr F-actin 
(FITC-phallodin). 
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The F -actin organisation of cells of passage number 12 was also 
investigated on hydrogels containing IOJ.lmol/g of peptide that had been 
deprotected with GST for 0, 1 or 3 days. The cells were fixed and stained after 4 
hours of culture. Cells of passage number 12 on TCP looked identical to cells of 
passage number 6 on TCP but the cells of passage number 12 on RGD-
containing hydrogels had a much greater surface area covered by F-actin 
compared to the respective polymers cultured with cells of passage number 6 as 
shown in Figure 5-59, pl03. The morphology of the F-actin network was again 
"spiky" as shown with cells of passage number 6 but the surface area covered 
and the number of extensions was much greater. The surface area of the polymer 
covered by the F-actin network appears to increase with increasing amount of 
deprotection. This would imply that, whilst the cell culture as assessed by MTT 
assay was not improved by increasing peptide deprotection time, the cell area 
and / or the F-actin network organisation could be improved by increasing 
peptide concentration through increasing peptide deprotection time. 
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Figure 5-59 Adhesion of human dermal fibrobla ts (FI833, pa sage 9) in serum free media 
to A) TCP or poly(GMMA-co-EGDMA-co-MacGR(4-Bbs)GOS) hydrogels containing 
IOJlmoVg of peptide and pre-treated with B) 0 GST, C) I day GST/GSH or D) 3 day 
GST/GSH. Cells were fIXed after 4 hours culture and the nuclei were stained blue with 
OAP! and F -actin was sta ined green with FITC-phallodin. 
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The "spiky" conformation of the cells on polymers containing RGD is 
probably due to strong integrin binding being made at point contacts. The 
remainder of the hydrogel is resistant to protein adsorption and cell contact. Thi 
leads to the formation of actin filaments spanning from the cell nucleus to areas 
of RGD-integrin point contact and not spread in the entire area surrounding the 
cell nucleus . This would also explain why greater numbers of extensions are seen 
when the RGD concentration is increased. Similar "spiky" F-actin organisation 
patterns have been observed in other systems utilising RGD where the substrate 
is highly hydrophilic such as PEG, HEMA81, hydroxyapatite210 and PEG/PEO l1 4. 
Figure 5-60 Rhodamine phalloidin staining for F-actin microfilament bundles in NtH 3T3 
fibbroblasts seeded on PS grafted with GRGDSY using varying amounts of EGAP 
combined with FI08. (c) 1 % EGAP (2.6x102 peptides/cm2). The size bar corresponds to 62 
!lm. Reproduced from Neff et alt•1I4 
t Reproduction of Figure 6c from ' eff, J. A., Tresco, P. A. & Caldwell, K. D. Surface 
Modification for the Controlled Studies of Cell-Ligand Interactions. Biomateria/s 20, 2377-2393 
(1999)" with the permission of Elsevier Ltd. 
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6 Conclusions & Future Work 
The aims of this research were to investigate the effects of inclusion of 
RGD peptides on the ability of biomaterials to support cell attachment, viability 
and normal functions for the purposes of tissue engineering. In particular the 
goals were to determine whether the use of RGD-peptides in a non-integrin 
selective manner was of value in comparison to and in conjunction with the 
strategy of promoting protein adsorption. The hypotheses were that the peptide 
would be effective at increasing the cell attachment and viability on substrates 
with low native abilities but be ineffective at increasing the attachment and 
viability of cells on substrates with a high native ability. Hydrogels synthesised 
from glycerol methacrylate, butyl methacrylate and ethylene glycol 
dimethacrylate were shown to have varying native abilities to attach and sustain 
cells and be suitable targets for RGD incorporation studies. The most appropriate 
method of synthesising the hydrogels was found to be as a thin film formed on 
the surface of PET by UV initiation due to considerations of handling and scale 
of reactions. 
It was speculated that the extent of the improvement and the point at 
which the intrinsic level of the ability of a substrate to adhere cells cannot be 
improved would be affected by the concentration of the peptide. This set the 
requirement that for effective comparison of substances the peptide concentration 
should be identical in substrates of different compositions. A review of current 
literature showed that controlling the peptide concentration by a modification 
synthesis method would be difficult due to alterations in coupling efficiencies 
under varying conditions including the nature of the substrate being modified. To 
keep the concentration of the peptide constant in all materials a copolymerisation 
method of incorporating RGD was selected. Protection for the side chains of 
RGD sequences during polymerisation appears to be a requirement for 
controlling the effective concentration of active moieties as lack of protection 
reduces the effectiveness of the peptide. 
194 
The copolymerisation of an RGD sequence containing standard peptide 
protecting chemistry with methacrylates was investigated. Linear polymers of 
glycerol methacrylate acetonide ester were shown to be deprotected by the same 
conditions required to deprotect the peptide (95% TF A, 4hours) with I ittle side 
chain hydrolysis. Hydrogels synthesised with ethylene glycol dimethacrylate 
were shown to be unstable towards TF A and the cross-linker was replaced with 
divinylbenzene. Hydrogels were synthesised containing the protected peptide but 
the TF A treatment was found to fracture the hydrogels to such an extent that they 
were unsuitable for cell culture purposes. 
The use of enzymatically cleavable protecting groups for the side chains 
of arginine was investigated. Arginine derivatised with the 4-bromobenzyl 
sulphonyl (4-Bbs) protecting group on the side chain was synthesised and 
purified. The removal of 4-Bbs by Glutathione-S-Transferase (GST) was 
investigated and it appeared that the reaction was first order with respect to both 
the GST concentration and the concentration ofthe amino acid. It was also found 
that the reaction reached equilibrium after 24 hours at 37°C. The equilibrium 
position and hence the extent of deprotection depended on the protecting group 
utilised for the amine tenninus of the arginine. It was found that 87% 
deprotection was achieved when Z was used but only 23% deprotection was 
achieved when Fmoc was used as the N-tenninus protecting group. It was hoped 
that, when the peptide was immobilised in a solid, the deprotection reaction 
would be driven to completion by the heterogeneous nature of the reaction. 
Peptides containing the enzymatically cleavable protected arginine were 
synthesised and utilised to make a library of polymers with glycerol methacrylate 
and butyl methacrylate. In serum-containing media glycerol methacrylate based 
polymers containing RGD either with or without a spacer ann were shown to 
promote increased cell spreading at higher concentrations of RGD (1-1 OJ,.lmol/g) 
but the viability assays showed no significant increase in cell number and 
activity. Under the same conditions no differences between peptide containing 
butyl methacrylate hydrogels and non-peptide containing controls could be 
discerned by both visual methods and viability assay based methods. To 
detennine whether the peptide had been fully deprotected after 24 hours reaction 
with GST the behaviour of cells on RGD-containing materials after 0, 1 and 3 
days deprotection with GST was examined. There were no significant differences 
195 
between the cell behaviours on materials that had been deprotected for 1 and 3 
days. However there were also no significant differences between the polymers 
containing peptide that had not been deprotected and those that had. It was found 
that serum-containing media possessed the ability to deprotect the arginine side 
chain of the peptide, probably due to GST or other enzymes in the fetal calf 
serum. 
In serum-free culture concentrations of 1 or lO)..lmol/g of peptide (with 
and without a spacer ann) in glycerol methacrylate hydrogels after 1 days GST 
treatment promoted significant improvement in cell viability and cell spreading. 
The presence of a spacer arm is not necessary for RGD to be effective in random 
cross-linked polymers that are synthesised from small monomeric units. It would 
be interesting to see whether the spacer arm was necessary in block polymers 
synthesised from oligomeric glycerol methacrylate units such as utilised in the 
research by Sun et a1 192• There was no significant alteration in both the cell 
spreading and the cell viability on butyl methacrylate hydrogels when any of the 
peptides were incorporated at any of the concentrations tested. It seems likely 
that the native ability of the BMA gels to promote cell adhesion and viability 
puts these materials above the non-improvement point where RGD is effective 
with the peptide-integrin affinity tested and the concentrations utilised. However 
there are some concerns over the continued presence of the 60J..lm coating during 
cell culture as the coating could have become detached during washing 
procedures. 
The analysis of cell culture on glycerol methacrylate materials that had 
been subjected to different length of time of GST deprotection showed that for 
large concentrations (I O)..lmol/g) maximal cell adhesion occurred after 1 days 
deprotection and further deprotection (3-5 days) did not increase the effect of the 
RGD peptide. For an intermediate concentration (1J..lmol/g) of peptide in glycerol 
methacrylate hydrogels the number and viability of cells cultured on the 
polymers were linearly dependent on the number of days deprotection. Low 
concentrations of peptide «0.1 J..lmol/g) did not promote an increase in cell 
number or viability even after 5 days deprotection with GST. At the 10J.lmollg 
concentration of peptide the cell number and viability was increased over the 
non-peptide containing control, therefore either the peptide has a non-integrin 
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specific effect on the ability of the polymer to adhere cells or the peptide has 
been deprotected by the culture conditions. 
To investigate whether peptides were deprotected by culture conditions 
glycerol methacrylate hydrogels containing the protected peptide sequence 
without a spacer arm were incubated with non-contacting cells in co-culture 
baskets. The adhesion and viability of cells on hydrogels containing Illmol/g was 
significantly increased by pre-treatment with non-contacting cells. A significant 
improvement in cell adhesion and viability was also observed for TCP after pre-
treatment with non-contacting cells, which is likely to be due to the adsorption of 
cell derived proteins. No improvement was observed for non-peptide containing 
controls, which is assumed to be due to lack of ability of the glycerol 
methacrylate hydrogels to adsorb cell derived proteins. The adhesion and 
viability of cells on hydrogels containing 10llmollg was not significantly 
increased by pre-treatment with non-contacting cells however under the same 
conditions no improvement was observed from pre-treatment with GST either. 
This is assumed to be due to a maximum cell response derived from peptide 
deprotection when cells were seeded on non-treated and treated polymers alike. 
From the non-improvement after pre-treatment with non-contacting cells on the 
polymers with high peptide concentration it can be concluded that no protein 
adsorption occurs on any glycerol methacrylate hydrogels regardless of the 
peptide concentration. Thus the improvement in the hydrogels containing 
Illmol/g of peptide after pre-treatment with non-contacting cells is due to 
deprotection of the peptide by soluble cell derived products e.g. GST. 
The promotion of cell adhesion and viability to GMMA hydrogels 
containing RGD peptides was more clearly observed at higher passage numbers 
as the relative cell adhesion and viability was reduced on TCP but maintained on 
the peptide-containing hydrogels. Consequently the results of cell culture on 
GM MA hydrogels containing lO~mol/g ofRGD gave 120% for passage 12 but 
only 60% for passage 6 when expressed as a % of the TCP control via the MTT 
assay. 
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The staining of cells on glycerol methacrylate hydrogels containing 
MacGR(4-Bbs)GDS showed the shape of the F-actin network on the peptide-
containing hydrogels was "spiky" compared to the orthogonal shape shown on 
TCP. It also showed that that the F-actin network was much less developed and 
covered a smaller area on the hydrogels compared to TCP. Cells of passage 
number 12 produced an F -actin network with a larger surface area than cells of 
passage number 6. 
It was shown that the incorporation of the vinyl containing peptide into 
GMMA hydroge!s was low and that the immobilised amounts of peptide were in 
the order of 13-32% that of the nominal peptide concentration. The percentage of 
input peptide that was immobilised was dependent on the input concentration and 
decreased with increasing peptide concentration. Swelling of the hydrogel in 
aqueous media meant that the concentration of the peptide was further diluted 
over a larger volume to give effective peptide concentration of 6-13% that of the 
nominal peptide concentration. The deprotection of the arginine side chain was 
not completely achieved by treatment with GST and consequently the active 
peptide concentration is lower than the immobilised peptide concentration. The 
actual amount of deprotected, active peptide could not be determined as the 
peptide was deprotected by cells, both by cells seeded on the surface and by non-
contacting cells in co-culture baskets. Significant improvements in cell adhesion, 
spreading and viability were observed in GMMA polymers with nominal 
concentrations over 1 J..lmollg, which is equal to or less than O.013J..lmollg active 
concentration. Maximal cell adhesion, spreading and viability was observed on 
GMMA polymers with nominal peptide concentrations of 10J.lmol/g, which is 
equal to or less than 0.13 J..lmol/g active concentration. Assuming an integrin 
penetration depth of 10nm these results would correspond to significant 
improvements in cell adhesion, spreading and viability at less than 0.013 
pmol/cm2 and maximal cell adhesion, spreading and viability at less than 0.13 
pmol/cm2• 
In contrast no improvement in cell adhesion, viability or spreading was 
observed on BMA hydrogels containing any of the peptide concentrations tested 
(up 10J..lmollg nominal concentration). This may be due to decreased active 
peptide concentration compared to the GMMA polymers via reduced 
incorporation efficiency or reduced deprotection efficiency. Alternatively the 
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lack of improvement in BMA hydrogels may be due to the need for larger 
concentrations of peptide to promote cell adhesion or because protein adsorption 
masks the peptide and prevents integrin binding. The active peptide 
concentration as perceived by cells cannot be determined and so the reason for 
the non-improvement in cell adhesion and viability on incorporation of this 
peptide in BMA hydrogels also cannot be determined by this study. This 
unfortunately means that several of the questions posed in the hypotheses are 
unable to be answered. This is a limitation of this method of producing RGD-
modified polymers. However the fact that the peptide utilised promotes maximal 
levels of cell adhesion and viability at concentrations lower than those reported 
in many other studies shows that the protection strategy has preserved the 
activity of the peptide that has been lost in other polymerisation methods. In 
addition the bulk derivatisation means that inaccuracies in determining the depth 
of modification have been eliminated, which is probably why the peptide 
concentration required for maximal cell adhesion is lower than that reported for 
substrates synthesised by modification procedures to polymers. Therefore this 
strategy has some advantages but it could be improved by finding alternative 
enzymatically cleavable protecting groups that can be removed with 100% 
efficiency. Benzyl sulphonamides with electron withdrawing groups ortho/para 
to the sulphonyl are known to be removed by GST and using a substituent that is 
more electron withdrawing that benzene and using more substituents should 
make the removal more effective. A likely candidate for high deprotection 
efficiency would be the 2,4,6-trinitrobenzyl sulphonyl group. As well as the 
removal of arginine side chain residues with GST the protection of other side 
chains followed by enzymatic removal should be possible. Protection of 
carboxylic acid side chains such as those that are found in glutamic acid and 
aspartic acid could be achieved with by esterification. Enzyme catalysed 
hydrolysis of esters is a well documented technique and it should be possible to 
find an enzyme I ester combination that could be utilised as a protection strategy 
for RGD peptides. Ideally the removal of all protecting groups could be achieved 
in one step with a enzyme cleavage cocktail. 
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Whilst the strategy of usmg enzyme deprotection to achieve 
copolymerisable RGD peptides has been successful and produced materials that 
may be suitable for tissue engineering where the peptide has improved cell 
adhesion, spreading and viability it has not been possible to study the effect of 
peptide concentration in different substrates. The effect of varying peptide 
concentration when immobilised against backgrounds of different abilities to 
adsorb proteins would be a valuable contribution to background knowledge for 
tissue engineering. The easiest method to perform this investigation would be to 
modify polymers containing carboxylic group with RGD peptides via N-
hydroxysuccinimide activation. The immobilisation of the peptide into different 
substrates would probably give different concentrations for the same input 
concentration. However utilisation of a large range of input concentrations 
followed by determination of the peptide concentration should result in polymers 
of different compositions but similar peptide concentrations being available for 
comparison. In addition the investigation should look at the cell adhesion, 
viability and other functions at various time points and utilise different primary 
cell types, which are weaknesses ofthe current investigation. 
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7 Materials and Methods 
7.1 Monomer Synthesis 
7.1.1 Synthesis of GMAc 
o 
Figure 7-1 2-methyl-acrylic acid 2,2-dimethyl-[I,3]dioxolan-4-ylmethyl ester (GMAc) 
Solketal was purchased from Sigma-Aldrich and was mixed with toluene 
and then rotary evaporated at 70°C for I hour to remove toluene, water and other 
impurities before use. All other reagents were purchased from Sigma-Aldrich 
and used without further purification. Dry solketal (leq) and (1.6eq) of 
triethylamine (TEA) was mixed with DCM, placed under nitrogen and cooled to 
O°e. Methacryloyl chloride (1.2eq) was added drop wise and reaction was left 
overnight before being quenched with H20. The organic phase was separated and 
DCM removed by rotary evaporation. The crude GMAc was purified by 
distillation under high vacuum (b.p. = 44°C) and stored and -8°C until use. A 
typical reaction used 330g (2.5 mol) solketal, 400g (4.0 mol) triethylamine and 
310g (3.0 mol) methacryloyl chloride with 1 L DCM and I L H20. Purity of the 
product was determined by 1 H NMR. 
lH NMR: 8 1.25 (3H, s, -C8H3), 1.35 (3H, s, -C9H3), 1.85 (3H, s, -C1H3), 
3.70 (lH, m, _C5(H)H_), 3.95 (IH, m, -C5(H)H-), 4.10 (2H, cl, J=5.SHz, -C7H2-), 
4.25 (lH, m, _C6H_), 5.50 (IH, s, =C4HAHB), 6.05 (lH, s, =C4HAHB) 
7.2 Polymer Synthesis 
7.2.1 Materials 
Glycerol methacrylate was purchased from Melrob Service Ltd, UK and 
used without further purification. Butyl methacrylate was purchased from Sigma-
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Aldrich and purified by distillation under reduced pressure prior to use. 
Azobisisobutironitrile (AIBN) was purchased from Sigma-Aldrich and re-
crystallised from methanol prior to use. All other reagents were purchased from 
Sigma-Aldrich and used without further purification. 
7.2.2 Linear Polymer Synthesis 
Linear polymers of 2-methyl-acrylic acid 2,2-dimethyl-[ 1 ,3]dioxolan-4-
ylmethyl ester and butyl methacrylate were synthesised in an ampoule using the 
freeze-pump-thaw method. The monomer or monomers were mixed with IPA or 
methanol and 1 wt % of AIBN. The solution was then placed in an ampoule and 
frozen with liquid nitrogen. The ampoule was evacuated under high vacuum and 
then the solution was allowed to thaw. This was freeze-pump-thaw process was 
repeated 3 times and then the ampoule sealed whilst under vacuum. The ampoule 
was then placed in a water bath at 60°C for 20-24 hours. The contents of the 
ampoule precipitated into diethyl ether, re-dissolved in ethanol and then re-
precipitated into diethyl ether. A typical reaction involved 3.01 06g of GMAc, 
0.3105g of AIBN and 50ml of IPA. 
7.2.3 Hydrogel Synthesis by Thermal Initiation 
Solutions of monomers (glycerol methacrylate, butyl methacrylate), 
cross-linker (ethylene glycol dimethacrylate) and 1 wt % AIBN were placed in a 
sealed container with propan-2-01 (1: 1 mass: volume) and purged with nitrogen 
for a minimum of 20 minutes. The solutions were syringed into moulds and then 
placed in an oven at 60°C overnight. Stock solutions were made up as per Table 
5-1 and were used for all hydrogels made by thermal initiation. 
Polymer GMA BMA EGDMA AIBN IPA 
Mass / g Mass / g Mass / g Mass / g Volume / ml 
100% GMA 22.5694 0 1.1356 0.2250 22.5 
75%GMA, 0.1910 19 
25% BMA 14.2864 4.7673 0.9668 
50%GMA, 0.2789 28 
50% BMA 13.9376 13.9948 1.3974 
25%GMA, 0.3001 30 
75% BMA 7.3848 22.1425 1.4743 
100% BMA 0 20.8981 0.5229 0.2099 20 
Table 7-1 Stock solutIOns used to make bydrogels syntheSised by thermal intitiation. 
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7.2.4 Hydrogel Synthesis by UV Initation 
All UV curing was conducted in a Dymax bond box with a medium 
pressure mercury lamp. The intensity of this system has been determined to be 
30mM/cm2 at 400nm at a distance of 3mm below the reflector. 
Method 1: 
Stock solutions of monomers and cross-linkers (as shown in Table 7-2) 
were mixed with a solution of 1 wt % initiator (2-hydroxy-2-
methylpropiophenone) in IPA were purged with nitrogen for a minimum of 20 
minutes. The solution was syringed into a mould, placed in a dymax bond box 
and irradiated with ultraviolet light for 40 seconds on each side and turned 3 
times (total irradiation time 160 seconds) 
Method 2: 
Solutions of monomers (GMMA, BMA, LMA, HEMA, DMAEM or 
styrene), cross-linker (EGDMA or DVB) and 1 wt % initiator (2-methyl-4'-
(methylthio )-2-morpholinopropiophenone (MMP), 2,2-dimethoxy-2-
phenyl acetophenone (DPP), 2-chlorothioxanthen-9-one (CTX) 2-hydroxy-2-
methylpropiophenone (HMPP) or a 50:50 blend of diphenyl(2,4,6-
trimethylbenzoyl) phosphine oxide (DPO) and HMPP) in a 50:50 mixture of 
glycerol and ethanol were placed in a multiwell plate. The multi-well plate was 
placed inside a box with a quartz window. The box was placed under vacuum 
and then nitrogen repeatedly. After a minimum of 3 cycles the box was placed in 
a Dymax bond box where it was irradiated with ultraviolet light for a maximum 
of 5 minutes (200 seconds) 
Method 3: 
Solutions of monomers (GMMA, BMA or combinations thereof), 2.5 
weight % cross-tinker (EGDMA) and 1 wt % initiator 2-methyl-4'-(methylthio)-
2-morpholinopropiophenone (MMP), 2,2-dimethoxy-2-phenylacetophenone 
(DPP), 2-chlorothioxanthen-9-one (CIX) 2-hydroxy-2-methylpropiophenone 
(HMPP) or a 50:50 blend of diphenyl(2,4,6-trimethylbenzoyl) phosphine oxide 
(DPO) and HMPP) were dissolved in methanol and purged with nitrogen for 20 
minutes in a covered vessel. Typically large scale stock solutions of monomers 
and cross-linkers (as shown in Table 7-2) were made up and stored at -8°C until 
use when they were warmed up to room temperature and weighed before a 
solution of 1% vollvol or weight/vol initiator was added at a ratio of 1 ml per g of 
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monomer solution. The solutions were syringed onto a sheet of material and 
drawn down the sheet using a 60 micron K-Bar. The sheet was then placed a box 
with a quartz window. The box was placed under vacuum and then nitrogen 
repeatedly. After a minimum of 3 cycles the box was placed in a Dymax bond 
box where it was irradiated with ultraviolet light for a maximum of 5 minutes 
(200 seconds). 
GMA BMA EGDMA 
Polymer Mass / g Mass / g Mass / g 
100%GMA 49.2333 0 1.2483 
75 % GMA, 
25% BMA 46.9695 15.6486 1.5654 
50%GMA, 
50% BMA 40.3614 40.317 2.0472 
25% GMA, 
75% BMA 25.4892 76.6554 2.5353 
100% BMA 0 45.0109 1.1249 
... Table 7-2 Stock solutions of monomers used for UV IDltlated polymerisations. 
7.3 Polymer Reactions 
7.3.1 Reaction of Linear Polymers with TFA 
The dried linear polymers of GMAc and BMA produced in section 7.2.2 
were dissolved in neat TF A (20 ml/g) and stirred for 1 or 4 hours at room 
temperature and pressure. A typical reaction used 1.2041g of poly(GMAc) and 
24ml of TF A. The reaction mixtures were precipitated in diethyl ether, filtered, 
re-dissolved in methanol and then re-precipitated into diethyl ether again before 
being dried and analysed by NMR. 
7.3.2 Reaction of Cross-linked Polymers with TF A 
Disks with a diameter of 1.5 cm were cut from sheets of thermally cured 
polymers synthesised by the protocols mentioned in section 7.2.3. The disks were 
washed three times with ethanol and half the disks were dried in a vacuum 
dessicator. Swollen disks had excess ethanol blotted from the surface before 
being placed in TF A (20 ml/g approx.) whereas dried disks were placed directly 
into TFA (20 mllg exact). The disks were allowed to react with the TFA for 4 
hours before they were removed with tweezers and rinsed with ethanol. All disks 
were then washed three times with ethanol. 
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7.4 Amino Acid Synthesis 
7.4.1 Materials 
All reagents were purchased from Sigma-Aldrich and used without 
further purification. 
7.4.2 Synthesis of Z-Arg(4-Bbs) 15 
HO 
4 
5 
Br 
N-Carbobenzoxy-L-Arginine (Z-Arg, leq) was dissolved In 3M 
NaOH(aq) (5ml / g) and acetone (I5ml / g) and then cooled to O°e. 4-
bromobenzyl sulphonyl chloride (3-4eq.) was dissolved in acetone (5ml I g) and 
added drop wise. A typical reaction used S.0388g Z-Arg-OH, 12.2241g 4-
bromobenzyl sulphonyl chloride, I5ml of 3 mol dm-3 NaOH(aq) and a total of 
I25ml acetone. The reaction continued for 2 hrs at O°C followed by 2 hrs at RT 
during which time the pH was monitored and kept at pH 9 or above. The final 
reaction mixture was acidified to -pH 6.5 with saturated citric acid solution and 
the acetone removed by rotary evaporation. Deionised water (I Oml Ig) was added 
and the solution further acidified to -pH3 before the product was extracted into 
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ethyl actetate. The organic fractions were combined, washed with water and 
brine and then reduced in volume to approx. 3ml /g. The product was 
precipitated into ice cold diethyl ether and then left to solidify at -8CC before the 
solvent was decanted off and the final traces of solvent removed under high 
vacuum. 40-50% yield). 
IH NMR: 6 1.55 (2H, m, -C4H2-), 1.80 (2H, m, -C3H2-), 2.15 (2H, rn, -
C5H2-), 3.20 (2H, broad s, _NbH_ / _NaH_) 3.35 (lH, broad s, _NdH_), 3.75 (lH, 
broad s, _NCH_), 4.15 (IH, m, _C2H_), 5.10 (2H, m, -C I2H2-), 7.20-7.40 (5H, m, 
aromatic H's), 7.65-7.80 (4H, m, aromatic H's). 
13C NMR: 627.1 (C\ 29.9 (C\ 36.9 (C\ 40.7 (C2), 110.6 (C I2), 120.7 
_ 129.9 (aromatic C's, C7- IO + C I3-16), 144.2 (Cl I), 157.3 (C6), 174.5 (Cl). 
Elemental Analysis; C: 42.74, H: 4.97, N: 9.36, Br: 15.44, S: 6.46 
(expected C: 45.6, H: 4.18, N: 10.6, Br: 15.20, S: 6.08). 
HPLC-MS ES+: elution time 16.53 minutes (5% ACN: 95% H20 cont. 
0.1 % TF A to 100% ACN gradient over 25 minutes, Omnisphere 5 C 18 column 
250 x 4.6 mm), mass peaks; 530, M(8I Br13C)H+ (25%); 529, M(8I Br)H+ (100%); 
528, MC9Br13C)H+ (23%); 527, MC9Br)H+ (92%). 
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7.4.3 Synthesis of Boc-Arg(4-Bbs) 
HO 
Br 
N-Boc -L-Arginine (Boc-Arg, leq) was dissolved in 3 mol dm·3 NaOH(aq) 
(5mllg) and dioxane (tOml/g) and then cooled to O°e. 4-
bromobenzylsulphonylchloride (3-4eq.) was dissolved in 1,4-dioxane (5mllg) 
and added drop wise. The reaction continued for 2 hrs at O°C followed by 2 hrs at 
R T during which time the pH was monitored and kept at pH 9 or above. The 
final reaction mixture was acidified to -pH 6.5 with saturated citric acid solution 
and the solvent removed by rotary evaporation. Deionised water (IOml /g) was 
added and the solution further acidified to -pH3 before the product was extracted 
into ethyl actetate. The organic fractions were combined and the product was 
extracted in 5% Na2C03. The aqueous fractions were combined, acidified to pH 
3 and then the product was extracted back into ethyl acetate. The ethyl acetate 
fractions were combined, reduced to -5% of the original volume and the product 
was precipitated into diethyl ether. The final white solid was filtered and dried 
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under vacuum. A typical reaction used 5.0093g of Boc-Arg-OH, 11.0123g of 4-
Bbs-CI, 25 ml of3 mol dm-3 NaOH(aq) and a total of75ml dioxane. 
IH NMR: 8 l.45 (9H, s, -C I3H3), 1.50-1.90 (4H, m, -C3H2- / -C4H2-), 
2.05 (2H, m, -C5H2-), 3.15 (2H, broad s, _NbH_ / _NaH_ ) 3.35 (1H, broad s, -
NdH_), 3.75 (lH, broad s, _NCH_), 4.10 (lH, m, _C2H_), 7.55-7.80 (4H, m, 
aromatic H's). 
13C NMR: 8 26.6 (C\ 28.7 (C 13), 30.1 (C3), 48.0 (C\ 57.8 (C2), 81.2 
(C I2), 127.8 (CID), 128.9 (C8), 132.8 (C\ 133.0 (C9), 155.2 (Cl I), 165.0 (C6), 
175.9 (Cl). 
Elemental Analysis; C: 38.44, H: 4.81, N: 10.97, Br: 15.73, S: 6.46 
(expected C: 41.38, H: 5.11, N: 11.36, Br: 16.20, S: 6.50). 
HPLC-MS ES+: elution time 15.60 minutes (5% ACN: 95% H20 cont. 
0.1 % TF A to 100% ACN gradient over 25 minutes, Omnisphere 5 C 18 column 
250 x 4.6 mm), mass peaks; 496.3, M(8I Br13C)H+ (17%); 495.3, M(8I Br)H+ 
(95%); 494.3 MC9Br13C)H+ (23%); 493.3, MC9Br)H+ (100%). 
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7.4.4 Synthesis ofH-Arg(4-Bhs) 
HO 
Br 
7.4.4.1 Removal ofZ from Z-Arg(4-Bbs) with PdlH£ 
Z-Arg(4-Bbs) (1.0566g) was dissolved in methanol (20 ml) and 200mg of 
palladium supported on carbon was added, the flask was then repeatedly 
degassed and purged with nitrogen. A hydrogen atmosphere was introduced and 
the reaction was allowed to stir overnight. The product was precipitated into 
ether and analysed by HPLC-MS. 
7.4.4.2 Removal ofZ from Z-Arg(4-Bbs) with HBr/AcOH 
Z-Arg(4-Bbs) was dissolved in HBr/AcOH (20mllg) and allowed to react 
at room temperature for 2 hours. The volume of liquid was reduced to -10% by 
distillation under reduced pressure and the product was precipitated into diethyl 
ether. H-Arg(4-Bbs) was triturated with 3 x 100ml diethyl ether to remove traces 
of HBr/AcOH. A typical reaction used 3.081Og of Z-Arg(4-Bbs) and 60ml of 
HBr/AcOH. 
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7.4.4.3 Removal of Boc from Boc-Arg(4-Bbs) with TFA 
Boc-Arg( 4-Bbs) was dissolved in TFA (20mllg) and allowed to react at 
room temperature for 2 hours. The volume of liquid was reduced to -10% by 
distillation under reduced pressure and the product was precipitated into diethyl 
ether. H-Arg(4-Bbs) was triturated with 3 x 100ml diethyl ether to remove traces 
ofTFA. A typical reaction used 3.0981g of Boc-Arg(4-Bbs) and 60ml ofTFA. 
IH NMR: b 1.15 (2H, t, -C3H2-, J=7.5Hz), 1.65 (2H, s, -C4H2-), 1.95 (2H, 
s, -C5H2-), 2.95 (2H, broad s, _NbH_ / _NaH_ ) 3.15 (1H, broad s, _NdH_), 3.55 
(lH, broad s, _NCH_), 4.05 (IH, m, _C2H_), 7.85-8.05 (4H, m, aromatic H's). 
\3C NMR: b 26.6 (C\ 27.3 (C\ 48.5 (C\ 51.7 (C2), 125.5 (C IO), 127.7 
(Cs), 128.7 (C\ 131.2 (C\ 156.7 (C6), 170.9 (Cl). 
Elemental Analysis; C: 34.51, H: 4.36, N: 13.11, Br: 20.54, S: 8.0 I 
(expected C: 36.65 , H: 4.36, N: 14.25, Br: 20.32, S: 8.15). 
HPLC-MS ES+: elution time 15.60 minutes (5% ACN: 95% H20 cont. 
0.1 % TF A to 100% ACN gradient over 25 minutes, Omnisphere 5 C 18 column 
250 x 4.6 mm), mass peaks; 496.3, M(SI BrI3C)H+ (17%); 495.3, M(8I Br)H+ 
(95%); 494.3 MC9Br\3C)H+ (23%); 493.3, MC9Br)H+ (100%). 
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7.4.5 Synthesis of Fmoc-Arg(4-Bbs) 
17 
HO 
17 
aNH 
H~Ar 
0==0 
7 
Br 
H-Arg(4-Bbs)-OH (2.49g, 5.65mmol) was dissolved in 6% aqueous 
sodium carbonate (21 ml) and the solution was cooled to O°C. A solution of 9-
fluorenylmethyl succinimidyl carbonate (fmoc-CI),(1.92g, 5.66mmol) in dioxane 
(lOml) was added drop wise and the reaction left to stir for Ih with the ice bath 
removed. The solution was diluted with water (lOOml) and washed with ether (2 
X 50ml) before acidification with saturated citric acid solution (30ml). The 
solution was extracted with ethyl acetate (3 X 100ml) and the combined extracts 
were washed with water (X 2), before drying over MgS04. The dried solution 
was concentrated in vacuo and the desired product precipitated by the addition of 
diethyl ether (3.3g, 89%). 
IH NMR: 8 1.30 (2H, m, -C4Hl-), 1.60 (2H, m, -C3Hl-), 2.15 (2H, m, -
CSH1-), 3.25 (2H, broad s, -NbH_ / -NaH_) 3.30 (IH, broad s, _NdH_), 3.70 (lH, 
broad s, _NCH_), 4.05 (lH, m, -C2H_), 4.20 (lH, m, -C13Hl-), 4.35 (2H, d, 
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JcI2_c13=6.9Hz, _C I2H l _), 7.20-7.40 (6H, m, aromatic H's), 7.65-7.80 (4H, m, 
aromatic H's), 7.95 (2H, d, aromatic H's). 
l3C NMR: cS 29.9 (C\ 31.5 (C3), 45.3(C\ 55.0 (C\ 67.7 (C I2), 127.1 -
133.0 (aromatic C's, C7- IO + C13-19), 144.2 (Cl I), 157.3 (C6), 174.5 (Cl). 
Elemental Analysis; C: 51.86, H: 4.39, N: 9.03, Br: 14.81, S: 6.10 
(expected C: 52.69, H: 4.42, N: 9.10, Br: 15.73, S: 6.46). 
HPLC-MS ES+: elution time 15.60 minutes (5% ACN: 95% H20 cont. 
0.1 % TF A to 100% ACN gradient over 25 minutes, Omnisphere 5 C 18 column 
250 x 4.6 mm). Mass peaks; 619.2, M(8IBr13C2)H+ (9%); 618.2, M(8I BrI3C)H+ 
(32%); 617.2, M(8I Br)H+ (100%); 616.2 MC9BrI3C)H+ (29%); 615.2, MC9Br)H+ 
(86%). 
7.4.6 Synthesis of Fmoc-ADDA 
2 4 8 12 
HO 
o )t 
o 
14 
19 18 
12-aminododecanoic acid (ADDA) was suspended in a 10% Na2C03 (aq) 
solution and cooled to O°C. 1 eq of Fmoc-CI in dioxane (I OmI per g) was 
added273 . The reaction was allowed to wann up to room temperature and stirred 
for 4 hours. The dioxane was removed by rotary evaporation and water (50ml per 
g of ADDA) was added. The solution was acidified to pH 3 by addition of 
concentrated HCL. The product (Fmoc-ADDA) was extracted into ethyl acetate 
that was then dried with magnesium sulphate and the solvent removed to give the 
crude product. This was re-crystallised from acetonitrile to form the pure 
product. A typical reaction used 5.0675g of 12-aminododecanoic acid and 
6.1505g of Fmoc-CI with 125ml of 10% Na2C03 (aq) and 50ml of dioxane. 
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IH NMR: () 1.25-1.60 (18H, m, -CH2-, C3-11 alkyl H's ), 2.15 (2H, s, -
C2H2-), 2.35 (2H, t, JcII-CI2=6.25Hz, -C I2Hz-), , 3.20 (lH, m, _NaH_), 4.20 (lH, 
m, -C I5H2-), 4.35 (2H, d, JCI5-CI4=6.25Hz, -CI4H2-), 7.25-7.80 (8H, m, aromatic 
H's). 
13C NMR: () 24.9-34.0 (C2-11 alkyl C's), 41.9 (C I5), 47.2 (C I2), 68.1 (C I4), 
119.9 -127.6 (aromatic C's, C7- IO + C13-1\ 141.3 (C\3), 145.3(CI). 
Elemental Analysis; C: 72.18, H: 8.29, N: 2.96 (expected C: 74.47, H: 
8.26, N: 3.10). 
HPLC-MS ES+: elution time 18.3 minutes (5% ACN: 95% H20 cont. 
0.1 % TF A to 100% ACN gradient over 25 minutes, Omnisphere 5 C 18 column 
250 x 4.6 mm). Mass peaks; 452.8, MH+ (100%); 453.8, M(13C)H+ (25%). 
7.5 Synthesis of Peptide Sequences 
7.5.1 Materials 
All amino acids were purchased from Merck Biosciences and used 
without further purification. 1-(Mesitylene-2-sulfonyl)-3-nitro-l H-l ,2,4-triazole 
(MSNT), 2-( 1 H-Benzotriazole-l-yl)-I, I ,3,3-tetramethyluronium 
hexafluorophosphate (HBTU), N-Hydroxybenzotriazole H20 (HOBt), 
Benzotriazole-I-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate 
(PyBOP). 4-dimethylaminopyridine (DMAP) and diisopropylcarbodiimide (DIC) 
were purchased from Merck Biosciences. All other reagents were purchased 
from Sigma-Aldrich. 
7.5.2 Resin Loading 
Established protocols for estimating the initial resin loading were found 
to be unsatisfactory so the following protocol was developed. 
Samples of the resins were removed and washed with absolute alcohol 
then dried in vacuum oven at RT for a minimum of 24hrs. 10mg aliquots of the 
resin were weighed into a 10ml volumetric flask and the volume made up with 
20% piperidine in DMF. The samples were left for a minimum of 4 hours with 
periodic shaking. Readings of the absorbance at 290nm were taken at 20 minute 
intervals to ensure the deprotection was complete. The equation below was used 
to determine the approximate loading of the resin. 
Loading in mmol per gram = Absorbance / (weight in mg * 0.525) 
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7.5.3 Deprotection and Monitoring 
Fmoc protecting groups were removed with 20% piperidine in DMF for 3 
minutes and then 7 minutes using fresh reagents during which time the resin was 
agitated using N2 gas. The deprotection was assessed by use of the picryl sulfonic 
acid test. A few resin beads were removed, washed with DMF and then 
suspended in fresh DMF. Two drops each of picryl sulfonic acid solution and 
10% diisopropylethylamine (DIPEA) in DMF were added and colour allowed to 
develop for 5 minutes. The solvent was decanted off and the resin washed with 
DMF. A dark red indicated the presence of free amines and showed the 
deprotection process was complete. The effectiveness of coupling reactions were 
also assessed using the picryl sulfonic acid test whereby the lack of red colour 
showed the completeness of the coupling step. 
7.5.4 Protected Peptides 
Protected peptide sequences were synthesised using the rink acid labile 
resin (0.6-0.8mmol /g capacity) with Fmoc protected amino acids. 
7.5.4.1 Resin Loading 
The resin was swelled in DCM for a minimum of 24hrs prior to use and 
placed under nitrogen before coupling the first amino acid. Excess DCM was 
removed from the resin and 5eq of the amino acid, 5eq of MSNT, 3.75 eq of 
methyl imidazole and DCM (10ml per g of resin) were mixed together under 
nitrogen and then added to the resin. The coupling was allowed to proceed for 1 
hour before the resin was washed with DCM x 3, DMF x 3, DCM x 3 and MeOH 
x 3. The resin was dried and the resin loading estimated using the procedure 
above. 
7.5.4.2 Chain Elongation 
Fmoc deprotections were carried out as per the protocol in section 7.5.3 
above. Subsequent amino acids were coupled to the growing sequence using 
standard PyBOP protocols of 5 eq. of the amino acid, 4.geq. PyBOP, 5eq. HOBt, 
10eq. DIPEA and tOml DMF per gram of resin. The coupling reaction was 
allowed to proceed for 30mins upon which time it was tested by the picryl 
sulfonic acid test described previously. If the test showed partial red colouring 
the reaction was allowed to proceed for a further 30mins before being tested 
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again. If the test was still showing partial free amines the resin was washed and 
the procedure repeated with fresh reagents. 
7.5.4.3 Cleavage of Peptide from Resin 
The resin was washed with DCM and then 1% TF A in DCM (I Oml per g 
of resin) was added. The mixture was agitated by N2 gas for 2 minutes and the 
solution was run into 10% pyridine in methanol (2ml per g of resin). This was 
repeated a further nine times and then the resin was washed with DCM then 
methanol. The extracts were combined, reduced in volume and precipitated into 
ice-cold hexane. 
7.5.5 Non-Protected and Partially-Protected Pep tides 
Peptides without protecting groups or with just the 4-bromobenzene 
sulphonyl protecting group on the arginine were synthesised using a Wang resin 
with a nominal resin loading of 1.1 mmol/g and Fmoc amino acid protection. 
7.5.5.1 Resin Loading 
The resin was swelled in DMF for a minimum of 24hrs prior to use and 
placed under nitrogen before coupling the first amino acid. A symmetrical 
anhydride was made by dissolving 10eq of the first amino acid in dry DCM, 
cooling to O°C and adding 5eq of DIe. The reaction was stirred for 20minutes 
and then the DCM was removed by rotary evaporation. The symmetrical 
anhydride was dissolved in DMF (1 Oml per g of resin) and added to the resin 
from which excess DMF had been removed. 0.1 eq of DMAP was added to the 
resin and allowed to react for 1 hour. 
7.5.5.2 Chain Elongation 
Fmoc deprotections were carried out as per the protocol in section 7.5.3 
above. Subsequent amino acids were coupled to the growing sequence using 
standard HBTU protocols of 5 eq. of the amino acid, 5eq. HBTU, 5eq. HOBt, 
lOeq. DIPEA and 10ml DMF per gram of resin. The coupling reaction was 
allowed to proceed for 60mins upon which time it was tested by the picryl 
sulfonic acid test described previously. If the test showed partial red colouring 
the resin was washed and the procedure repeated with fresh reagents. 
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7.5.5.3 Cleavage of Peptide from Resin 
The resins were washed with DCM and methanol and dried prior to 
cleavage to remove all traces of DMF. Peptides were cleaved from the resin 
using a cleavage cocktail of 95% TF A, 2.5% water and 2.5% triisopropylsilane 
(TIS) (10 ml per g of resin) for I hour. The resin was washed with 1 x cleavage 
cocktail,3 x DCM and 3 x ACN. The solvents and TFA were stripped off in a 
distillation type procedure and the peptide was precipitated into diethyl ether. 
The products were isolated by centrifugation of the solidldiethyl ether mixture 
then filtration of the solid followed by re-precipitation from methanol into 
diethyl ether and centrifugation. The final solid was filtered and dried under 
vacuum for 24 hours before being stored at -8°C until use. 
7.5.6 Analysis and Purification of Peptide Sequences 
All HPLC analyses were done using a Waters 2690 separation module 
with a Waters 996 photodiode array detector and an Omnisphere 5 C 18 column 
(250 x 4.6 mm) unless otherwise stated. A gradient of 95% water (containing) 
0.1 % trifluoroacetic acid): 5% acetonitrile to 100% acetonitrile over 25 minutes 
was employed. A Micromass Platform LCZ mass spectrometer was used to 
analyse the traces. Peptides that were determined to have a purity of less than 
90% after precipitation from diethyl ether were purified by preparative reverse 
phase HPLC. 
7.5.6.1 Fully protected peptides 
MacGR(Pbf)GO(tBu)S(tBu) 
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HPLC-MS ES+: elution time 11.81 minutes (5% ACN: 95% H20 cont. 
0.1 % TF A to 100% ACN gradient over 25 minutes, Omnisphere 5 C 18 column 
250 x 4.6 mm). This analysis was performed on a Varian Star HPLC machine. 
923.1 MH+ (100%); 924.1 M( I3C)H+ (42%). 78% purity by integration of peaks 
generated by detector at 254nm before preparative HPLC, 91 % purity after 
purification. 
o 0 yo/\_~O 
'···l' 
'~It" '~I~yl::y. OH 
J HN~NH MacAddaGR(Pbf)GD(tBu)S(tBu) ~(L' 
HPLC-MS ES+: elution time 11.81 minutes (5% ACN: 95% H20 cont. 
0.1% TFA to 100% ACN gradient over 25 minutes, Omnisphere 5 C18 column 
250 x 4.6 mm). This analysis was performed on a Varian Star HPLC machine. 
1120.8 MH+ (100%); 1121.8 M( I3C)H+ (55%). 91% purity by integration of 
peaks generated by detector at 254nm. 
7.5.6.2 Partially Protected peptides 
J A~J M acGR(4-Bbs)GDS ,~ ~Ay~) '" 
HO 
MacGR(4-Bbs)GDS: HPLC-MS ES+: elution time 11.65 minutes (5% 
ACN: 95% H20 cont. 0.1 % TF A to 100% ACN gradient over 25 minutes, 
Omnisphere 5 C 18 column 250 x 4.6 mm). Mass peaks; 781.1, M(81 Br\3C2)H+ 
(12%); 780.1, M(8I BrI3C)H+ (39%); 779.1, M(8I Br)H+ (100%); 778.1 
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MC9Br13C)H+ (31 %); 777.1, MC9Br)H+ (92%). 93% purity by integration of 
peaks generated by diode array. 
o ~~t~\~~\o" 
HN A MacAddaGR(4-Bbs)GDS 
HN NH 
I 
Br 
0 50, 
MacAddaGR(4-Bbs)GDS: HPLC-MS ES+: elution time 15.67 minutes 
(5% ACN: 95% H20 cont. 0.1 % TF A to 100% ACN gradient over 25 minutes, 
Omnisphere 5 C18 column 250 x 4.6 mm). Mass peaks; 978.3, M(81 Br13C2)H+ 
(17%); 977.3, M(81 BrI3C)H+ (48%); 976.3, M(81 Br)H+ (100%); 975.3 
MC9Br13C)H+ (39%); 974.3, MC9Br)H+ (81 %). 64% purity by integration of 
peaks generated by diode array before preparative HPLC, 96% purity after 
puri fi cati on. 
7.6 Investie;ation of GST deprotection 
7.6.1 Materials 
All materials were purchased from Sigma-Aldrich and used without 
further purification. 
7.6.2 Determination of GST Deprotection by Sulphite Assay 
Solutions containing 500~M of reduced glutathione (GSH), 0.05-
0.5mg/ml glutathione-S-transferase (GST) and 0-500~M of protected arginine 
derivatives were produced from stock solutions of the relevant compounds and 
made up to lml with lO~mol dm-3 potassium phosphate buffer (PPB, pH 7.4). 
GSH stock solutions were made up weekly and stored at 3-4°C, GST stock 
solutions were made up in Sml batches and frozen in aliquots until use. 
The solutions were incubated at the relevant temperatures for a set 
amount of time upon which they were analysed immediately by the methods 
detailed below. 
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An assay for sulphite formation utilising pararosaniline/formaldehyde as 
used by Zhao et al. and published by Leinweber et al. was also utilised to detect 
the removal of the protecting group274,275. A stock solution of 0.3035g of 
pararosaniline HCL dye was made up with 10ml of ethanol. 1.6ml of this 
solution and 4.4ml of concentrated sulphuric acid were combined and made up to 
100ml with ultra-pure water. O.4ml of 40% aqueous formaldehyde was added 
along with 200mg of activated charcoal to form the assay solution, which was 
made fresh each day. 
500~1 of each Z-Arg( 4-Bbs) incubation with GST or sulfite standard was 
added to 200~1 of saturated Hg(II)CI(aq) solution and centrifuged to precipitate 
the insoluble GSH. 250~1 of the supernatant was added to 1 ml of the assay 
solution in a disposable cuvette. The colour was allowed to develop for 15 
minutes exactly before being read at 570nm. 
Sulphite standards each containing 500~mol dm-3 of GSH, of 0, 50, 100, 
200, 500 and I 000 ~mol dm-3 of sodium sulfite were prepared and formed a 
linear correlation graph. 
7.6.3 Determination of GST Deprotection by HPLC 
The enzyme incubation solutions were made up as before (section 7.6.3) 
except that O-IOOO~mol dm-3 of a reference amino acid was also included. The 
reference amino acid was incorporated from a stock solution made up with 
methanol or acetonitrile. 
All HPLC analyses were done using a Waters 2690 separation module 
with a Waters 996 photodiode array detector and an Omnisphere 5 C 18 column 
(250 x 4.6mm). A gradient of 95% water (containing) 0.1 % trifluoroacetic acid): 
5% acetonitrile to 100% acetonitrile over 25 minutes was employed with a 25min 
downwards gradient included where enzyme was present to wash the enzyme 
from the column. The amino acids were detected using a photodiode array from 
200 to 320nm. The concentration of the arginine derivative amino acid was 
determined by integrating the peak areas and using the ratio of peak areas to 
determine the concentration from a calibration chart. The calibration charts were 
formulated using 0, 20, 40, 60, 80, 100, 200, 300, 400 and 500~M solutions of 
the amino acid with 50, 100, or 1 OOO~M of the reference amino acid and 
500mmol dm-3 ofGSH. 
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7.7 Peptide-Containing Hydrogel Synthesis 
7.7.1 Synthesis of polymers 
Stock solutions of the peptides were made with methanol to a 
concentration of 10 picomoles / ml. These stock solutions were diluted with 
methanol to form solutions with concentrations of 1, 0.1 and 0.01 pmol/m!. Stock 
solutions of monomers, cross-linker and 1 wt% initiator were made up and stored 
at -8°C in the dark until use. Peptide and monomer stock solutions were 
volumetrically measured (volumes adjusted for density) and combined 
immediately prior to use. Thermally cured polymer sheets were synthesised as 
described in section 5.3.3 and UV cured polymer thin-films were synthesised as 
described in section 5.1.2. 
7.7.2 Enzyme Deprotection of Peptides 
Disks of polymers were cut out and placed into 24 well plates in a sterile 
culture hood. The disks were washed three times with ethanol and three times 
with PBS. A stock solution of GST 1 mg/ml and GSH 10mmol dm·3 in PBS was 
made up and then filter sterilised. The stock solution was diluted by a factor of 
20 with sterile PBS resulting in a final concentration of GST 0.05mg/ml and 
GSH 500 flM. The final enzyme-containing solution was added to wells 
containing polymers (0.5 mllwell) and these were placed in an incubator at 37°C 
and 5% C02 for a set time period. After the enzyme incubations were complete 
the polymers were washed three times with PBS and twice with serum free 
media prior to cell culture. 
7.8 Cell Culture 
All materials were obtained from Sigma-Aldrich UK. Deionised water 
was used throughout. Dulbecco's modified eagles media (DMEM) supplemented 
with 2xlO-3 mol L-1 glutamine, 0.625 flg mrl amphotercin B, 100 I.U. ml 
penicillin and 100 flg mrl streptomycin was routinely utilised for all 
experiments. In addition where serum containing media was utilised 10% v/v 
fetal calf serum was added. 
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7.S.1 Cell Maintenance 
Fibroblasts were obtained from human skin obtained from patients 
undergoing elective surgery who gave informed consent for skin not required for 
their treatment to be used for research (as detailed in reference276). Skin was 
placed in 0.1 % trypsin w/v overnight before the epidermis was peeled from the 
dermis. This dermis was washed in phosphate-buffered saline (pH 7.2), finely 
minced and then placed in 0.5% collagenase-A at 37°C for 16 h. Cells were then 
cultured in DMEM media supplemented with 10% v/v neonatal calf serum, 2x 1 0-
3 mol L-1 glutamine, 0.625 mg mrl amphotercin B, 100 i.u. ml penicillin and 100 
mg mrl streptomycin. Cells were passaged routinely using 0.02% (w/v) EDTA 
and used for culture on polymers between passage numbers 5 and 12. 
7.S.2 Cell Culture on Polymers 
Cells were harvested at -90% confluency by incubating with trypsin until 
cells were detached. Serum-containing media was added to neutralise the trypsin 
and the cell suspension was centrifuged and the media containing trypsin was 
decanted. After harvesting cells were suspended in the appropriate media (either 
serum free or containing 10% FCS). The concentration of cells was determined 
by mixing 20J.lL of the cell suspension with 20J.lL of tryphan blue and counting 
the number of live cells in a known volume using a haemocytometer. The cell 
suspension was diluted to give an appropriate volume that would contain 100,000 
cells (20-40J.lL). This volume was applied to each well containing polymer or 
control substances and the cells were allowed to adhere for 20 minutes. After this 
time 1 ml of the appropriate media was applied to the wells and the cells were 
incubated for a set time period after which time the cells were photographed 
through a phase contrast microscope and/or analysed via the MTT assay. 
7.8.3 Competition with Soluble RGD 
A solution of 1 mg/ml GRGDS in serum-free media was prepared. After 
24 hours of cell culture as described above the media was removed from all 
wells. 0.5ml of GRGDS containing media was added to half of the wells and 0.5 
ml of serum free media was applied to the other half of the wells as a control. 
Photographs of the cells were taken at 0, 15, 30, 45 and 60 minutes after the 
application of the GRGDS-containing media through a phase contrast 
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mIcroscope. After 60 minutes the cells were analysed by the MTT assay as 
described below. 
7.8.4 Incubation with Non-Contacting Cells 
Cells were harvested at -90% confluency by incubating with trypsin until 
cells were detached. Serum-containing media was added to neutralise the trypsin 
and the cell suspension was centrifuged and the media containing trypsin was 
decanted. After harvesting cells were suspended in serum free media. The 
concentration of cells was determined by mixing 20llL of the cell suspension 
with 20llL of tryphan blue and counting the number of live cells in a known 
volume using a haemocytometer. The cell suspension was diluted to give an 
appropriate volume that would contain 100,000 cells (20-40IlL). This volume 
was applied to a co-culture basket suspended in a well above a polymer or 
control substances and the cells were allowed to adhere for 20 minutes. After this 
time 1 ml of the appropriate media was applied to the wells and the cells were 
incubated for a set time. After this time the co-culture baskets were removed and 
the polymers were sterilised with ethanol to kill any cells that had migrated onto 
the surface. The surfaces were washed x 3 with ethanol and then normal cell 
culture was performed on the polymers as per section 7.8.2. 
7.8.5 MTT Assay 
Cells were washed with PBS and then 1 ml of MTT solution was added 
(0.5 mg MTT / ml PBS) to each well. The cells were incubated at 37°C and 5% 
CO2 for 40 minutes. The MTT solution was removed and 300llL of ethoxy 
ethanol was added to each well to solubilise the formazan colour formed by the 
assay. lS0llL of ethoxy ethanol was removed from each well and placed in a 96 
well plate. The absorbance at 540 nm was read using a Dynatech MRSOOO plate 
reader with a reference wavelength of 630nm. 
7.8.6 Histology 
After a set time point (30mins, 1,2,4 or 24 hours) cells were washed with 
PBS and then fixed for 10 minutes with 10% formalin in PBS. The cells were 
washed with PBS x 3 and then 0.1 % triton was added for 10 minutes to 
permeabilise the cell membranes. The cells were again washed with PBS x 3 and 
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then 250J..lI of 4' ,6-diamidino-2-phenylindole dihydrochloride (DAPI) solution 
(300nM in PBS) was added for 20 minutes. Following a further 3 PBS washes a 
solution of FITC-phalloidin (0.5J..lg/ml in PBS containing 1% methanol) was 
added for 5 minutes. After a further 3 PBS washes the cells were observed 
visually using epi-fluorescence microscopy using an ImageXpress® automated 
cellular imaging and analysis system (DAPI Aex = 358 nm, Aem = 461 m; FITC 
Aex = 490 nm, Aem = 523 nm; Axon Instruments, CA, USA). 
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